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Abstract   
 Intestinal ischaemia especially in the postoperative period is a complication that is 
dreaded by all general surgeons and poses a considerable rise in mortality and morbidity of 
patients, not to mention the burden it puts on the physician and on the healthcare system. Its 
diagnosis is always subjective relying mostly on the physicians’ awareness and clinical suspicion 
rather than on any quantitative method. This project explores a quantitative tool and adapts 
online rapid sampling microdialysis (from its use in monitoring brain tissue ischaemia) to 
monitor ischaemia in human bowel and bowel anastomosis. It describes its translation from the 
bench top model, to the pilot model, to the animal model, and finally its application in the 
clinical setting to monitor patients for bowel ischaemia. 
 The online microdialysis analyzer used in monitoring brain tissue in Kings College 
Hospital was modified and converted for use in the setting to monitor bowel in the labs of the 
Bioengineering Department at Imperial College London, under collaboration with the 
Department of Bio Surgery and Surgical Technology. The system was designed and construction 
supervised by Dr. Martyn Boutelle; and work on the system to construct and optimize carried out 
by PhD student Emma Corcoles. The clinical collaborate of the project was supervised by 
Professor Ara Darzi and carried out by Mr. Samer Deeba with joint supervision by Professor 
George Hanna. The catheter, connections, and deployment was optimized at St. Mary’s Hospital, 
part of Imperial College NHS trust.   
This project did prove the efficacy of microdialysis in monitoring bowel ischaemia in the 
clinical setting, but needs further work and development in the design of the catheter and 
miniaturizing the analyzer to be more reliable and robust. Multicenter trials are needed to gain its 
wide acceptance in the clinical practice. 
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Chapter 1 
 
Introduction 
 
 
 
This chapter explains the background of intestinal ischaemia and its effect in the clinical setting 
on patients and on the difficulty in diagnosis. It also demonstrates what is available in the market 
to study intestinal ischaemia in patients quantitatively focusing on the need of such a tool to the 
physician  
It then explores the available technology of Microdialysis both in research and in clinical 
applications in the human body systems with emphasis on the gastrointestinal system up to this 
present date. 
It concludes by stating the hypothesis we proposed and the project designed to defend and prove 
this hypothesis true.  
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1.1. Bowel Ischaemia: Ischaemic Colitis: 
1.1.1. Vascular anatomy of the colon 
The pathophysiology of ischaemic colitis is best appreciated when the vascular anatomy 
of the colon is well identified. The large intestine, better referred to as the colon, has its blood 
supply derived from branches of both the superior mesenteric artery (SMA) feeding the midgut 
and from the inferior mesenteric artery (IMA) feeding the hindgut, and some branches of the 
internal iliac artery  distally supplying the middle and distal rectum. 
The SMA arises anteriorly from the aorta at the level of the first lumbar vertebra and 
supplies the small intestine all the way to the terminal ileum; it also continues to supply the colon 
to the level of the distal one third of the transverse colon. The ileocolic branch of the SMA arises 
towards the terminal end of the SMA on the right side and gives of  5 terminal branches to the 
terminal ileum (ascending and descending ileal branches), appendix (appendiceal branch), and 
the cecum (anterior and posterior branches). The right colic artery divides to form the ascending 
and the descending branches that supply the larger portion of the ascending colon or the right 
colon. The origin of the right colic artery off the SMA is variable and is absent in around 2-
18%.
1, 2
The middle colic artery originates proximally from the SMA posterior to the body of the 
pancreas and traverses through the transverse mesocolon towards the hepatic flexure. Close to 
the colon it divides into a right and left branch. The right branch anastomoses with the right colic 
artery and the left branch with the artery branching from the left colic. The middle colic artery is 
not present in 20% of patients.
3
 All the above anastomoses form an arcade better known as the 
meandering artery of Drummond, also referred to as the marginal artery.  The marginal artery is 
a major contributer to collateral blood supply to different parts of the colon when the major 
feeding vessel is compromised in any disease process. 
21 
 
The IMA arises from the abdominal aorta at the level of the third lumbar vertebra after 
the origin of the renal arteries and about 5 centimeters below the lower edge of the third part of 
the duodenum. It traverses to the left lateral side about 7 cms before it divides into a left colic 
artery supplying the distal transverse colon and descending colon, and joining the left branch of 
the middle colic to form the above mentioned artery of Drummond. Its other branches are the 
descending branch, and the sigmoidal artery. The sigmoidal artery supplies the distal descending 
colon and the sigmoid colon, and the IMA descending branch continues to form the superior 
rectal artery supplying the upper one third of the rectum. The middle and distal thirds of the 
rectum are supplied by the middle and inferior hemorrhoidal arteries, respectively, which are 
branches of the internal iliac artery.  
 
Figure1.1: Vascular anatomy of the colon and the respective feeding arteries. Illustartion by TT from 2. 
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The connections mentioned above between the SMA, IMA , and internal iliac artery 
branches are of clinical importance especially to the colorectal surgeon and patients.
2
 The 
marginal artery of Drummond
4
 is close and parallel to the wall of the colon, and it is formed by 
branches from the IMA and the SMA, so of clinical relevance is that if one circulation is 
compromised the colon still survives from the other through collaterals mainly the artery of 
Drummond. To the surgeon, and after resecting part of the colon such as the sigmoid, the 
anastomosis constructed relies on the marginal branch and collaterals of the SMA circulation to 
survive since the main blood supply of the remaining descending colon, which is the proximal 
limb of the anastomosis, has been tied off surgically as with what happens in oncologic 
resections. The collaterals that exist between the IMA and the internal iliac arteries (IIA) seem to 
be of less clinical importance. They occur mainly through the superior (branch of IMA) and 
middle rectal arteries (branch of IIA). The distal rectum has a considerate amount of collaterals 
in the mesorectum from the IIA.
2
 
1.1.2. Etiology and pathogenesis of ischaemia: 
There are several factors that are responsible for the regulation of the blood flow of the 
colon: local autoregulatory mechanisms, extrinsic influences, demand of the tissue according to 
its needs like motility and metabolism, and circulating as well as local humoral agents. The main 
cause of ischaemia of the colon is a mismatch between supply of blood bringing in oxygen and 
nutrients and demand to these by the tissue. This balance between supply and demand can be 
affected by changes in the systemic circulation, and anatomic or functional changes in the 
mesenteric blood flow such as states of hypoperfusion, anatomic artery occlusion, or generalized 
states of artery vasospasm leading to decreased blood flow into the tissue. The colon and 
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especially the mucosa is not that resistant to ischaemia and we usually start witnessing changes 
in the mucosa within ten minutes of ischaemia.
5
  
Disruption of the blood supply to the colon can be attributed to numerous pathologic 
processes such as trauma, thrombosis, and embolization of the mesenteric arteries. Certain 
operations are associated with an increased risk of ischaemic colitis like aortic repair operations 
where the risk is in the range of 5-9% in elective cases and up to 60% in emergency ruptured 
cases.
6
 The extent of the ischaemiain the affected segments  depend on the proximity of the 
vessels’ occlusion; lesions closer to the IMA origin manifest clinically with descending/sigmoid 
colon necrosis, while distal lesions further in the  branches  of the main arteries manifest with 
patchy necrosis or ischaemia pending necrosis if there is adequate blood collaterals supplying 
that area. Venous outflow obstruction is uncommon and is more associated with pelvic 
trauma/surgery patients with hypercoagulable states like a malignancy, portal hypertension, and 
pancreatitis. Vasospasm resulting in ischaemia is usually the result of profound systemic insults 
causing intense vasoconstriction of the mesenteric feeding vessels as a response to the ensuing 
hypotension and in response to try to make up by increasing the systemic vascular resistance in 
an attempt to increase the systemic pressure. Certain medications can also precipitate that like 
diuretics, digitalis, catecholamines, and cocaine. Large bowel obstruction can also predispose to 
ischaemia like in cases of tumours, fecal impaction, adhesions, volvulus, and diverticular 
disease.
7
 
Several regional factors predispose the colon for ischaemia. The colon has less blood 
perfusion per 100gram of tissue than the rest of the gastrointestinal tract
8
 and hence there is less 
reserve of blood flow to mobilize in the situations where reserve is needed. Another factor is the 
presence of the extensive network of capillary anastomosis in the muscularis and submucosal 
24 
 
layers, which is less developed, in the thick colon than in the thin small bowel hence contributing 
to the attenuation of collateral flow when needed. The right colon is more susceptible to 
ischaemia because it possesses longer vasa recta (small terminal blood vessels) which are more 
predisposed to vasospasm than the short left colon vasa recta. Another factor experimentally 
shown to increase the predisposition of the colon to ischaemia is the accompanying decrease in 
blood flow as the colon is contracting which is the total opposite to what happens in the small 
bowel during contraction and digestion, hence increasing the chances of the colon to become 
ischaemic. Patients known to be on non-steroidal anti-inflammatory drugs are also more prone 
than others to develop ischaemic colitis by inhibiting the cyclooxygenase pathway hence 
diverting the metabolism of arachidonic acid into the vasoconstrictor leukotrienes.
9
 These 
vasoconstrictor inflammatory mediators along with free radicals formed can cause vascular 
insufficiency and ulceration of the mucosa.
10
 
1.1.3. Types and distribution of ischaemic colitis(IC). 
There are two types of IC: The nongangrenous (85%) and the gangrenous type (15%).
7
 
The nongangrenous type involves the mucosa, submucosa, and even the muscularis; whereas the 
gangrenous type is transmural. If ischaemia involves the first two layers of the bowel wall then it 
heals with no consequence, if the muscularis is involved then it heals with a stricture formation, 
and if it is transmural then surgical excision is mandatory. 
11, 12
 
In 70- 75% of patients presenting with IC; the left colon and/or rectum are affected.. The 
splenic flexure constitutes about 20 % and the right colon about 10%. Ligation of the IMA 
usually involves the descending colon and the sigmoid, whilst systemic low flow states present 
as IC in the retroperitoneal part of the right colon. Non-occlusive ischaemianormally affects 
watershed areas such as the splenic flexure and the rectosigmoid junction.
8, 13
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1.1.4. Clinical Presentation. 
The clinical presentation is a spectrum of symptoms ranging from nonspecific abdominal 
pain for the nongangrenous mucosal ischaemia to full-blown sepsis and acute surgical abdomen 
for the gangrenous type because of colon wall perforation. The extent of the ischaemia varies 
according to severity, extent, and rapidity of the insult. Ischaemic insults as a consequence of 
embolic phenomena have a quicker and more intense clinical presentation than insults as a 
consequence of chronic atherosclerotic vascular insufficiency which have a more insidious onset 
and usually the colon develops vascular collaterals by the time atherosclerosis totally obstructs 
its main supply which is in this case the IMA. 
Self-limiting nongangrenous IC is usually the case. Typically the patients are above 60 
years of age with no previous abdominal complains. 
11, 13, 14
 A recent study by Park et. al from 
Hallym medical center in Seoul, South Korea was performed on 467 patients to identify risk 
factors that predispose to IC. They identified that positive predictors include: old age, 
hemodialysis, hypertension, diabetes mellitus, hypoalbuminemia, and the use of constipation 
inducing medications are risk factors for developing IC in patients presenting with lower 
abdominal pain with or without bloody diarrhoea.
15
 
The presentation of the patient is that of abdominal pain, diarrhoea, change in bowel 
habits, and occasionally passage of blood per rectum. If bleeding is profuse then the diagnosis of 
IC should be questioned and other causes should be ruled out. The pain is usually sudden in 
onset and localizes to the left lower quadrant, and is crampy in nature associated with an urge to 
defecate; nausea, vomiting, and loss of appetite are common. Examination reveals stable 
cardiovascular parameters with low grade fever, mild abdominal distention and tenderness 
localized to left iliac fossa. Digital rectal examination reveals some blood on the gloves. 
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Laboratory results reveal some leukocytosis with a shift to the left. These symptoms are usually 
self-limited and resolve spontaneously. From this group of patients some might progress to the 
chronic form of the disease, and these include the patients with the older age group, longer 
resolution periods, and longer time for the laboratory results to normalize.
7
 
The other group will be the patients presenting with full thickness gangrenous IC. The 
presentation is that of signs and symptoms of an abdominal catastrophe with full-blown sepsis 
and shock. The presentation is much more acute than the previous group. The patient usually has 
higher fevers and has cardiovascular instability with tachycardia and hypotension. The 
abdominal examination is that of a board like abdomen that is tender in all quadrants and 
eliciting all signs of peritonitis. Gangrenous IC often manifests in chronically hospitalized 
patients especially in high dependency units and may not show its symptomatology because of 
the debilitated state the patient is in from the original illness. So, the physician must always keep 
a high index of suspicion in these patients and should always question bowel viability when 
other causes of sepsis are ruled out.
16
 
Both gangrenous and non gangrenous types are being more frequently seen in young 
patients and a high index of suspicion should be present in these contexts: coagulopathies
11
, 
sickle cell disease
17
, vasculitis
18
, use of vasoactive medications
9, 19
, marathon runners
20
, and 
cocaine abuse.
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1.1.5. Diagnosis. 
The physicians’ high index of suspicion in the right clinical presentation and scenario 
remains the best adjunct to early diagnosis and management of IC. Serial physical examination 
complemented with serial radiologic and endoscopic studies is the mainstay of diagnosis. A 
patient suspected with nongangrenous IC with no signs of systemic sepsis, negative findings on 
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abdominal films, and a physical examination showing localized signs in the left lower quadrant 
is best confirmed with the diagnosis using colonoscopy. Patients are suspected of gangrenous 
forms of the disease if they have a septic presentation, abdominal films showing air under the 
diaphragm (perforation of the colon), air within the bowel wall, or portal venous air, and a 
physical examination suggestive of an acute abdomen. These patients usually have an infarcted 
colon wall and must be taken to an explorat laparotomy straight away.
22
 Serum markers like 
lactate and lactate dehydroginase levels are non specific but can be used as a follow up after the 
diagnosis has been confirmed using other modalities.
23
 Plain abdominal films or contrast films 
using barium enema can be used but have fallen out of routine ever since CT scan was more 
widely used in the eighties. The physician should bear in mind that the use of barium as a 
contrast can cause further contamination in the abdominal cavity in patients that have a 
perforation or even cause a iatrogenic perforation.
24
 Abdominal ultrasound can help in diagnosis 
and relies on nonspecific findings like a thickened bowel wall and collections in the pericolic 
area just like CT scan does.
25, 26
 Colonoscopy remains the gold standard in the diagnosis for it 
has the ability to visualize the mucosa and even take tissue biopsy for histologic evaluation.
27
 
Hemorrhagic patches seen at colonoscopy represent bleeding into the submucosa reflects the 
same ―thumb printing ―we see in the barium studies. Segmental distribution of these patches with 
or without the presence of ulceration strongly suggests IC. Serial colonoscopies hand in hand 
with serial abdominal physical examination are necessary to follow up on the condition and 
diagnose the outcome and the clinical sequels, if any, of the ischaemic injury. The early 
diagnostic colonoscopy should be done within the first 48 hours of presentation
28
 for later the 
submucosal hemorrhages may be resorbed by the circulation or even slough into the lumen and 
patches of ulceration may be seen instead. Caution is indicated when performing colonoscopy in 
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these patients; it should not be attempted at all in the presence of peritonitis (these patients 
should have a laparotomy straight away). Distension of the colon with room air to a pressure of 
30 mmHg further diminishes colonic blood flow and might even cause or amplify the ischaemia. 
29, 30
 However, the use of carbon dioxide has a vasodilator effect and might help avoid the above. 
The endoscopic and histologic examination of the colon in question depends on the stage 
of ischaemia and on the intensity of the insult.
31
 Punctate ulcers interspersed among areas of 
alternating pale mucosa and hyperemic mucosa represent early ischaemic changes. Biopsies from 
these pale areas will show submucosal hemorrhage and edema; whereas the hyperemic areas will 
show non-specific inflammatory infiltrates.
31
 Rare changes include the appearance of ghost cells 
but more common changes are: vascular congestion, loss of mucin and surface epithelial cells, 
and degeneration of crypt architecture the extent of each depends on the severity of the insult. At 
the early stages of ischaemia a moderate inflammatory cellular infiltrate is present in the lamina 
propria.
31
 When ischaemia progresses from the above nongangrenous state to the fully infracted, 
gangrenous state, the above changes progress also to extensive areas of gray green to black 
mucosa and submucosa with small perforations seen in between. When ischaemia becomes 
chronic and the initial insult was not enough to cause gangrenous colitis, the colon does recover 
to a certain extent according to the extent of the primary insult. Some atrophy is seen in the 
mucosa with dispersed areas of granulation tissue. In the state of scarring and stricture formation; 
the endoscopic image is that of a whitish narrowing in the lumen and biopsy reveals 
predominantly fibrosis, with minimal inflammation and some regenerating and damaged 
crypts.
31
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The major mesenteric vessels like the IMA are usually patent in IC, with the occlusion 
being mainly at the arteriolar level, thus mesenteric angiography is of minimal benefit unless 
acute embolic phenomena to the IMA or the ileocecal artery are contemplated.
32
 
1.1.6. Differential Diagnosis. 
IC can be of different aetiologies each of which has a different pathophysiology. Acute 
mesenteric ischaemia is the most serious, with sudden occlusion of the IMA due to an embolus 
originating in the proximal vascular system (heart or aorta) and its presentation is very serious. 
The patient presents with severe abdominal pain beyond physical findings
33
 These patients are 
known to have vasculopathy elsewhere like history of transient ischaemic attacks in the brain or 
peripheral vascular disease with claudication, atherosclerosis of the aorta, or atrial fibrillation 
recieving treatment. The gold standard of diagnosis is mesenteric arteriography. 
Mesenteric venous occlusion is another cause and is characterized by vague insidious 
onset abdominal pain crampy in nature, with distention and vomiting later in the course of the 
disease. Association with liver disease, inflammatory bowel disease, hematologic disease, 
hypercoagualopathies, and malignancies are common. CT scan may reveal an occlusion in the 
mesenteric veins or the confluence of the mesenteric veins when forming the portal vein. 
The diagnosis of diverticular disease should also be entertained, especially in patients 
who have documented previous attacks. Examination reveals peritonitis in the left lower 
quadrant with leukocytosis. CT scan can confirm the diagnosis with the aid of rectal contrast. 
 Infectious colitis can also mimic the presentation, and is characterized by watery 
diarrhoea, crampy abdominal pain, and generalized fatigue. A history of recent travel is common 
in these patients. Antibiotic overuse usually precedes the presentation of pseudomembranous 
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colitis and the infective agent would be C. difficile. A rigid sigmoidoscopy may show the 
membranes and the oedema associated with the latter. 
 
1.1.7. Management. 
  This is dependent on the presentation. If the signs and symptoms of intestinal ischaemia 
are those compatible with non gangrenous ischaemia, then the patient is treated conservatively. 
Usually the patient is put on intravenous hydration with broad spectrum antibiotics covering for 
intestinal flora, the bowel is rested by keeping the patient nil by mouth. If there is an associated 
ileus, a nasogastric tube is inserted to deflate the stomach and help in resolving the ileus. The 
patient is optimized hemodynamically and any medication that can precipitate or augment the 
ischaemia is withheld. The patient is followed up using serial abdominal examinations looking 
for emergent signs of peritonitis or any hemodynamic instability. This is complimented with 
serial radiologic examinations and endoscopic visualization along with serial monitoring of 
serum inflammatory markers like lactate, c-reactive protien (CRP), and LDH. Medications that 
improve colonic blood flow like histamine, serotonin, vasoactive intestinal peptide, and 
papaverine.are not part of the routine management of IC, but have shown some benefit in 
experimental models. 
13
 
Patients presenting with septic hemodynamic status and an abdominal examination of an 
acute board like abdomen with generalized peritonitis have very little chances of recovering if 
treated conservatively and their only chance is a laparotomy for prompt resection of that 
ischaemic segment as early as possible. No bowel preparation solution is administered to these 
patients for it will only make the fecal peritonitis worse. 
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About 80% of patients respond to medical therapy and their symptoms start improving within the 
first two days after presentation while the endoscopic findings need a few weeks to resolve and 
for the edema and the submucosal hemorrhage to resorb back into the system.
32
 Patients that 
have partial wall necrosis might heal into a stricture or an ulcer yet these patients might be 
asymptomatic despite abnormal endoscopic and radiologic findings. These patients should be 
followed up closely to document healing or on the other hand the development of strictures or 
persistent colitis. Persistent colitis is treated with topical steroid enemas not systemic steroids.
11
 
Patients not responding and presenting with repetitive attacks of sepsis; or forming strictures 
giving symptoms of pseudo-obstruction are offered elective resection surgery.  
The remaining 20% of patients present with an acute illness and hemodynamic instability 
and sepsis, necessitating a laparotomy for resection. These are the patients that deteriorate 
clinically from the previous group and develop sepsis, have peritonitis on presentation, have free 
air in the abdomen, and have extensive gangrene visualized by colonoscopy. The extent of the 
resection should be delineated preoperatively for the serosa might look normal although the 
mucosa inside is severly ischaemic. Any resected specimen should be examined intraoperatively 
to check for viable mucosa and if that proved the opposite on inspection then further resection is 
undertaken until the specimen has viable edges; only then is an anastomosis constructed with a 
covering reversible ileostomy to protect it. Other means of intraoperative assessment of  bowel 
viability include: hand-held Doppler
34
, measurement of tonometric (mucosal) intramural pH
35
, 
pulse oximetry for colonic oxygen saturation
36
, and intravenous fluorescein.
36
 All these have 
limited clinical acceptance and the surgeon usually relies on his gross subjective examination of 
the mucosa looking for a healthy pink color, absence of oedema and ulcers, as well as absence of 
skip areas of degenerated mucosa.
11
 In patients with right sided ischaemia, and if the terminal 
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ileum and transverse colon show gross signs of good viability, no gross abdominal 
contamination, and no sign of hemodynamic instability then an ileocolic anastomosis is 
constructed. If the ischaemia has targeted the left colon then invariably a Hartmann’s procedure 
is undertaken or an terminal colostomy is exteriorized along with a mucous fistula of the distal 
segment if length permits. Construction of an anastomosis on the left is contraindicated by 
several studies since the degree of contamination from a colon perforation is invariably 
overwhelming and no anastomosis will hold in such compromised conditions.
7, 11
 In patients with 
right sided colitis, where the ileum, and transverse colon are deemed viable with gross healthy 
mucosa, if there is no overwhelming contamination, and if the patient is hemodynamically stable, 
then an ileocolostomy is performed. 
1.1.8. Prognosis. 
Mortality and morbidity of IC varies according to presentation, severity, comorbidity of 
patients, and treatment modalities. Most mildly affected patients are asymptomatic after medical 
treatment. Severely affected patients and those that have strictures need to undergo surgery and 
have a higher morbidity and mortality rate. Establishing prognostic factors promptly is of great 
importance in deciding the best therapeutic strategy for each case. The main risk factors are  high 
blood pressure, cardiovascular diseases, diabetes, chronic obstructive pulmonary disease, and 
chronic renal insufficiency. 
37
 Surgical postoperative complications (such as bleeding or wound 
infections) occur in up to 21%; and these include surgical re-exploration due to anastomotic 
leakage with consecutive peritonitis, bleeding, abscess formation, or burst abdomen. Post-
operative mortality reaches as high as 47% to 60% as reported in the literature. 
38
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1.2. Ischaemic colitis after aortic surgery. 
One of the major complications following repair of abdominal aortic aneurysm (AAA) is 
ischaemic colitis with an incidence of up to 42%
39
 of which up to 73% may need a reoperation
6
 
which is also associated with a significant increase in morbidity, mortality, and prolongation of 
hospital stay
40
. This happens when the colon has been receiving its blood supply from the IMA 
that was ligated during the repair of the AAA, and the collateral circulation is not enough to meet 
the metabolic demands of the colon previously supplied by the IMA. Although a number of risk 
factors predisposing to this complication have been identified, there remains a lag period 
between the onset of ischaemia and the definitive diagnosis post operatively and hence the 
management that follows the diagnosis.  
The risk factors for such a complication have been identified as rupture, intra-operative 
hypotension, cross clamping time, hypoxemia, arrhythmias, age, SMA stenosis, low cardiac 
output, hypothermia, postoperative acidosis, postoperative oliguria, use of vasoactive drugs 
postoperatively, and coagulopathy
6
. All of these predispose to IC and even gangrene resulting in 
hazardous and life threatening sequels for the patient. In such scenarios, it is well understood that 
the quicker the diagnosis is, the quicker the management; and hence the better the outcome since 
sepsis is contained to a minimum.  
There are numerous perioperative factors that are associated with an increased risk of IC 
too. The preoperative presence of intestinal angina or patients with diagnosed coeliac, superior 
mesenteric, or hypogastric artery occlusive disease is indicative of preexisting mesenteric 
vasculopathy increasing the risk of vascular compromise to the colon and hence increasing the 
risk of IC or even small bowel ischaemia postoperatively. Other factors are the presence of 
hemodynamic instability, hypoxemia, retroperitoneal hematoma, prolonged cross clamp time, 
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ligation of the IMA, inadequate collaterals to the colon, iatrogenic trauma to colon, and bowel 
distension.
6
 
There are several intra-operative modalities that can be used to limit the risk of IC during 
aortic repair. These include avoidance of distal embolization of the meandering artery, 
decreasing the tension on retraction of the colon and its mesentery, and ultimately the re-
implantation of the IMA on the graft when the collateral supply is deemed insufficient. Collateral 
blood supply can be assessed by several methods: transanal Doppler examination of the superior 
rectal artery, IMA stump pressure measurement, intraoperative angiography to assess collaterals, 
and fluorescein are all used.
41
 Postoperatively examination of the abdomen is usually masked by 
pain attributed to the operation but clinical development of progressive oliguria, tachycardia, 
hypotension, and elevated blood lactate should alert the intensivist. Treatment does not differ 
from the above, with supportive measures for the mild cases and surgery with resection and 
diversion to the more severe forms.  
The most important factors associated with better prognosis are early physician suspicion, 
early diagnosis, and prompt management with alleviation of the exacerbating factors. Early 
diagnosis with endoscopy and serial examination either endoscopically or at the bedside will tell 
the physician early on if the process is progressing to a necrotic colitis or if it is subsiding. As we 
ascertain from the above, a better qualitative tool is needed to diagnose this disease entity, and 
better, a tool that diagnoses this entity and follows it up at the bedside is even more acceptable 
amongst clinicians to diagnose early progression.  
 Up till the present day there is no proven bedside quantitative tool that is available to the 
physician to objectively assess for ischaemia and follow up on the patient that was suspected of 
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having IC. Clearly, such a tool if present would aid a lot in early diagnosis, and hence earlier 
management and consequently a decrease in mortality and morbidity.  
 1.3. Anastomotic Leaks. 
Leaks in the bowel wall might occur after any closure of bowel lumen and after joining of 
two bowel segments. It is most likely to follow the formation of a low rectal anastomosis where 
it has the most catastrophic clinical sequels. The patients developing leaks are more likely in the 
future to develop reduced rectal capacity, defecatory problems, fecal urgency, and incontinence 
when compared with patients without  leaks.
42
 
There is no major system to categorize leaks.
43
 There is stratification according to the 
presentation of the leak. A minor leak is a silent one with no systemic manifestations but found 
in radiologic studies as a small amount of contrast contained in a cavity next to the lumen of the 
anastomosis; it requires no intervention. A major leak is one that causes systemic manifestations 
like fever, hemodynamic instability, sepsis, and peritonitis requiring usually further surgery. 
Radiologic studies in these cases usually show an overt defect in the anastomosis, with contrast 
freely extravasating through the lumen into the peritoneal cavity. Leaks of fecal material from an 
anastomosis may cause generalized peritonitis with an alarming increase in mortality, localized 
peritonitis associated with abscess formation, or fistula formation. Each of these has its own 
management and the sooner the diagnosis of the leak the better the prognosis. 
There is considerable variation between series in reported overall leak rates, ranging 
between 3.5-6%.
44, 45
 However, clinically significant leak rates are in the range of 3-15%.
43
 
There is a difference in the leak rates of anterior resections of the sigmoid colon, the incidence 
being higher as the anastomosis becomes lower towards the rectum. The reported rates depend 
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on the inclusion criteria of leaks, the majority of series reporting clinically relevant leaks but not 
the silent ones. Mortality rates after clinically evident leaks are in the range of 6-40%. 
45
 
 1.3.1. Risk factors. 
A lot of risk factors were investigated in several published studies but the most important 
factor that is highly associated with leaks is the position, being a  low rectal anastomosis; this is 
defined as an anastomosis below the peritoneal reflection.
46
 A multivariate analysis taking into 
consideration several patient and operative variables including indication for operation, co-
morbidities, bowel preparation, and intraoperative events did show that only a distance of less 
than 7cm from the anal verge is a significant risk factor to develop a leak.
47
 Other investigators 
found out that certain factors do carry an increased risk. Leukocytosis, sepsis, technically 
challenging anastomosis, postoperative blood transfusions, chronic obstructive lung disease, 
bowel obstruction, peritonitis, hypoalbuminaemia, and use of steroids are independent risk 
factors for developing a leak. 
44
A more recent study showed that preoperative variables 
significantly associated with developing leaks in a colorectal anastomosis include weight loss, 
malnutrition, cardiovascular disease, other comorbidities, and alcohol use.
48
 Factors other  than a 
short distance to the anal verge were insignificant, for example: ASA status, protracted surgery, 
blood transfusions, contamination, high body mass index, smoking, bowel preparations, type of 
anastomosis, technique of stapling, and use of drains. Laparoscopic surgery for colorectal 
resection does not add any risk to the development of leaks as shown by the surgical therapy 
study group.
49
 For patients with Crohn’s disease the leak rate is similar to the other groups 
(9.7%) however the fistulae rate is significantly higher.
50
 Ulcerative colitis patients undergoing 
restorative proctocolectomy have a leak rate of around 6%. 
51, 52
 As for radiotherapy it was not 
found in a multivariate meta-analysis that there is a difference in leak rates between patients with 
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preoperative radiotherapy and patients with no radiotherapy,  however, the former group do have 
higher complication rates.
53
 Furthermore, the Dutch TME Radiotherapy trial failed to show any 
difference between the two groups.
54
 The universal risk factors that predispose the anastomosis 
to leak are: tension on the anastomosis, distal obstruction, poor sealing technique, and ischaemia 
of any of the joining segments.
43-45, 55
 
1.3.2. Minimizing Leaks. 
The general principles that all surgeons abide by when performing an anastomosis are: 
absence of distal obstruction, freedom form tension, and adequate blood supply to the two sides 
of the anastomosis.
43
 As for the technique of suturing it was not shown that automatic stapling of 
the anastomosis is superior to hand suturing. 
56
 
Delivery of adequate oxygen tension to meet the metabolic demands of the healing process is 
crucial, as Sheridan et al have shown. This is optimized by maintaining adequate cardiovascular 
status perioperatively by maintenance of blood pressure, hemoglobin level, and blood oxygen 
saturation.
57
  
To ensure a tension free anastomosis, the splenic flexure has to be mobilized to free the 
proximal limb of the anastomosis and the descending colon used for the anastomosis. This would 
decrease the tension and ensure adequate  blood supply in the proximal limb of the anastomosis, 
for the descending flexure has been shown to have better oxygen tension than the sigmoid colon 
after IMA ligation
58
. This also ensures that the dead space in the pelvis is adequately filled with 
bowel to minimize collections and subsequent postoperative infections.
46
 Malnutrition has also 
been associated with increased risk of leak, as an albumin level <30 g/dl in the blood plasma 
along with recent weight loss of more than 5 kilograms have been shown to be risk factors.
44, 59
 
Early postoperative feeding is recommended for it has been shown to decrease the time needed 
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for a recovery and there is no evidence to show that it affects leak rates.
60
 Bowel preparation has 
been used before but studies have shown that it does not influence leak rates so the recent trend 
is to avoid bowel preps especially as it can cause dehydration, electrolyte imbalances and 
starvation in the perioperative period.
61
 The use of drains have been controversial for low rectal 
anastomosis and data suggest that draining a low anastomosis might give a false sense of 
security, induce infections, and even cause fistula formation.
62
 However some authors advocate 
the use of drains in low rectal anastomosis cases where the drain helps in evacuating collections 
that might drain through an anastomosis.
63
 A covering stoma is always recommended when there 
is a low anastomosis, poor perioperative state, technical difficulties, and a patient with many risk 
factors for developing leaks. Stomas do not decrease the risk of leak but do reduce the risk of 
developing clinical consequences of leaks.
64
 
1.3.3. Diagnosis of leaks. 
Any clinical deterioration and signs of sepsis should raise the physician’s suspicion of a 
leak. Signs that an alert physician should look for are: fever, new onset pelvic pain, extended 
ileus, renal failure, and leukocytosis.
48
 Complimentary radiologic studies like CT scan or 
contrast enemas can be used to confirm the diagnosis, with CT scan being more sensitive along 
with the ability to show abscess formation in the pelvis.
48
 It is evident that a more quantitative 
method is needed rather than the physician’s suspicion to diagnose or even anticipate the 
development of leaks. For at the time of the diagnosis of the leak enough time has passed for the 
onset of an overwhelming infection and sepsis. It is clear that a method that would diagnose the 
leak, long before its clinical consequences develop, is needed to decrease the morbidity and 
mortality associated with leaks; not to mention, the rise in hospital stay and cost needed to 
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manage leaks. Up to this point in time there is no proven bedside quantitative method that can 
aid the physician in the early diagnosis of a leak. 
1.3.4. Management of leaks. 
1.3.4.1. Major leaks. 
Clearly, these patients will have hemodynamic instability and they need resuscitation and 
IV antibiotics, in addition to monitoring with central lines, urine catheters, and arterial lines. 
After stabilization, lavage is mandatory with a laparotomy and then formation of a defunctioning 
stoma. In right sided colonic anastomosis leaks, the anastomosis can be refashioned and adequate 
drainage achieved with a drain. In left sided leaks, it depends on the stoma condition. If the 
anastomosis has a small clear defect, it is closed and a stoma fashioned, of course with adequate 
drainage of the abdominal cavity. If the anastomosis has completely broken apart, the proximal 
end is brought out as a colostomy and the distal end is either closed and left inside the abdomen 
or length permitting is brought out as a mucous fistula.
65
 
1.3.4.2. Leaks with localized consequences. 
The management depends on the presentation and on the investigation by the CT scan 
with water soluble contrast. If there is a minimal leak contained in a small cavity then the 
treatment is conservative with IV antibiotics. If there is a large cavity containing the leak then 
percutaneous drainage is mandatory under radiologic guidance with success rates of 80%.
66
 If 
drainage under radiologic guidance is not feasible, then an operation is needed. If the contrast is 
free flowing in the abdomen then a laparotomy is also needed.
65
 
1.3.4.3. Fistulae and strictures. 
Fistulae occur when the anastomosis leaks and a collection develops in the vicinity, then 
this collection finds its way through the skin or adjacent viscera like vagina, bladder, small 
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bowel. In the absence of peritonitis the treatment is conservative with parenteral nutrition, 
elemental diet, and elimination of a distal obstruction. The more distal in the bowel the fistula, 
the less likely it will close and a surgical repair is warranted. The use of bioprosthetic material 
like fibrin glue and animal collagen products like the Surgisis
®
 has been described in literature 
for closure of distal fistulas with questionable results.
67
 Stricture formation in the site of the 
anastomosis is mainly due to anastomotic leak and ischaemia followed by cancer recurrence.
68
 
The stricture is repaired when there is need to reverse a proximal stoma, obstruction or 
defecation problems occur, or when we need to survey proximal bowel when failing to pass a 
colonoscope through the stricture. Dilation with endoscopy of Hagar dilators can be employed or 
surgery if that fails.
69
 
 1.4. Intraoperative means to assess bowel viability: 
During surgery, there are quantitative means that the surgeon can rely on to assess the 
viability of questionable bowel and these include intravenous fluorescein (FL), intramural pH, 
laser Doppler, continuous wave Doppler ultrasound (CWDU), and pulse oxymetry. Each of these 
is reported in literature but none has gained wide acceptance.Other less widely used methods on 
patients but reported in literature in animals and labs include electromyography (EMG), 
99
mTc-
labeled albumin microspheres (RLAM), and hydrogen gas clearance (HC). 
Although many of the techniques listed have demonstrated their ability to enhance the 
differentiation between viable and nonviable bowel, none has found widespread clinical 
application due to a variety of practical considerations (e.g., cumbersome, highly sophisticated, 
or expensive instrumentation). CWDU and FL have enjoyed the widest clinical application but 
each has drawbacks limiting its application. Henceforth a wider accepted tool is needed to assess 
for bowel viability intraoperatively. 
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1.4.1. Photoplethysmographic Pulse oxymetery (PPO) 
PO has been accepted during the last decade for monitoring oxygen saturation of arterial 
blood. It is based on the principle of absorbency of red infrared light from which the pulsatile 
component is isolated to derive arterial oxygen saturation. When deployed transanally, it has 
been shown to be an efficient method for continuous monitoring of distal colonic blood flow.
70
 
The PO pulse curve has also been used to determine gastric viability during eosophageal tube 
reconstruction from the stomach. Saturation reading of > 84% in the gastric tube (constructed 
from the stomach wall to reconstruct for the resected eosophagus) resulted in a viable 
anastomosis between the tube and the proximal esophagus.
71
 
In patients undergoing aortic repair surgery it was found that endoluminal pulse oximetry 
is reliable in detecting colonic ischaemia at a very early stage after aortic reconstruction.
72
 
Furthermore, the characteristic findings of colonic ischaemia in animal controlled studies were 
the absence of pulse signals during ischaemia.
73
 
 1.4.2. Laser Doppler Flowmetry (LDF). 
In short, the principle of LDF relies on changes in wavelength (Doppler shift) of a laser 
beam that hits moving red blood cells. The magnitude and frequency of these changes are 
directly related to the speed and number of the moving blood cells. Reflected light is captured by 
a returning fiber, recorded, and analyzed by a computer program. This technology can be used to 
assess the blood flow as it is read by the returning fiber. 
In aortic surgery, the incidence of ischaemic colitis is in the range of 5% and can be 
raised to 60% in ruptured emergency cases. This complication considerably increases the 
postoperative mortality of the patient to up to 40-100% .
40
 LDF has been used to assess  colon 
viability after aortic reconstruction and has proven its efficacy in doing so.
74
 It has also been 
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used recently in monitoring the perfusion and viability of transplanted intestine and has also 
proven its efficacy there.
75
 It was shown to correlate with other flow measurements such as with 
RLAM, the isotope washout technique, electromagnetic flow probes, and HC.
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1.4.3. Hand-held continuous wave Doppler Ultrasound (CWDU). 
This is another form of Doppler that can be used intraoperatively and has been reported 
in literature. It is basically an adaptation of the bedside clinical exam that the vascular surgeons 
use to assess peripheral pulses; however, it is modified to assess mesenteric flow. A hand held 
Doppler pencil device is deployed against the mesentery where the arteries supplying the 
intestine in question lie, and an audible signal is assessed. The sound can be graded as follows 
after both mesenteric and antimesenteric margins of the bowel have been examined for the 
presence or absence of Doppler pulsatile flow. Grade 1, both mesenteric and antimesenteric flow 
present; grade 2, only antimesenteric flow present; grade 3, only mesenteric flow present; grade 
4, no Doppler flow present. Grades 1 and 2 are considered viable and grades 3 and 4 nonviable 
by the CWDU method.
76
  
1.4.4. Intramucosal pH measurements. 
Bergofsky introduced tonometry as a noninvasive method  to determine the intramucosal 
pH (pHi) in hollow organs, which reflects the blood supply to the mucosa.
77
 When ischaemia 
sets in there is increase production of lactic acid and hence acidosis develops in the mucosa, 
lowering its pHi. Therefore, measuring that pH by a tonometer, through a tube with a sensor next 
to the mucosa, will act as a surrogate marker of ischaemia in that organ or even in the systemic 
circulation. Gastric tonometry has been widely evaluated as a potential prognostic indicator in 
cardiac and septic patients,
78
 and to determine the viability of the gastroesophageal anastomosis 
after thoracic esophagectomy.
79
 In patients undergoing abdominal aortic repair, sigmoid 
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tonometry was shown to be a predictor of outcome and of ischaemic colitis,
80
 and to study 
pouchitis in ileoanal pouches in patients with ulcerative colitis who had their definitive repair.
81
 
1.4.5. Intravenous fluorescein (FL). 
The pioneers in the use of FL were   Lange and Boyd in 1942, who proposed viewing the 
fluorescence pattern of tissue under ultraviolet illumination after the intravenous administration 
of sodium fluorescein, can assess the perfusion of those tissues. The first reported prospective 
clinical trial in patients with intestinal ischaemia was designed by Bulktey.
82
  That study shows 
that fluorescein assessment is  more accurate than Doppler examination, in conjunction with 
clinical assessment of the bowel in question.
83
 This has gained wide acceptance amongst 
surgeons and have been reported repetitively in literature, even to be used with laparoscopy 
when assessing for bowel viability.
84
 
1.4.6. Electromyography (EMG). 
This is a method used and reported frequently in animal models; however  reports of its 
use in patients are rare. It quantifies the electromyographic response of the intestine when a 
stimulus is applied, and the response correlates with the perfusion and viability of that segment 
of intestine. It was found by Brolin et. al. that EMG measurements may be useful in bowel 
viability assessment; but when taking measurements of moderately ischaemic bowel, the EMG 
readings may not be as reliable as assessment in correlation  with Doppler ultrasonographic 
findings.
85
 
1.4.7. Radioactive labeled albumin microspheres (RLAM). 
This method involves the use of radioactive microspheres that are injected in the 
circulation and then their uptake in the bowel in question is measured by means of a Geiger 
counter. The more the activity the counter shows, the more the perfusion. Experimental data 
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showed that this is feasible; however, its use in patients is limited to the radiology department in 
scintigraphy and not intraoperatively.
86-88
 
1.4.8. Hydrogen gas clearance. 
The principal behind this technology is the following: the rate at which the H2, which is a 
biologically inert gas, is cleared from the perfused tissue is directly proportional to the blood 
flow in that tissue. The H2 gas is incorporated in the tissue by breathing or by locally generating 
it by a probe where a nano-ampere current causes electrolysis of H2O thus generating the gas. 
Then after cessation of breathing or cessation of the electrolysis current the washout of the gas is 
measured by a H2 sensing electrode which records the washout as a current, portraying it as a 
decrease in current as the blood flow washes out the H2. This has been used extensively in 
research in animals but rarely in patients. 
89-91
 
Unfortunately, none of the above methods is usually used to assess for bowel ischaemia 
and the physician relies always on his clinical assessment of the patient on the ward, and on the 
bowel color, peristalsis, temperature, and bleeding during the operation.All the above methods 
act as a surrogate measure of blood flow to ischaemic bowel; none is a real time, quantitative, 
method of measuring ischaemia or the biochemical signature of ischaemia stand alone.  A robust 
real-time quantitative method to measure ischaemia and its metabolic effects in the tissue has yet 
to be proven efficacious and accepted for widespread clinical use.  
 
 
Tool Methodology Disadvantages 
PPO Relies on absorbance infrared 
light from the tissue to derive 
saturation. 
Surrogate marker since 
monitors O2 saturation in 
the blood not tissue 
metabolism. 
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LDF Monitors changes in 
wavelength of a laser beam 
hitting RBC’s in tissue. 
Surrogate marker since it 
assesses blood flow not 
tissue metabolism. 
 
CWDU Produces audible signal 
correlating with blood flow. 
Surrogate marker since it 
assesses blood flow. 
pH Tonometry Measures pH of tissue. Measures one metabolite of 
ischaemia (lactate) not 
both glucose and lactate 
and their change with 
respect to time. 
Intravenous 
Fluorescein 
Measures uptake of a dye in 
the tissue under UV light. 
Surrogate marker since it 
measure uptake from blood 
not products of 
metabolism. 
EMG Quantifies response of 
intestinal muscle to electric 
stimuli. 
Surrogate marker of the 
viability of the tissue, not 
metabolic measure. 
RLAM Measures using Gieger 
counter the uptake form the 
circulation of a radiolabelled 
compound. 
Surrogate marker, 
measuring blood flow not 
metabolic products. 
H2 gas clearance Measures the clearance of 
locally produced tissue H2. 
Surrogate marker since it 
measures perfusion not 
metabolic products. 
 
 
1.5. Metabolic changes in tissue due to ischaemia. 
Ischaemia is a pathological condition in which the demand for oxygen in the tissue far 
exceeds the supply and hence the metabolic needs of the tissue. This will increase the extraction 
of oxygen to the maximum limits and leads to flow dependent oxygen consumption. Because of 
this deficit in oxygen delivery, the tissue metabolism becomes anaerobic with changes in the 
pathways of glycolysis with consequent changes in the metabolite concentrations such as 
glucose, lactate, pyruvate, and glycerol that can be sampled and measured with different 
available tools. 
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  Under aerobic conditions glucose enters glycolysis in the cytosol and is converted to two 
pyruvate molecules which in turn enter the mitochondria for further oxidative decarboxylation to 
yield acetyl-coenzyme A. This enters the citric acid cycle or better known as Krebs cycle and is 
oxidized into CO2 in the same common final pathway for the oxidation of fuel molecules like 
amino acids, fatty acids, and carbohydrates.  
 
Figure 1.2. The Krebs cycle and its end results in energy compounds.Illustration by SD from92 
In case of ischaemic stress, the cells of the tissue and especially those of the intestinal 
mucosa that are very sensitive to ischaemia undertake a different pathway than the Krebs cycle 
in order to produce energy. The two pyruvate molecules are converted into lactate by lactate 
dehydrogenase and lactate is then an end product which burdens the cells and renders their 
medium acidic rather than neutral which in turns interferes with the regular cellular function. 
47 
 
This increase in lactate is handled by the liver after its transport from the periphery where it is 
reconverted into pyruvate and enters the gluconeogenesis forming glucose which again is 
transported back to the tissue for different uses (Cori Cycle).  
A decrease in the oxygen tension has a drastic effect on the regional metabolism. Glucose 
delivery to the tissues decreases and then terminates with decreasing blood flow. The cells 
extract whatever glucose left in their stores, in the interstitial fluid, and from the regional 
collaterals; hence there is a decrease in the glucose concentration as well as the oxygen tension. 
Anaerobic metabolism inhibits the Krebs cycle by accumulation of NADH due to inhibition of 
oxidative phosphorylation. Pyruvate dehydrogenase in turn increases lactate concentrations due 
to conversion of pyruvate to lactate allowing the regeneration of NAD
+ 
and continuation of 
glycolysis. Lactate is exported out of the cells resulting in increased levels in the tissue and 
causing acidosis and a drop in tissue pH. The use of tissue lactate /pyruvate ratio (L/P) is a good 
marker of ischaemic metabolism since in that situation pyruvate decreases and yields lactate 
hence increasing the L/P. Another good marker is the lactate/glucose (L/G) which also increases 
in ischaemia since the glucose available is utilized in the tissue with no replenishment and the 
end product of such metabolism is the production of lactate not CO
 
2
 
with an eventual rise in the 
L/G ratio.  
Conditions where there is an overall increase in aerobic metabolism but no ischaemic 
insult (such as sepsis) increases the lactate levels as well as the pyruvate levels due to increase in 
production. Glucose levels as well increase in tissues due to increase in glycogenolysis and the 
maintained delivery of glucose to tissue hence the two ratios L/P and L/G remain fairly constant 
as opposed to anaerobic metabolism in ischaemic insults.
93
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Measuring glycerol in the interstitial fluid can also be used as a marker of ischaemic 
insult to the cells in the tissue. Decreasing the ATP energy production and rendering the 
extracellular fluid acidic by increasing lactate production decreases the tissue pH suddenly. In 
turn, this causes enzyme dysfunction and affects the ion gradient governing the cellular 
membrane and its ion pumps. Amongst the pumps that are affected in such environmental 
changes of the cell is the calcium ion pump which creates an influx of Ca
+2
 that in turn activates 
phospholipases; that in turn attack the cell membrane. The membrane disintegrates to form 
glycerol and fatty acids from phospholipids that accumulate in the extracellular fluid. Therefore 
the concentration of glycerol sampled in the ischaemic tissue can also be used as a late marker of 
tissue breakdown due to anaerobic metabolism.
94
 Hence as a conclusion measuring tissue 
metabolites from the interstitial fluid like glucose, lactate, pyruvate, and later on, glycerol is a 
good criterion of sufficient blood flow and oxygen delivery to the tissue. 
 
 
1.6. Microdialysis Principles. 
 
The principles of microdialysis are to sample the extracellular fluid from whichever 
tissue and to study the metabolic constituents of that tissue. To achieve the above, a tubular 
microcatheter is introduced into the tissue and is perfused with a certain fluid that equilibrates 
with the extracellular fluid through diffusion due to the difference of the concentration gradient 
through a semi-permeable membrane that engulfs the perforated perfusing shaft of the catheter. 
This enables the catheter to act as a capillary in that tissue and the dialysate that is pumped out is 
nothing but a sample from the extracellular fluid and can be studied for all the metabolites that 
are small enough to cross the semi- permeable membrane, typically those less than 30KDa in 
size. Larger pore catheters do exist for proteins that are less than 100KDa in size but in this 
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project, these proteins are not of interest, not to mention the very expensive cost of those large 
pore catheters.  
 
 
 
Figure 1.3: Microdialysis catheter acts as a capillary membrane. Figure under permission from 
CMA.95 
The one important thing to bear in mind is that the catheter samples the extracellular fluid not the 
intracellular one and only the extracellular fluid surrounding the catheter which has been 
calculated to be equivalent to almost 100 mg of tissue.
96
 The diffusion coefficient and 
permeability of the analyte governs its migration through the membrane that excludes the heavier 
molecular weight enzymes responsible for the degradation of the analyte otherwise. Then these 
analytes are sampled out of the catheter by the current of the perfusate and are delivered out as a 
dialysate. As explained there is no fluid removed from the extracellular space hence continuous 
sampling can be done with no change in the physiology of the extracellular fluid in that area 
around the catheter. The process as explained above yields very low sample volumes in the range 
of 10µl every minute. The sampling adds a factor of dilution since the diffused sample is diluted 
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by the stream of fluid from the perfusate not to mention a small artifact in the concentration due 
to insensible losses of evaporation while collecting it. To minimize all these artifacts a solution 
has been proposed to couple the dialysate collection into an air tight collection container 
incorporated into the catheter outflow, and then the collected sample would be analyzed from 
that air tight container. Therefore, the sample in the container would represent an average 
concentration of those low molecular weight hydrophilic analytes collected over that period. The 
longer the time delay between collections of samples the larger the sample but the more the 
chance is to have changes happening in the concentration of the analytes that might go unnoticed 
since it is pooled in the container with the rest of the sample. Introduction of the catheter in the 
tissue by tunneling it might inflict minimum trauma in the tissue and some cell lysis which in 
turn may affect the sampling and the concentrations yielded in the dialysate. This depends on the 
size and length of catheter: the wider and longer the catheter is, the more the traumatized surface 
area of the tissue, and the more the artifact.  Analyte concentrations depend also on the perfusion 
rate since the less the rates the more it takes to clear out the fluids from the traumatized cells. So 
it is expected that this will equilibrate after some time ranging from minutes to hours according 
to the above parameters and the tissue involved.
97, 98
 This has been studied using electron and 
light microscopy that did show ultrastructural changes in the tissue and cells surrounding the 
tunneled catheter which can affect the analyte concentrations.
99
 But recent advances in catheter 
technology, construction, and material used have been shown to cause only minor and patchy 
inflammatory changes in the vicinity of the catheter.
100
 All this has been found to normalize and 
equilibrate in the range of 30 minutes in adipose tissue
97
 and one hour in skin
98
 but this work 
presented here in bowel did show that it is a lot less in bowel which is in the range of 10-12 
minutes as will be explained later. 
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1.6.1. Setup of a microdialysis system. 
The microdialysis system consists of the following: a microdialysis catheter, a pump, 
collecting vials known as microvials, and an analysis system. There is a variety of catheters 
available in the market each has specific properties according to the tissue intended for and 
varies by the length, width, permeability of the dialysis membrane, along with the shape of the 
inflow and outflow tubing of the catheter. The pumps used clinically can be hand held to deliver 
a specific amount of perfusate per minute or for research purposes, can be stationary but do 
perfuse into many ports with a greater control of the rate and timing of perfusion. CMA 
Microdialysis (Stockholm, Sweden) is the leading company in microdialysis. They provide 
clinical pumps like the CMA 107 pump (Stockholm, Sweden) that is portable and light. On the 
other hand, they also provide research pumps like the CMA 400 (Stockholm, Sweden) with 
many outflow routes for multiple catheter simultaneous infusion and more precise perfusion 
rates. As mentioned above; the dialysate, after exchange with the tissue extracellular fluid, 
delivered through the outflow tube of the catheter and is collected via an airtight microvial that is 
analyzed separately by an analyzer.  
52 
 
Figure 1.4: Available CMA pumps. Under 
permission from CMA95 
The analyzers present in the market are mainly of the kinetic enzymatic analyzers that use 
substrate specific enzymes for metabolites like glucose (G), lactate (L), pyruvate (P), and 
glycerol (Gly) that oxidizes these metabolites generating hydrogen peroxide. This is coupled 
with another enzymatic reaction using peroxidase that catalyses a reaction between the generated 
hydrogen peroxide, 4-amino-antipyrine, and phenol (or dichlorohydroxy-benzensulphonic acid in 
the case of glycerol as a substrate) to form a red violet quinineoamine. The end colored product 
is measured photometrically as a change of absorbance at 546 nm wavelength. The rate of the 
absorbance change is proportional to the rate of production of the red violet quinineomine which 
is in turn proportional to the rate of the substrate being oxidized to hydrogen peroxide to begin 
with. Hence it is a measure of that substrate and can be correlated to it in the analyzer that does 
all the above automatically after it samples from the air tight vial mentioned above with the 
dialysate in it. All these catheters, pumps, and analyzers are present in the market and are 
engineered, developed, and marketed by CMA Microdialysis® (Stockholm, Sweden) which 
currently is the only company that has FDA and CE approvals of the use of these catheters in 
human subjects. 
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Figure1.5. A sample CMA off-line analyzer. Under permission from CMA95 
The work in this thesis does use the same technology of the micro-catheters but the 
analysis system is a totally different concept that was engineered and developed at the 
Department of Bioengineering at Imperial College London and will be explained in due detail 
further in the text. 
1.6.2. Principles of Microdialysis recovery 
Microdialysis as explained above relies on the action of diffusion across a semi-
permeable membrane and its principles in sampling the extracellular fluid. Therefore, it is only 
logical that there is not enough time for the diffusion to reach equilibrium since the stream of 
perfusion fluid inside the catheter is in constant flow. Hence, there is always a state of non-
equilibrium and the concentration of the metabolites in the dialysate fluid is always less than the 
actual concentration of the metabolites in the extracellular fluid. The ratio of the dialysate 
concentration over the actual concentration is known as the ―relative recovery‖ (RR) and is 
inversely proportional to the rate of perfusion in the catheter and can never reach 100% in vivo.  
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Several methods can be used to determine the RR in vitro. Jacobson introduced the zero 
flow method where the fact that passive diffusion across the membrane in states of zero flow 
depends on the concentration gradient of the metabolites and is used as a measurement of the 
RR.
101
 Another method in measuring the RR is the no-net-flux-method by Lonnroth.
102
  This 
method states that when there is no concentration gradient across a dialysis membrane, the net 
flux of metabolites will be zero. The compound of interest is titrated to the perfusion fluid 
around the estimated outside concentration of that compound. When the flux of this added 
compound is zero then the titrated concentration equals the true concentration the outside 
medium. This is also used in the retrodialysis method. In this method, known concentrations of a 
compound similar or identical to the compound studied are added to the perfusion fluid as an 
internal standard. Then the concentration of this compound is measured in the dialysate fluid 
then the RR would be: 
 
Where the Cin and Cout are the concentrations of the compound entering in the perfusion fluid and 
leaving in the dialysate, respectively. This retrodialysis method is the easiest and quickest 
method to determine RR.  
In vivo recovery depends on so many parameters like the flow rate, length of the 
membrane, binding to the membrane and tubing with tissue proteins, blood flow, speed of 
diffusion, molecular weight, shape and charge of the substance, physiology of the tissue, and 
temperature. As you see all of the above are fairly constant except for the flow rate that we can 
stabilize using the pump, henceforth for a given flow rate, in a specific tissue, for the same 
catheter membrane the RR of a given substance is constant.
103
 
55 
 
However, the change in the physiology of the tissue sometimes cannot be controlled. For 
example as shown by Stallknecht et.al that the RR of glycerol increased from 0.75 to 
approximately 0.95 in human skeletal muscle during strenuous exercises of the knee.
104
 In that 
study using retro-dialysis the labeled glycerol that was pumped in the perfusion fluid disappeared 
with exercise due to the clearance action of the hyperperfusion of tissue with blood during 
exercise. Also in a study with human myocardium it was shown that the RR decreased with 
decreasing temperature of the tissue which is expected since the Brownian movements of 
particles and hence diffusion decrease with decrease in temperatures.
105
 These factors advise us 
as researchers that the RR of a substance should be measured anytime we have a change in 
physiology of the tissue but should remain constant as long as we are dealing with the same 
tissue physiology at constant temperatures. 
When monitoring metabolism, a flow rate is chosen as a balance between adequate RR 
and enough fluid dialysate retrieval for analysis, since the dialysate are frequently in 
microvolumes or even nano-liters. This problem can be solved by using the rapid sampling 
method since as will be shown any amount of dialysate even the amount that is delivered by the 
catheter over 30 seconds is enough to get a measurement of the metabolite in question.
106, 107
 
Microdialysate samples when measured off-line reflect a mean concentration of that metabolite 
over the period of collecting the sample, whereas blood samples provide a snapshot point 
measurement of that substance at the time of blood sampling. In the case of in vivo microdialysis 
and under non stable conditions, like changes in temperature of the patient or the physiology of 
the tissue or its pH like in ischaemia, the recovery is better estimated at short intervals of time. 
This is to ensure that a change in the dialysate concentration is a real change in the tissue 
concentration rather than in a change in the RR of that substance. Another way of decreasing or 
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even eliminating the artifact of a change in RR is the use of ratio changes in substances like the 
L/G or L/P ratio where the change of RR is eliminated since the RR will change uniformly for all 
substances as the environment around the catheter changes. Therefore if we use the quotient of 
two concentrations (that have changed likewise due to changes in their RR) the ratio will be 
unaffected by such changes. We note also that microdialysis reflects metabolism samples with a 
minor delay in time proportional to the perfusion rate, length of connecting tubes, length of 
catheter tubes, and the time delay for the analysis. All these are taken in consideration when 
analyzing the microdialysis data  
 1.6.3. Various uses of clinical microdialysis 
The technique of using microdialysis was developed around the year 1974 and was first 
published by Ungerstedt who is currently a world authority in this subject.
108
 Then with the 
evolution of this technique, it has been used in tissues of human subjects to monitor metabolism 
in areas usually not accessible.
109
 Since monitoring the metabolism of several tissues has become 
increasingly important for the physician, microdialysis has gained considerable acceptance in 
that field with many developments in the technology for application in patients. 
In the clinical setting, metabolic control has been increasingly recognized as important. 
For example it has been shown that during surgical stress and in the intensive care setting in 
critically ill patients, a good control of blood glucose has been shown to reduce both mortality 
and morbidity.
110
 Microdialysis has the potential to monitor the energy metabolism of the tissues 
through monitoring the relevant metabolites like glucose, lactate, and pyruvate.  
1.6.3.1. Microdialysis as a diagnostic tool: 
In the adult patient, repetitive sampling might be tolerated, however, this is not the case 
in peadiatric patients. Frequent sampling, and in the case of rapid sampling microdialysis, 
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continuous sampling is one of the major advantages of microdialysis, and does prove useful in 
infants and neonates where repetitive sampling might cause a lot of distress to the infant and the 
parents. In that instance a microdialysis catheter can be deployed once and used for repetitive 
sampling if not continuous. This has been proven of ultimate efficacy where a catheter is left in 
the subcutaneous tissue of neonates for repetitive sampling of glucose by Hildingsson et. al in 
1996.
111
 Another major advantage of microdialysis as a diagnostic tool is its applicability in 
tissues that were previously very difficult to monitor or access. A good example of such tissue is 
the brain.  
The use of this technology has been extensively investigated as a diagnostic tool in the 
brain tissue looking for markers of ischaemia and cell damage like glucose, lactate, pyruvate, and 
glycerol.
112-115
 Other non routine metabolites have also been correlated and measured by 
microdialysis that can help the physician predict the better outcome patients in patients with head 
trauma. It was found that frontal lobe IL-6 levels measured by microdialysis are higher in 
survivors than in non-survivors as compared to equal levels in the plasma in both groups.
115, 116
  
Because of its feasibility in monitoring brain metabolism and ischaemia, other tissue 
monitoring has been explored like in the monitoring of transplanted liver and kidney viability 
and the monitoring of catastrophic intra-abdominal ischaemia after major abdominal surgery. 
Early intervention because of detection of ischaemia may help in avoiding re-transplantations 
and abdominal clinical disasters because of unnoticed ischaemia.
117, 118
 The use of microdialysis 
has been also explored to monitor viability of free flap in plastic surgery, with very encouraging 
results. Ischaemia found, by microdialysis monitoring, early on in the post-operative course 
warranted early surgical intervention, sufficient to save the flap before ischaemia caused non 
reversible damage to the free flap. This decreases the burden of finding another free flap to cover 
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the defect in the patient, not to mention the burden of another long operation and all its sequellae 
for the patient.
119
 
1.6.3.2. Clinical uses of Microdialysis 
In addition to muscle, brain, and surgical flaps, microdialysis has been used also to 
monitor metabolism and inflammatory reactions in human tissue like in liver, kidney, lung, and 
heart. Large pore catheters have been used to monitor inflammatory markers in liver grafts post 
transplant where a rise in inducible protein-10 was found beneficial while a rise in interleukin 8 
and complement activation protein 5a were associated with rejection
120
 The catheters have been 
deployed in human kidneys undergoing oncologic resections and proved that the glucose and 
pyruvate significantly decrease during renal artery occlusion while lactate and glycerol increase 
significantly.
121
  Microdialysis also was used in lung tissue to prove that atelactasis influences 
antibiotic availability postoperatively and hence predisposes to pneumonia in atelactatic 
segments
122
. 
Microdialysis is having its impact on the study of the human heart remodeling and injury 
occurring during ischaemia/ reperfusion of the human heart and the role of metalloprotienases 
(MMP) in the heart muscle has recently been a debated. Microdialysis is adding a lot of 
information on this subject and has recently been explored extensively. MMP activity has been 
shown to influence the reactivation of hibernating myocardium after reperfusion according to 
Spinale et. al. Inhibiting certain MMP’s while enhancing others might prove to be a beneficial 
therapy in promoting hibernating myocardium to a functional one rather than to a scarred one.
123
 
It was also used in human heart to monitor for ischaemic metabolites after extensive work on 
animal models and did prove that lactate tends to stabilize while the heart is on bypass pump and 
then decreases significantly after reperfusion.
124
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1.6.4. Microdialysis in research. 
Microdialysis started in research to measure the concentrations of metabolites in the 
extracellular space of various tissues subjected to ischemia in vitro and in vivo. Several uses have 
been deployed in the research setting with microdialysis: 
1.6.4.1. Microdialysis to measure concentrations. 
By using the microdialysis microcatheter, it is feasible to measure the metabolites in a tissue 
and hence monitor its metabolism with a semi-invasive technique as compared to the more 
invasive arteriovenous sampling or non feasible techniques in research like positron emission 
tomography and magnetic resonance imaging. For instance a research study used microdialysis 
to outline where the defect in increasing lipolysis during hypoglycemia in patients with diabetes 
type I is located and proved that it is in skeletal muscle.
125
 Another proved that insulin resistance 
in the above patients is associated with impaired peripheral tissue lipolysis.
126
  Work has been 
done also using microdialysis to monitor the oxidative stress in tissues by measuring the ratio of 
reduced to oxidized glutathione in the dialysate. Glutathione has a main function in free radical 
scavenging hence any increase in that ratio indicates the increase in reduced glutathione 
indicating an increase in free radicals which are byproducts of ischaemic metabolism.
127
 This 
ratio can be used as a surrogate marker of ischaemia instead of measuring glucose and lactate 
concentrations. 
The technique can also used to deliver substances and drugs rather than just sampling them. 
This will allow the study of the pharmacokinetic and therapeutic effect of the drug in the tissue 
rather than systemically. A study from the Netherlands Maaschrift University in 2003, for 
example, shows that the local effect of the tissue lipolysis is the same to β-adrenergic stimulation 
in lean and obese men, but the systemic response does differ due to other factors.
128
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1.6.4.2. Microdialysis to measure net uptake and release of metabolites. 
Changes in a certain substrate measured with microdialysis indicate changes in the metabolic 
processes in that tissue; an example would be changes in the adipose tissue glycerol 
concentration signifies a change in lipolysis in that tissue or a change in glucose concentration in 
liver tissue might signify a change in the rate of gluceogenesis. However all these are relative 
and in order to know exactly if there is a net uptake or release the metabolite interstitial 
concentration has to be compared to its concentration in the blood plasma. An interstitial 
concentration higher than the one in the plasma signifies a net production of the metabolite and 
the opposite hold true.
129
 Studies conducted on human skeletal muscle using microdialysis do 
demonstrate this phenomenon. Glycerol increased in the adipose tissue during strenuous exercise 
indicating an increase in lipolysis while the opposite happened in muscle tissue where glycerol 
increased during rest and low-level exercise but not at high-level exercise. This implies that 
muscle lipolysis is highest at rest and uptake of glycerol increases in muscle tissue as the 
exercise level increases.
104
  
Studies of glucose and insulin metabolism in skeletal muscle has shown that microdialysis 
was able to demonstrate that elevation of insulin within physiologic levels does increase the 
permeability of the skeletal muscle to glucose whereas abnormal increase in insulin levels 
increases blood flow to the muscle but not further increase in the permeability of the muscle to 
glucose. Hence using microdialysis and calculating the difference in concentrations of a 
metabolite between the arterial and the interstitial can help in studying the metabolic processes 
going on that tissue.
130
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1.6.4.3. Microdialysis with tracer to measure the production and utilization rates. 
As explained earlier, microdialysis is an efficient tool to study the equilibrium of the tissues with 
the serum plasma; it can also be used to trace substrates from the plasma to the interstitial fluid 
and back where the substrates are labeled. Several methods are available for use microdialysis 
and tracer molecules to study kinetics of metabolism: 
1.6.4.3.1. The four pool method:131 
This method was developed to study the transport kinetics of amino acids in human skeletal 
muscle. This involved measuring concentrations of the aminoacids in four compartments: artery, 
veins, interstitial fluid, and muscle biopsies. This allows calculation of protein turnover rates, 
membrane transport rates, and transit between blood and interstitial fluid. The drawback of this 
method is that it is unreliable for amino acids with a large concentration gradient between blood 
and muscle. 
1.6.4.3.2. Tracer infusion with the catheter: 132 
If a tracer molecule is infused into the catheter and the rate of the disappearance of this 
tracer is calculated then this reflects the metabolism of this molecule in the tissue the catheter is 
in (along with mass transport and kinetics of the molecule in the particular tissue). This was used 
to study the effect of insulin and insulin resistance on glucose metabolism in muscle adipose 
tissue. The disadvantages of this method are that it is qualitative but not quantitative since the 
amount of tissue involved in the uptake is not known (which is the tissue in contact with the 
catheter and a certain cylinder of tissue around it). 
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1.6.4.3.3. Tracer infusion in the catheter and monitoring its products in tissue:133 
This is basically the same as the above but instead of measuring what is left in the catheter 
the products of the tracer molecule are measured in the tissue, hence we know what fraction of 
the molecule is utilized and through which pathway. An example is tracing 
13
C labeled glucose 
in adipose tissue and measuring the isotopomers of lactate in the tissue. It was found in the above 
reference that overfeeding healthy individuals increased lipogenesis in adipose tissue through the 
pentose phosphate pathway. This method is also a non-quantitative method but a qualitative one 
since the amount of tissue involved is also an approximation. 
1.6.5. Limitations of Microdialysis. 
  A major drawback with the conventional off-line microdialysis is the time delay in 
between the sample collection in order to obtain sufficient sample volumes for the automated 
analyzer to analyze. This would mean that the moderate perfusion rates used in the range of 
2µl/min to have an acceptable recovery would take a lot of time for the microvial to fill enough 
volume for the analyzer, needless to say that using slow rates of 0.3µl/min for good recovery will 
take even more time to collect (in the order of ten times slower). This would also mean that 
during a single collection period certain events that happen within minutes might go unnoticed 
since they are pooled with the other dialysate collected over that period which is usually in the 
range of 30 minutes to 4 hours sometimes. This can all be avoided by the use of the on-line rapid 
sampling microdialysis system developed by Imperial College Bioengineering that automatically 
samples and analyzes every 30 seconds. 
Another foreseen problem is that not all tissues are homogeneous. The catheter samples 
only from the interstitial space around the catheter with radial sampling of 1-2 mm
134, 135
, and 
hence the positioning of the catheter strongly influences the results.
136
 However in the 
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monitoring of bowel, as Sommer showed in his 2004 study where he monitored ischaemia in the 
bowel of piglets through three simultaneous catheters placed in the lumen (intraluminal), wall 
(intramural), and outside the wall (intraperitoneal) of the ischaemic bowel,
137
  intraperitoneal and 
intramural placement of the catheter are equally effective in monitoring ischaemia, while the 
intraluminal positioning lags behind since it does not sample the glucose which is probably 
washed away by the moving fluids in the lumen of the intestine. 
 1.7. The use of microdialysis in bowel monitoring 
 
As explained above; microdialysis have been deployed extensively in various human 
tissue as a diagnostic and clinical tool; likewise human bowel has its share in the use of this tool 
as a metabolic monitor.  The pioneer of microdialysis use in monitoring intestinal ischaemia was 
Tenhunen et al in 1996 where they proved that a microdialysis catheter can be used to measure 
ischaemic metabolites in the bowel wall of piglets during induced splanchnic ischaemia and 
reperfusion.
138
 Some work also followed that year in Japan by Hirata and his group where they 
used the microdialysis catheter to monitor changes in hydroxide as reperfusion occurs in 
ischaemic bowel
139
. A study further on by Oldner and colleagues did show that there are changes 
in lactate levels in the wall of the ileum and in the liver parenchyma indicating metabolic 
derangement prior to systemic measurements of increase in lactate.
140
 These findings aroused 
interest in using microdialysis in the monitoring of intestinal ischaemia. All the studies 
conducted at that period in time were animal studies with difference in the deployment in the 
catheter: intramural, intraluminal, intraperitoneal, and finally intravascular. 
Intramural deployment, namely in the wall of the bowel itself, has been used by many 
researchers, with differences in the technique of fixation. The procedure requires skill; correct 
and stable placement is of importance to ensure correct measurements.
136, 141
 Possible 
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disadvantages for this technique is the risk of perforation during insertion in the bowel wall and 
the possible risk of strangulation of the bowel mesentery around the catheter if it is poorly 
stabilized. However, if the above drawbacks are avoided intramural monitoring portrays the 
fastest changes in the metabolites in question, and hence is the best monitor. 
Intraluminal deployment, in the lumen free floating next to the mucosa, is another way of 
insertion that is less traumatic and allegedly more sensitive since the mucosa is the most 
sensitive of the bowel layers to ischaemia. During ischaemia the permeability of the mucosal 
cells increases and hence lactate is released into the lumen which in turn is sampled by the 
catheter.
142
 Therefore because of the easy accessibility to the bowel lumen the possibility of 
placing the catheter there makes it a feasible option.
137, 143
 The question arises if systemic 
hyperlactatemia affects the regional lactate concentrations in cases like sepsis, Tenhunen tackled 
the issue and found this wrong.
143, 144
 Intestinal ischaemia has been shown to increase lactate and 
other metabolites of ischaemia like glycerol in a gradual manner in the lumen of the bowel.
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However this has been done in piglets and to introduce the catheter in the lumen of patients it 
will be limited to the use of endoscopy so only the lower sigmoid, and the distal duodenum will 
be accessible. Otherwise, we will have to subject the patient to anesthesia and a 
minilaparotomy/laparoscopy to introduce the catheter in the lumen of the small bowel risking a 
bowel perforation.  A later study did show that intraluminal positioning is inferior to intramural/ 
intraperitoneal since there is a lot of artifact from the movement of the catheter in the lumen and 
the washout of the metabolites by the moving fecal material. 
137
 
Intraperitoneal deployment is on the abdominal side of the bowel free floating. Studies 
have shown that the peritoneal side of the bowel does display biochemical changes of ischaemia 
after the intramural position but before the systemic circulation does, and this is expected since 
65 
 
the local response is much more prominent before the systemic response follows through after 
the metabolites have reached and distributed in the circulation to change the systemic 
concentrations.
145, 146
 Korth and his group showed that there are changes that go together in the 
levels of lactate in the bowel wall and the peritoneum during cardiac arrest in pigs.
147
 Likewise 
Klaus et. al showed that L/P ratio does increase from a microdialysis sample of the peritoneum 
of pigs with ischaemic bowel.
148
 Sommer showed that regional or complete intestinal ischaemia 
can be monitored likewise using intraperitoneal or intramural microdialysis in pigs with 
comparable metabolic changes in lactate.
137
 This method is highly dependable on the position of 
the catheter and there should be a way of ensuring that the catheter be fixed next to the bowel 
area in question and  not to drift away in the peritoneum for it will be sampling some other area 
that has no interest to the physician.
136
 The catheter can be placed in the peritoneal cavity next to 
the area that needs to be monitored like a segment of bowel of questionable viability or an 
anastomosis with questionable vascular supply and then tunneled outside the cavity like any 
other surgical catheter is. The dialysate will then be analyzed for the biomarkers of ischaemia 
such as high levels of lactate. This has been done previously to monitor the anastomosis in 
patients after  right hemicolectomies, using manual sampling, with encouraging results.
149
 The 
question remains if we can use this technology in patients that did not undergo operative 
intervention and deploy the catheter intraperitoneally using ultra sound or CT scan guidance and 
then monitor the cavity in situations like septic intensive care patients or otherwise. 
Intravascular placement of the catheter in the mesenteric or portal veins, have been used 
before and did prove efficacious in the pig model.
150
 However, its use in patients without the 
need for an invasive radiologic procedure or even an operative intervention subjects the patient 
to increased risk of complications like bleeding, line sepsis, and inaccessibility of the mesenteric 
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veins. In addition removing the catheter will lead to uncontrollable bleeding from the portal, or 
the mesenteric veins. 
 
1.8. Hypothesis and Proposal. 
After the above review of literature, we see that there is a clinical need to develop a 
quantitative method to assess for bowel ischaemia and anastomotic ischaemia rather than relying 
on the surgeons’ subjective assessment and the non-quantitative methods outlined above. This is 
evident especially in the critical post-operative period where every hour of delay in diagnosis 
adds to the burden of the disease on the patient by increasing morbidity and mortality, on the 
physician by pausing the challenge in management, and on the hospital by increasing stay and 
consequently the cost of hospitalization. 
Microdialysis has been used extensively, as explained above, in the monitoring of tissues 
for ischaemia, in both research, animal, and clinical setting; however, its use for monitoring 
bowel was either extensive in the animal model, or limited in the form of offline monitoring in 
the clinical setting.
129, 141, 149
 We can see that microdialysis in its use to monitor bowel ischaemia 
was rarely used as an intramural device to monitor for the metabolites of ischaemia like glucose 
and lactate in the bowel itself; rather, it was used intra-abdominally and intraluminally as a 
surrogate marker for ischaemia manifested in the bowel tissue i.e. intramurally. Clearly, 
monitoring for the metabolites of ischaemia in the abdomen will assess for ischaemia but it will 
be non-specific to the abdomen along with all its contents with influenced  the systemic changes 
of these metabolites rather than being intramural monitoring with specificity to the bowel wall. 
Microdialysis also was never used as a rapid sampling (rs) analysis but always offline. 
That is the dialysate was always sampled manually by the researcher every few hours or so 
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which adds artifact to the sampling not to mention being laborious and time consuming to the 
sampler. The artifact added by manually sampling is the artifact attributed to the evaporation of 
the water from the sample, a process that cannot be avoided and hence falsely increases the 
concentrations of the metabolites in the sampled specimen of the dialysate. The specimen is also 
pooled over a period of hours so that it accumulates enough sample size to be read by the off-line 
analyzer. This pooling effect will mask any changes to the dialysate metabolites that might 
happen within minutes, and hence these changes are missed in the analysis since the analysis 
corresponds to concentrations pooled over hours and not minutes (where these changes occur).  
Having seen the above need and variables, we hypothesize that we can use the online rapid 
sampling system used to monitor ischaemia in the brain
151
 to monitor bowel ischaemia in an 
online-rs fashion and sample intramurally. To do so we propose a plan: 
1. Construct and optimize the rs-online analyzer and modify it along with the available 
market catheters to be suitable to be used in bowel monitoring.  
2. Acquire an ethics approval to use this system on human subjects. 
3. Test and pilot its feasibility and its functionality in human subjects. 
4. Test it in the animal model prior to getting it to the clinical bedside setting. 
5. Clinical testing in the bedside setting. 
The ultimate objective of the above proposal is to pioneer a device that can be used by the 
physician to alert for ongoing ischaemia in bowel in the postoperative period especially in the 
peri-anastomotic area. The above steps will be explained in detail in the methods section. 
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Chapter 2 
 
Methodology and pilot study 
 
 
  
In this chapter, we discuss the steps taken to construct and optimize the rs analyzer. Then 
we explain the steps taken to pilot study the analyzer in the operative setting (study I). We use 
the apparatus in the operating theater to monitor colon wall for ischaemia during resection of that 
segment of colon, which obviously is ischaemic after transection of the feeding artery. After the 
methodology of the pilot study we explain the results and interpret them.  
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2.1. Construct and optimize the rapid sampling microdialysis analyzer. 
The analyzer was constructed from raw components in the laboratories of the Department 
of Bioengineering at Imperial College London. The principle behind the analyzer rapid sampler 
is that it should inject a perfusate in the catheter and collect the dialysate from it to analyze 
simultaneously, and the collection/ analysis should be automated. We need to run the catheter 
from the system so we have to use the available CE approved catheters for human use, and 
modify them to adapt to the system. On the other hand, the system should be self sufficient to 
inject the perfusate in the catheter inflow tube and collect dialysate from its outflow. That 
dialysate is the solution that is to be analyzed automatically by the analyzer with a set time 
frequency. 
The concept that the system uses for analysis relies on an electro- chemicomechanical 
system. The dialysate solution is channeled to a certain container we call the chemical bed where 
a redox reaction occurs on the substrate in question (glucose or lactate). A buffer and a substrate 
specific oxidase enzyme in the chemical bed facilitate this reaction. The electrons freed by 
reducing the substrate are picked up by electronic flow cells connected to the outflow of the 
chemical bed and then channeled to a potentiostat. There the electrons are read as current and fed 
into a computer program that displays the current as peaks. (Figures 2.1 and 2.2) 
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Figure2.1: Chemical Redox reaction freeing electrons. 
 
Figure2.2: the schematic of the concept of the rapid sampling analyzer.  
 
The above explains in a schematic how the system runs. Then using that as a blueprint, 
the constituents of the system were purchased and assembled. Extensive research had to be done 
to find all the parts and order them. In total there are eight major parts of the system each made 
of several others: the following tables explain the parts of each of the above mentioned parts: 
SOx 
Substrate 
Product 
O2 
H2O2 
H2O 
H2O2 
HRP 
2Fc(III) 
2Fc(II) 
2e
- 
Enzyme Reactor  Electrode 
Reduction 
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1. The CMA pump box is made of  
400 CMA pump CMA microdialysis 
CMA catheters CMA microdialysis 
perfusion fluid CMA microdialysis 
Hamilton 1000series syringe Hamilton company 
Tubing adapter MicroBiotech 
FEP tubing  MicroBiotech 
Sterilize connectors Alaris Medical Systems 
Table 2.1: CMA pump box parts and corresponding manufacturers.  
 
2. The reaction box  
a. Valve and connectors 
Valco valve VALCO  
Spanner  RS 
VISF VALCO 
Hamilton Syringes Hamilton 
1700 gastight syr. Hamilton 
22s needles Hamilton 
HPLC syringes Hamilton 
22s needles Hamilton 
Alan key 
VALCO 
www.vici.com 
Table2.2a:  Valve box parts and accessories 
b. Reactors and enzymes 
High pressure inline filter Anachem 
Extra frits filter end fittings  Anachem 
Mixed cellulose ester 
membranes Millipore 
Filters disc holders Millipore 
Hole punchers paperpunch.com 
Spanner  RS 
Table 2.2b: Chemical beds parts and accessories 
c. Electrodes: Bas electrodes from BA Systems  
3. The buffer pump: HPLC pump was purchased from FLUX Instruments 
4. Solvent box with Ferrocene monocarboxylate buffer. 
1000ml bottle VWR Ltd 
500ml bottle VWR Ltd 
250ml bottle VWR Ltd 
Box RS 
red PEEK tubing Upchurch 
yellow PEEK tubing Upchurch 
blue PEEK tubing Upchurch 
green PEEK tubing Upchurch 
Plier-type tubing cutter Alltech International 
Ferrules and Fittings  Upchurch 
Ferrules and Fittings  Upchurch 
Ferrules and Fittings  Upchurch 
Unions Upchurch 
T- union Upchurch 
Glucose Oxydase Genzyme Diagnostic 
Lactate Oxydase Genzyme Diagnostic 
Horseradish Peroxidase Genzyme Diagnostic 
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100ml bottle VWR Ltd 
Special Bottle lit Anachem 
Table 2.3a. Collection bottles of the system 
 
 
 
 
Table 2.3b. Chemicals needed for the reaction 
 
 
 
5. Potentiostats: 
Powerlab-ADInstruments ADInstruments 
Potentiostats E-DAC 
Table 2.4. Potentiostats needed 
6. Apple MacBook Pro laptop that can run apple software and PC in parallel. 
7. Uninterrupted Power Supply (UPS) from APC 
8. Trolley to mount everything on top: Profile endoscopic trolley from Pentax. It also has a fully 
mobile arm mounted on the top shelf edge and is mobile in all directions. 
A custom made online analyzer was assembled in the Department of Bioengineering, 
Imperial College London. The valve box was mounted on the trolley on its arm to easily position 
the box where we want next to the patient. The valve box is made of the valve (Valco 
Instruments, Schenkon, Switzerland). The valve has two chambers inside it one for glucose and 
one for lactate analysis, each is 200 nl in size. The ferrocene buffer is pumped by the HPLC 
pump (Rheos 2000, Flux Instruments, Basel, Switzerland) through a green PEEK tubing into the 
valve. Before it enters the valve, the tubing bifurcates into two tubes one entering the glucose 
chamber and one entering the lactate chamber. The dialysate from the microdialysis catheter is 
Ferrocenecarboxylic Acid:  Fluka 
Sodium Chloride: Sigma 
Ethylenediaminetetracetic 
Acid: Sigma 
Sodium Citrate: Sigma 
Kathon CG Preservative: 
Chesham Chemicals 
Ltd 
Vacuum Filters VWR Int. Ltd 
Membranes 47mm-Anodisc: 
Whatman 
International 
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fed into the valve. A time interval is set to the valve to switch automatically between the two 
chambers. On every switch, the valve channels all the dialysate to that chamber. The dialysate 
mixes with the buffer(containing sodium citrate (0.1 M), sodium chloride (10 mM), Ferrocene 
monocarboxylate (1.5 mM),  pH = 7.0)  pumped in the chamber and then goes out of that 
chamber to the reactor bed via a yellow PEEK tubing. The redox reaction (schematic above, Fig 
2.2) happens in the beds containing the appropriate oxidase enzyme (glucose oxidase (GOx) for 
glucose or lactate oxidase (LOx) for lactate) and horseradish peroxidase (HRP) (Genzyme 
Diagnostics, Kent, UK). These enzymes are saturated on an abutting filter paper supplied by 
Whatmann International
®
 inside the chemical bed.
  
Out of either bed comes another connector 
leading into the BAS electrode [(BASi, West Lafayette, IN) held at a potential of –100mV 
(Ag/AgCl, [Cl
–
] = 10 mM) by a potentiostat (E-DAQ, Sydney, Australia)] that pick up the free 
ferricinium (Fc
+
) ions produced. The remaining fluid emerges from the electrode through the 
green PEEK out into a disposal container. This scheme applies for glucose on one side of the 
valve, and on the  otherfor the lactate sampling. 
The electrodes are connected via their three electrical outputs to the potentiostats, and 
through these to the ADIntruments Powerlab, situated on the second shelf of the trolley via 
regular connecting wires. The output of the potentiostats after converting the electrons sampled 
by the electrode to current is connected to the laptop, situated on the top shelf of the trolley, via 
its USB port. Data was collected using a Powerlab data collection system (8 S/P, ADInstruments, 
New South Wales, Australia) controlled by a Powerbook portable computer (Apple Computers, 
Cupertino, CA) running Chart
®
 5.6 (ADInstruments, New South Wales, Australia). 
The FLUX HPLC pump is set in the lower shelf and its output is connected via the green 
PEEK tubing to the Valco valve and a back pressure regulator ensures that there is no back 
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pressure in the tube for the pump to override. This pumps buffer, into the running system, and 
water and methanol into the system to clean it after sampling. The inflow of the HPLC pump is 
connected to the container bottle and that can be changed according to what solution we want to 
infuse in the system: be it methanol, water, or buffer. 
A syringe pump (CMA 400 pump, CMA, Stockholm, Sweden) was used to pump the 
perfusion solution (perfusion fluid T1, CMA Microdialysis, Stockholm, Sweden) at a flow rate 
set according to study parameters. The syringe on the pump is connected to the inflow of the 
catheter by an Alaris
®
 extension. The outflow of the catheter is connected to the above Valco 
valve by a custom modified extension FEP tubing and in the valve by a short Hamilton needle 
fitted to the FEP tube on one end and in the Valve in the second end. (Needle 22 gauge, 0.75 
inches, Hamilton, GR, Switzerland). 
The above explains in detail the system assembly. Following assembly, the system evaluated 
in the lab to assess functionality. Solutions containing exact concentration of both glucose and 
lactate were formulated. These solutions were injected into the valve entry port using a Hamilton 
Syringe. The current peaks on the beds were recorded and several readings were taken for 0.5, 1, 
2, and 4 mM of standard solutions of both L and G. Each peak recorded was exactly double in 
amplitude to the peak before it, corresponding to double the concentration of standard. Same 
thing applied when using lactate or glucose peaks. 
A sample catheter was then dipped in the above standards and a perfusate injected in the 
catheter at a rate of 2μL/min. The dialysate from the catheter was channeled into the valve. The 
peaks that were recorded correspond to the concentration in the dialysate, which is lower than the 
standard, but still at double amplitudes when using different solutions that differ with a factor of 
two in concentration (refer to section 2.3.3.2 for more details of calibration). The reason behind 
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the peaks being lower in amplitude is the recovery of the microdialysis probe, which is never 
100%.  
The bioengineering partner constructed and adapted the system for GI monitoring. The 
system was also optimized to increase the calibration range needed for bowel monitoring. Other 
variables such as temperature, flow rate of perfusate, pressure of chemical beds, and recovery 
were also studied.   
 2.2. Ethics approval. 
An application for the regional ethics committee was submitted and a meeting scheduled 
to discuss the methodology. Subsequent meetings led to the approval of the study ―the use of 
rapid sampling microdialysis for intraoperative monitoring of bowel ischaemia‖ reference 
#06/Q0403/21. An amendment was then submitted, and approved for the study using the rapid 
sampling microdialysis in the intensive care setting postoperatively in post aortic repair patients.  
All patients were consented prior to enrolling them in any of the studies and a full detail 
information sheet given to them with contact details of the researchers. Appendices D and E 
show the letters of the ethics approval, information sheets given to patients, and consent forms 
used in the human subject studies (I and III). The ethics of the study utilizing pig bowel 
anastomosis was conducted in France Elancourt in an animal research facility under license from 
the French government Ministry of Agriculture # A78760. This license covers the work done.  
2.3. Methods of pilot study (study I). 
This study was designed to pilot test the system and the catheter. The best scenario where 
we monitor ischaemia is a bowel resection operation. In that setting, there is a piece of bowel 
resected and this necessarily becomes ischaemic. We took the analyzer to the operating theatre 
and tunnelled the catheter in the bowel wall of the resected specimen before any arteries feeding 
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the specimen were ligated. Then we monitored the glucose and lactate from the dialysate, as the 
specimen was being resected in the operating theatre (Figure 2.3). This way we were basically 
monitoring a segment of bowel before, during, and after ischaemia.  
 
Figure 2.3: catheter placed in the colon wall to monitor ischaemia as it sets in during 
and after resection. 
2.3.1. Catheter modification: 
The CMA 62 Gastrointestinal catheter is NICE and CE approved for use in monitoring of the 
intestinal tract. 
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Figure 2.3a: The CMA 62 catheter. Under permission 
CMA95 
The catheter is made in the following manner. It has inflow tubing that has a luer lock  
mechanism that screws tight to the perfusing syringe. Then the length of the inflow tubing is 60 
centimeters that feeds the perfusate into the inflow shaft after the junction of the inflow and 
outflow tubings. After that junction the catheter continues as one shaft but made of two tubings; 
the continuation of the inflow and the outflow which is 18cms. At the end of that is the dialysis 
semipermeable membrane, 3cms in length where the whole exchange process with the tissue 
takes place.  
 
Figure 2.4: Cross section of the catheter shaft. Illustration by SD from CMA microdialysis95. 
The outflow tubing from the membrane carries the dialysate and goes through the above 
mentioned shaft until it reaches the junction where it splits of from the shaft and continues on its 
own as separate outflow tubing, 22 cms in length. That ends in a special collection vial holder 
where the vial sits in and is held snug tight against the outflow needle of the outflow tubing end. 
There the vial is inserted to collect the dialysate. The catheter comes with the tunneler that is a 
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splitable introducer. It is intended to introduce the tunneler in the tissue at hand, take the needle 
of the tunneler out, thread the catheter in, then remove the plastic tunneler by splitting its edges, 
and withdraw it out. The whole catheter comes with an outside covering tube made of 
polyethylene and a PEBAX
® 
fixing device. 
 
 
 
Figure 2.5: The tunneler. 1, handle. 2, splittable handles. 3, plastic catheter. 4, Needle. Under 
permission CMA95 
 However, this catheter is designed for use during offline sampling where the researcher 
samples it manually with a minimum of a two-hour lag. The dialysate is collected in the vial and 
later analyzed for the concentrations of the substrate. Certainly and in this study, we cannot use 
this way because the whole operation takes 40 minutes and then if we sampled one sample we 
certainly will not be monitoring as the changes happen when ischaemia sets in. We had to devise 
a way to: 
1. Implant the catheter without breaking it and tearing the bowel since the split catheter 
will shred the bowel wall when we split it. 
2. Fix the catheter in a sturdy enough manner to withstand the surgeon’s manipulation 
and not break or kink. 
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3. Devise and construct a connection to connect the catheter inflow from the pump, and 
outflow to the Valco valve of the analyzer. 
4. Maintain sterility. 
5. Be close enough to the surgical field, but away from the surgeon’s space.  
2.3.1.1. Catheter implantation. 
To improvise a way of deploying the catheter in the bowel wall, I had to go to the 
labarotory and test it on bench top models.. Several techniques were thought of and tried on 
swine gastrointestinal tissue. I considered swine stomach and tried it there; however the stomach 
in pigs is too thick and does not mimic the human colon. The small bowel in pigs is too thin and 
fragile and definitely sticking a needle in it to tunnel the catheter through will cause a through 
and through perforation, not to mention splitting the split plastic catheter. I then acquired some 
pig colon tissue which resembles the human colon in thickness and we tried our implantation 
technique there. The needle of the introducer was easily introduced in the seromuscular layer of 
the swine colon in the lab, especially that the colon was thawed from frozen and that per se adds 
some hard consistency to it. The needle was then removed from the introducer keeping the stylet 
in the colon wall and the catheter was introduced in the plastic splitable stylet. However, every 
time the introducer was split to get it out; the colon wall gave way and tore. This complication 
cannot be tolerated in the operative setting not because it will tear the colon wall, the colon is 
going to be resected anyways; but because it will contaminate the field with intestinal contents 
and increases the risk of postoperative infections. I had to devise a way to split the introducer 
with no trauma to tissue. I tried doing it slowly to no avail. I tried splitting the breaking of the 
two handles of the introducer and then tunneling it, which decreased the trauma on the colon 
wall since the first split is the most traumatic and then the introducer splits easily. This did not 
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work since the mere motion of the two splitted ends in the colon wall as they are being removed 
tore the wall.  After the above trials on the pig colon, we needed to find a way to tunnel that 
catheter without using the introducer or even splitting it.  
It was noticed that the introducer is a 16 gauge tunneler and is too big of a caliber for the 
catheter. The catheter can easily fit in a 20 gauge tunneler, and to decrease on the risk of 
breaking it or de-gloving the membrane of it, an 18 should be more than enough. Therefore, I 
explored the following idea. Why not tunnel the catheter through a regular 18 gauge Abbott
® 
(Abbott Laboratories, Abbott Park, Il)
 
angiocatheter that is used for intravenous (IV) access. I do 
not have to split it we can tunnel the angiocatheter in the colon wall; withdraw the needle out, 
keeping the angiocatheter in place. Then the microdialysis catheter can be introduced in one end 
of the angiocatheter and then the angiocatheter withdrawn from the other end, leaving the 
microdialysis catheter tunneled in the tissue. This was tried out in the pigs’ colon and even small 
bowel. It was successful and caused no perforations or shredding of the colon and even the swine 
small bowel thin wall. This later proved to be efficacious and trouble free when deployed in the 
sigmoid colon of patients in the operating theater and caused no complications such as 
perforation or tearing of the colon wall. 
2.3.1.2. Catheter fixation. 
After the catheter was tunneled in the wall, it had to be fixed in some manner to 
withstand the forces of moving it around while the surgeon is manipulating the bowel during the 
surgery. This was easily foreseen since the catheter will be subjected to pulling, tugging, pushing 
and kinking if it is caught against retraction or the patient’s abdominal wall and the surgeon is 
manipulating the bowel it is in, then it would easily dislodge from its tunnel. 
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The catheter was fixed and tried out in the lab using again swine bowel model. There 
were many techniques used but they usually were not sturdy enough to withstand the pulling 
forces. First, the catheter was denuded of its covering cuff and tunneled in the pig bowel in the 
above manner. Several 3/0 vicryl sutures were taken in the bowel wall and tied snug to the 
catheter itself.  
 
 
Figure 2.6: Catheter fixed in swine bowel with 3/0 vicryl sutures. 
 
This did not hold it in place after a gentle pull applied to its end. Then, we tunneled the catheter 
and used the same technique that we use to fix a surgical drain: I tied the suture first to itself and 
then to the catheter snug, to no avail. I tied another suture tight enough to hold it in place but that 
occluded the catheter since it is very soft.  
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Therefore, I thought that I had to fix the catheter to an external support and then fix that 
support. The catheter comes with an external covering that covers the entire shaft and is held in 
place at its base by a screwing to the proximal end of the shaft. 
 
Figure 2.7: Catheter fits in the covering shaft. 
 So if the shaft was screwed in place and the covering cut at its distal end to let the inside 
shaft of the catheter and its membrane out, then the covering can be fixed with tight sutures, and 
in turn fix the catheter in place and the shaft and the membrane will protrude through the cut end 
to implant in the tissue. This was done and the PEBAX
® 
fixing device used to wrap around the 
covering and then in turn the device was sutured and fixed to the bowel wall.  
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Figure 2.8: Catheter snug covered with its protective shaft and the whole thing is fixed to 
the PEBAX with sutures on the bowel. 
This was transiently successful since the device was sutured towards the proximal end of 
the covering and because it is a stiff covering, its stiffness and memory dislodged the catheter 
from its position. Therefore, we fixed it in the same manner but now I fixed it towards the distal 
end of the catheter covering just before where it was cut to allow the shaft and the membrane to 
come out so it resisted the pulling and tugging exerted at the other end.  Later, we discovered a 
different problem with this fixation technique. When the catheter pulls, and the tissue fixed 
underneath it gives way; the catheter goes out a millimeter or so, but when the pull is released 
the catheter goes back into its tunnel. Because the tunnel is very snug on the catheter it holds it in 
place while the shaft continues to push in, so the catheter kinks at the origin of the 
semipermeable membrane, which is the weakest point of the catheter. This kinking leads to 
dysfunction of the catheter. Another suture had to be added at the entry point of the 
semipermeable membrane in the tissue. This seromascular sleeve suture was fashioned in a 
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manner not to fix the membrane but to hold it in place while the above kinking happened so it 
keeps that weakest point in line with the shaft and not giving enough space to kink. This proved 
sturdy enough in the lab and had to be tried in the operative setting while the surgery was 
undertaken. 
At that point during the surgical procedure other flaws in the fixing technique were 
discovered and these had to be addressed. No matter how many sutures we took to fix the 
catheter covering and the PEBAX fixator around it; the catheter would withstand around 20 
minutes of manipulation and then it broke, kinked, or dislodged from the tunnel around it. So in 
order to alleviate the pulling forces on the catheter we had to loop the catheter around itself so 
when there was pulling  force applied inadvertently by the manipulation of the specimen during 
resection, these forces were dissipated in the loop and not transmitted to pull out the catheter. 
This finally worked and the catheter was sturdy enough to hold till the end of the resection. 
  
Figure 2.9: Loop of the catheter in the covering and the seromuscular entry suture shown in a 
pig bowel. 
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2.3.1.3. Catheter connections. 
The catheter will obviously be used in a sterile field during the operative procedure and 
the analyzer is a non sterile field. So, a certain connection must be used to elongate the inflow 
and outflow tubes of the catheter to enable perfusion of the catheter and sample dialysate to 
analyze it from a close distance to the operative field. The inlet tubing was connected to the 
syringe in the pump by a sterile tube extension 1.5 meters long with a capacity of 0.4ml (Alaris 
Medical
®
 systems Dublin, Ohio). This connection is sterile and screws tight into the pump 
syringe and the catheter on the two ends so it does not disconnect easily.  
 
Figure 2.10: Alaris Medical inlet tube extension with the catheter.This shows two PEBAX 
fixators to fix the loop when deploying the catheter. 
The outlet tubing of the catheter was extended using a sterilized 1.5 meter long fine fluorinated 
Ethylene Propylene (FEP) tubing (CMA Microdialysis AB, Stockholm, Sweden) the end of 
which was connected to the on-line analyzer by means of a needle adapter (Needle 22 gauge, 
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0.75 inches from Hamilton, GR, Switzerland) that fits snug tight in the Valco
®
 valve and 
connected to the FEP tubing by a sterilized blue connector. However on the outflow side of the 
catheter a certain connection had to be improvised since the catheter comes with the outflow end 
made ready for vial sampling, not for online sampling by the custom made analyzer. The 
connection at that end was made in the following fashion. The outflow vial holder containing the 
needle that pierced through the vial was cut from a non sterile catheter (figure 2.11.b). The 
plastic holders were then sawed off in the lab and smoothened exposing the needle giving a 
connector that looks like a ―bell‖ (figure 2.11.c). That needle was then used to connect to the 
catheter since it fits the size of the outflow tube of the catheter (figure 2.11.d). On the other end, 
and before the operation, a sterilize blue connector was jammed into the other end of the bell 
after softening it using methanol; that blue connector can be easily connected to the FEP tubing 
elongating the outflow of the catheter. Several bells were constructed using this method and was 
put on standby to be used later during the intraoperative sampling to connect the outflow to the 
FEP extension and ultimately to the VALCO valve at the other end by a Hamilton 22 gauge 
needle. 
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Figure 2.11: Steps in custom making the catheter connections 
 
 a. CMA catheter in situ 
 
 
b. Cutting of the vial receptor end. 
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c. receptor end edges sawed off to expose the needle inside, and custom sterilize connection 
jammed in the other end to allow for valve needle connection. 
 
d. The final extension of the outflow tube. 
 
 
The above connectors enabled enough length for the distance between the surgical field 
where the catheter was deployed and the analyzer next to it that was usually placed towards the 
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upper left side of the patient while the patient was in extended Lloyd-Davis Position on the 
operative table. 
 
Figure2.12. The final catheter modification. 
2.3.1.4. Maintaining sterility. 
The CMA 62 microdialysis catheter comes sterile packed and has been sterilized using 
gamma radiation. The other non sterile parts were sterilized (using chlorhexidine solution) before 
the operation and the whole assembled at the beginning of a case as will be explained in  2.3.2.1 
2.3.1.5. Operating near the field. 
The operative setting: the analyzer is directly next to the patient’s side as the connectors 
connect the inflow and the outflow of the catheter to the analyzer; note the preparation trolley at 
the lower right hand side, with the chlorhexidine solution still showing (red solution on the 
preparation trolly).  
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Figure 2.13. The operative setting 
 2.3.2. Practical steps in a clinical surgical procedure: 
The system was optimized for temperature, flow rate, pressure, volume, and speed by the 
team from the Department of Bioengineering supervised by Dr. Boutelle. It was intended to 
recruit patients undergoing both gastric and colon resections however it was found later that 
monitoring from gastric resection patients was unfeasible due to several reasons and technical 
difficulties (explained in table 2.6). However, the patients that we did monitor while having 
gastric resections did help improve our technique drastically. The reasons for that are as follows. 
The field of the gastric resection surgery is wider and the stomach resected has a larger area so it 
provides us with more tissue to test the fixation of the catheter. The stomach wall also is thicker 
than the colon wall, and since we were doing this for the first time, we wanted to be safe in 
testing our tunneling technique and fixation later on. Colon intraoperative perforations are much 
more contaminating than gastric ones. So, we needed to make sure that our tunneling technique 
is a safe one, minimizing risk of a perforation. Gastric resection cases are usually longer cases 
than colon resections and that provided us with time to explore our lab-developed technique 
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without adding considerable time to an already long case. The monitoring data from these gastric 
cases were sampled, but not analyzed. In each case the catheter did not withstand the length of 
the procedure and either kinked, dislodged, or broke during the manipulation so we knew that 
monitoring the stomach until total resection is not feasible and confirmed that the colon is a 
better option for us.  Several steps were specified to complete each case and monitor the bowel 
being resected, and were adhered to throughout the data collection from our cohort of 
colectomies: 
1. Setup of the sterile trolley in theatre prior to the start of the operation. 
2. Setup of the apparatus prior to the start of the case. 
3. Intraoperative timing and priming of the catheter and the connections. 
4. Implanting the catheter in the bowel and its timing. 
5. Time lag for delivery of dialysate. 
6. Running the sampling and monitoring the bowel until delivery of the specimen. 
7. Post delivery monitoring. 
2.3.2.1. Trolley Setup. 
The operative field is of course a sterile field and to incorporate a catheter there, it should be 
sterile along with its connections. The catheter and the inflow extension come as sterile in a 
sterile container from the market and from the companies that manufacture them. However, there 
are some parts that are not sterile and should be deemed so prior to the start of the operation. 
About 30 minutes prior to the operation and when the nurses are preparing their setup of the 
instruments, I would do the following. On a mobile trolley in the setup room I would scrub up 
and wear a sterile gown. Then and with the help of the circulating nurse I would cover the trolley 
with a sterile drape that the nurse supplies and opens for me in a sterile fashion. On that draped 
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trolley, I would put three 250 ml shallow containers (Rocialle Medical Ltd, Cambridge, UK): 
one filled with chlorhexidine solution, one filled with sterile water and the third empty. In the 
hexidine solution, I will immerse the non sterile FEP (previously flushed with sterile water by 
the Hamilton syringe) tube extension with its blue connectors (Microbiotech AB, Stockholm, 
Sweden), along with the custom made connection bell that was explained previously. These are 
left there to soak for a minimum of 30 minutes. After that, the soaked material is taken out and 
rinsed in the water several times. The chlorhexidine and water containers are disposed of and the 
rinsed FEP and bell are allowed to dry off in the third container. On the trolley, other sterile 
disposables are opened. These include: two 2.5 ml syringes, inflow extension, the catheter from 
its container along with the fixing PEBAX device, a 20 blade, an 18 gauge Abbott
® 
(Abbott 
Laboratories, Abbott Park, Il)
 
 angiocatheter, a 20 gauge needle, and 2/0 vicryl ties. 
The nurse then opens the ampoule with the sterile perfusion fluid, I, still in sterile gown, 
withdraw the 5 ml of perfusate from it in the two 2.5 syringes using the 20 gauge needle. One of 
the syringes is connected to the extension Alaris 0.4 ml extension tubing (Alaris Medical, 
California); this compromises the inflow syringe and connection to the catheter but it is not 
attached to the catheter inflow tube yet. 
The catheter is prepared in the following manner: 
  The sterile pack is opened. The catheter is inside its sheath; the sheath is marked 
by a scratch with the blade corresponding to where the semipermeable membrane 
starts of at the tip of the catheter.  
 The catheter is withdrawn from its sheath.  
 The sheath is cut by the blade at the above mark.  
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 The catheter is re-threaded through its sheath. Therefore, the result is the catheter 
inside its sheath and the membrane sticking out through that open end.  
 The PEBAX fixer is then deployed on top of the tip of the sheath just before the 
outtake of the membrane.  
 The PEBAX is then fixed to the sheath with 2/0 viryl ties in its grooves to make 
sure it does not dislodge during the operation. The catheter is now ready to be 
primed. 
2.3.2.2. Set up of the apparatus prior to the case. 
The morning of the operation, the apparatus is prepared by the Bioengineer. The system 
is cleaned by running methanol through it at high flow of 2000μL/min using the HPLC pump for 
5 minutes, followed by ultra filtered water at the same flow rate for 5 minutes.The water cleaning 
is to get rid of the methanol in the system since it denatures the enzymes. Then the ferrocene 
buffer pumped through the system at a flow rate of 200μL/min for 10 minutes and this will flush 
all water out from the system and replace it by the buffer. The enzyme beds are then connected 
to the Valco valve at each side.  
To calibrate the system previously prepared 0.5mM, 1mM, 2mM, and 4mM solutions of glucose 
and lactate are used. These are pumped into the valve with a Hamilton syringe one at a time and 
the peaks recorded on the Chart with comments marking each peak to its concentration in the 
syringe. The system is now calibrated and ready to analyze. It is wheeled down into theatres and 
parked next to the theatre and left there for later use. 
2.3.2.3. Intraoperative timing and priming of the catheter and the connections. 
The case starts and the surgeon performs the midline laparotomy and starts his dissection 
of the colon. After the mobilization of the colon and before any arteries are cut in the mesentery, 
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the surgeon signals to us that he needs around 10 minutes to start transecting feeding arteries. At 
that point, the apparatus is wheeled in the theater and parked on the left hand side of the 
operating table behind the surgeon away from the field. I, still in scrubs hand over the 
bioengineer the syringe with the inflow extension. She in turn deploys the syringe in the CMA 
pump and pumps, using the high rate button on the pump, perfusate into the connector from the 
syringe until the perfusate jets out of the connector. This means that the connector is full of fluid 
and then I connect its other sterile end into the inflow tube of the catheter and the pump is set to 
run at 10μl/min to prime the catheter. The catheter tip is immersed in sterile water so that when 
the perfusate reaches it, it fills up the outflow tube. We know that the catheter is primed when the 
outflow tube starts putting out fluid. At this point, the outflow tube is cut at it tip and the bell 
connector is connected to it and the FEP to the bell. Instantaneously the FEP starts putting out 
fluid since it was previously primed by flushing water into it. The valve needle is connected to 
the other end and pushed into the Valco valve. Now the catheter is ready to be deployed in the 
colon wall and connected to the pump at its inflow tube and to the valve at its outflow side. 
2.3.2.4. Implanting the catheter in the bowel and its timing. 
By that time, the surgeon is now ready to start his arterial transection. Therefore, the 
sterile trolley is wheeled closer to the field and the catheter moved from it to the field with its 
connections hanging out and reaching the analyzer as explained above. The 18-gauge ventflon 
needle from the trolley is used and tunneled very superficially in the antimesenteric seromuscular 
layer of the colon. The needle is withdrawn keeping the ventflon in the colon wall and the 
catheter tip (semi permeable membrane) is threaded through the ventflon and that in turn 
withdrawn from the colon wall leaving the catheter in situ. Two vicryl 2/0 sutures are taken in 
the PEBAX fixator to hold it in place and one seromuscular suture on top of the catheter entry 
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site to tuck it in place.  The sheath along with the catheter are looped as explained previously and 
fixed to the colon wall for further sturdiness.  
 
Figure2.14. The catheter implanted in the colon wall and fixed by the PEBAX fixator. 
The seromuscular suture is seen at the forceps tip explaining how it tucks the entry site of the 
catheter inwards avoiding its exteriorization and hence kinking. 
 
2.3.2.5. Time lag for delivery of dialysate. 
The CMA pump is now set at 4μl/min . The surgeon waits for us about 12 minutes until 
we get the first peak. During this time, he mobilizes the colon further to be ready for resection as 
soon as he starts cutting the arterial supply. This is the time needed for the dialysate from the 
colon wall to traverse the catheter and the FEP tubing and reach the valve to get a reading. This 
dialysate at the valve is the dialysate put out by the catheter 12 minutes previously and hence the 
lag period is known. At this point, the surgeon carries on his procedure and starts transecting 
arteries and telling us when he does that so we add comments on the chart corresponding to that 
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step of the operation. The system is set so that we get a reading of glucose and lactate as peaks 
every 30 seconds. 
2.3.2.6. Running the sampling and monitoring the bowel until delivery of the specimen. 
The apparatus is run for the length of the resection while recording all the major steps 
that are highlighted by the surgeon while he goes through the procedure. These include IMA 
transection, superior rectal artery transection, and marginal artery transection. At the end, the 
mesentery is transected and the specimen delivered outside the field along with the catheter in it 
and the extensions still connected to the apparatus at that time.  
2.3.2.7. Post delivery monitoring. 
The specimen is kept on the specimen table for about 20 minutes before sending it off to 
the histology lab for sectioning. During these twenty minutes the catheter is left in situ and 
sampling continues from the clearly ischaemic colon now. The fixation sutures are then cut and 
the catheter withdrawn from the specimen thus ending our sampling in the operating theater. The 
apparatus is then wheeled out and back to the lab for cleaning in the same above manner. The 
data is saved for analysis later. The catheter and all the disposables are then disposed of properly 
along with the sharps from the sterile trolley. 
2.3.2.8. Recruited cases. 
In total there were 22 cases recruited comprised of gastrectomies and colectomies 
together. Seven cases were recruited from the 22 to be analyzed as our cohort of patients and 15 
were excluded for to technical reasons. We did not recruit the gastrectomies due to the reasons 
explained above and the gastrectomy sampling was done to perfect our technique only. The 
tables that follow explain the recruited cases and the failed cases with corresponding reason for 
exclusion. 
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Case and 
sequence # 
Type Reason for inclusion 
Case 4 Colectomy The catheter was placed the regular way explained above, it 
kinked and displaced almost towards the end of the 
procedure but a full data set was obtained. 
Case 16 Colectomy The catheter was tunneled and sampled with no problems. 
Cases 18-22 Colectomy All ran with no trouble encountered while tunneling, fixing, 
or sampling. Towards the end of the recruitment period we 
perfected the technique and encountered no technical 
problems. 
Table 2.5: The recruited cases explained 
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Case and  
sequence # 
Type Reason for exclusion 
Case 1 Gastrectomy The catheter was tunneled in and fixed. It kinked and displaced 
around 30 minutes into the procedure, keeping the last 1 
centimeter of its tip in the stomach wall but surprisingly sampled 
until the end of the procedure. 
Case 2 LAR* The catheter was placed in with the cuff, and it did kink and 
displace but kept sampling until the end of sampling. It was fixed 
using the butterfly sutures only (with no loop due to lack of space 
in the specimen) and a seromuscular suture at the entry point. 
Case 3 Gastrectomy The set up preparations were made however, the catheter was not 
deployed because of unavailability of clear tissue in the specimen 
being resected. The consultant surgeon on the case made this 
decision 
Case 5 Gastrectomy The catheter broke during tunneling while threading it in the 
ventflon. The semipermeable membrane caught on the edge of the 
ventflon and ripped from the catheter tip. The procedure 
abandoned 
Case 6 LAR The catheter was not sampling properly. It was found broken 
within 20 minutes of the procedure. No data was collected. 
Case 7 Gastrectomy The setup was prepared but the catheter was not deployed for 
patient reasons. The consultant found that the angle of tunneling 
is too deep while he is trying to tunnel the ventflon in the stomach 
wall. He decided to abort. 
Case 8 LAR There was no problem with the catheter at neither the tunneling 
site nor the entry site; and yielded acceptable results. However, 
the catheter kinked at apex of U but that was an error in fixing it 
since the U loop was made to acute. 
Case 9 Gastrectomy Procedure abandoned for patient reasons. There was not enough 
tissue away from the tumor to deploy the catheter in. The surgeon 
definitely did not want to risk his oncologic resection so he 
decided to abort. 
Case 10 LAR The catheter was perfectly tunneled and fixated in a U loop 
fashion, however it did not put out when connected to the valve 
by its outflow extension. The procedure had to be aborted. 
†
 
Case 11 Gastrectomy The set up was done. However the patient had metastatic in the 
peritoneum and liver so the resection was aborted 
Case 12 Gastrectomy The set up was done, however for technical reasons and because it 
was started late in the day, the fellow had clinical commitments 
and could not stay for the catheter tunneling. The case was 
aborted. 
Case 13 LAR The catheter was tunneled and fixed the usual manner, but it 
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never put out any dialysate. It was found that the registrar on the 
case had put a clip on its outflow extension presumably by 
mistake. 
Case 14 Gastrectomy This was a smooth fixation and run. 
Case 15 Gastrectomy The surgeon did not see the patient fit to be recruited as there was 
technical complications with that procedure. 
Case 17 Colectomy The catheter tore while suturing because the tie was very tight on 
its base where the semi permeable membrane starts of. 
 
Table 2.6: The failed cases with the reasons for failure and exclusion. * Low anterior resection. 
† It was later found in the lab that the backup pressure in the system did not allow the catheter to 
empty in the valve; we have been using the system for a good six months now both in the lab and 
in the theater and its low diameter tubing’s got blocked by debris and glucose resins.  The system 
was cleaned well with high pressure water run at a set rate of 2000μL/min for a period of ten 
hours. 
 
2.3.3. Analysis of the raw data. 
2.3.3.1. Data collection. 
Data is collected using the Powerlab Chart
®
 program. The concentrations of the 
metabolites are displayed as current peaks on the running graph of the program with respect to 
time.  
 
Figure 2.15. The graphs as shown in the Chart program. The red corresponding to glucose and 
the green to lactate with respect to time. Double the peaks corresponding to double 
concentrations in calibrating the analyzer. 
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The peak amplitude corresponds to the current amplitude generating that peak as it is 
inputted into the potentiostat from the chemical redox reaction corresponding to a certain 
concentration of the metabolite, be it glucose or lactate. The peak amplitude of each peak is 
inputted manually into an Excel program. On the excel sheet there is the time of the current and 
its corresponding peak amplitude in µA (micro-amperes). 
2.3.3.2. Conversion of current peaks (µA) to concentration (mM) 
As explained before the system is calibrated before the start of each sampling with 
standards of glucose/lactate solutions of 0.5, 1, 2, and 4mM. Each concentration of the standards 
is injected 3 times into the valve producing three peaks for each of the metabolites. The 
amplitude of these three peaks is averaged to get the average peak amplitude. This is done 
repetitively for all the four concentrations. The four average peak amplitudes (y-axis) are plotted 
against their respective concentrations (x-axis) with the line passing through the zero point. The 
resulting slope of the line is the conversion coefficient of the peak amplitudes in mA to 
concentration in mM.   
 
Figure 2.16. This is a sample of the graph used to calculate the slope, which is the 
conversion factor of amplitude to concentration for a lactate monitoring. The lactate points are 
in green and the slope of the resulting line is 0.93 which is the conversion factor in this case. 
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For the study that uses sampling on a short period of time like study I, the above conversion 
coefficient is sufficient enough and reliable since the reaction beds do not lose reactivity over a 
short period of time.  
The peak amplitudes are then converted to concentrations by dividing the individual 
values of the peak amplitudes by the conversion coefficient which is the slope of the line or the 
corrected slope according to the study at hand. The time of the sampling is then changed to 
minutes. A graph then plotted of the concentration of the metabolite versus time for each of 
glucose and lactate in that data from the patient. 
2.3.4 Statistics relevant to Study I 
For each sampling set the lag period was calculated by timing the implantation of the 
catheter (time zero) and the appearance of the first peak in the sampling which corresponds to the 
concentration of the dialysate as it first came out of the catheter at the time of implantation. This 
time lag was corrected for during the analysis.  The time delay from the outflow of the catheter 
to the analysis nanochamber was on average 12 minutes. Chart was also used for data analysis, 
the values were presented as mean ± standard error. The graphs plotted in the same manner as 
explained above with the key steps in the operation outlined in the graphs as they occur; such as 
inferior mesenteric artery (IMA) transection, marginal artery transection, mesocolon transected, 
and specimen delivery.  
To study the effects of ischaemia on the metabolites, the ischaemic insult, which is the 
transection of the IMA, was set to time zero during the analysis. All the data before that 
corresponds to healthy tissue and all the data after that correspond to ischaemic tissue. The data 
of the seven patients was averaged according to the above assumption. The values were 
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presented as mean±standard error. The increments of glucose and lactate obtained were plotted 
against a common axis of time. L/G ratio was also calculated for the average. Single population 
student t-tests was performed, at 10 minutes and 17 minutes post artery transection and on the 
mean of last 5 minutes of data recorded, to test the null hypothesis that values were zero. P-
values, p< 0.05 were considered significant.  
2.4. Results of Study I. 
Seven patients having colectomies were recruited for data collection and analysis 
between the period of June 2006 and March 2007. The patients all were undergoing colon 
resections for both benign and malignant processes. All the graphs show glucose concentration 
traces in red and lactate concentration trace in green. The microdialysis catheter was tunneled in 
and the surgeon waited for the analyzer to start putting out peaks, meaning that the dialysate has 
arrived at the valve of the analyzer and then he continued the resection. The longitudinal marks 
in the graph point out the time of feeding artery transection, which are the major ischaemic 
insults to the tissue. Appendix A shows a sample of the raw data of the cohort. 
i. Patient 1: 6/7/06  
65 year old male presenting with repetitive sigmoid diverticular disease attacks for 
elective sigmoid colectomy. The patient was prepared for surgery and an open sigmoid 
colectomy performed. Online rapid sampling microdialysis showed the following glucose and 
lactate traces: 
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 Figure 2.17. Monitoring graph of patient 1 
The glucose level drops from 4.2mM to 0.6mM at the time of IMA transection (11:27) and then 
recovers to 5.6mM in 15 minutes. At the point of artery transection there is no sudden change of 
the lactate value but with time we notice a steady increase in the lactate concentration. Twenty 
minutes later the remaining feeding mesentery of the sigmoid colon is transected and the 
specimen is delivered outside the operative field but the catheter stays in the specimen and 
analysis continues. At this point, the glucose decreases in the coming few minutes from 5.2mM 
to a value of 4.4mM, but we notice some attempt at recovery and it remains fairly stable at 
around this value for 7 minutes and then starts decreasing to reach a value of 2.4mM 23 minutes 
after specimen delivery. Then it increases back again to a value of 3.7mM during a period of 10 
minutes; lactate during that period is satble at 5.2mM but then after that period ellapses it rises 
steadily to reach a value of 9.3mM towards the end of the recording. Glucose concentration on 
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the other hand after that 10 minute period fails to recover and decreases steadily to reach 0.9mM 
towards the end of the recording. 
ii.Patient 2: 1/9/06 
This is a 76 year old male presenting with a cancer in his right colon, for a right 
hemicolectomy on elective basis. Rapid sampling microdialysis revealed the following graph: 
  
Figure 2.18. Monitoring graph of patient 2. Right colic artery transection, ileocolic 
artery transection, mesentery transection and specimen delivery all shown in boxes 
After the right colic artery transection we notice a decrease in the glucose concentration from 
3.5mM to 3.1mM over two minutes only to rebound back again to 3.8mM after 4 minutes from 
the artery transection. Lactate, on the other hand remains, fairly stable. After the Ileocolic artery 
transection we see the same behavior of the glucose pool; it decreases from 3.6mM to 3.1mM 
over two minutes only to rebound back again to 5.8mM in yet another 4 minutes from artery 
transection. Lactate after this transection starts increasing from 0.8mM to 1.7mM and this is 
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during the period when there is no more a major artery feeding the specimen but the mesentery 
only. When glucose rebounds back we see that lactate increases in parallel to reach 1.7mM the 
exact time when glucose starts decreasing again. After that, the mesentery is transected and the 
specimen is delivered outside the operative field with the catheter still sampling in place. Then 
we see the lactate concentration increasing steadily to 2.1mM and glucose decreasing to 2.2mM 
towards the end of sampling. Towards the end, the catheter was dislodged out of the specimen by 
the surgeon’s manipulation and we see a parallel nearly instant drop in the metabolites 
concentration. This is because of sharp decrease in recovery since the catheter is no longer in 
contact with any colon tissue. 
There are two time intervals at 10:40 and 11:59 where we notice a parallel change in metabolite 
concentrations. Whether that change is a true change in the metabolite concentrations or a 
transient increase in recovery of the probes remains subject to speculation. 
 
iii. Patient 3: 1/12/06 
This is a 71 year old man presenting with diverticular disease of the sigmoid colon with several 
attacks. He had an elective sigmoid colectomy. The rapid sampling microdialysis graph of his 
colon glucose and lactate concentration is the following: 
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 Figure 2.19. Monitoring graph of patient 3 
We notice the same behavior of the glucose concentration for just after the artery 
transection the glucose decreases from 2.4mM to 2.2mM only to show the same rebound 
increase to 2.9mM in 3 minutes. Then the marginal artery is transected and we see glucose 
decrease from 2.5mM to 2.4mM only to go back again to 2.8mM in 6 minutes. Lactate remains 
stable until late in resection of both feeding arteries and then as the surgeon is going through the 
colon mesentery we start noticing lactate increase from 0.7mM to 1.7mM directly after the 
specimen delivery and finally to 3.7mM at the end of the recording. Glucose decreases steadily 
after specimen is out to reach 0.29 at the end of the recording. 
iv. Patient 4: 16/2/07  
This is an 84 year old lady presenting with a left colon tumor for elective sigmoid 
resection. The graph from rapid sampling microdialysis is the following: 
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 Figure 2.20. Monitoring graph of patient 4 
We notice from the graphs that the concentrations of glucose and lactate tend be fairly 
stable until the marginal artery is cut. This is followed by the glucose concentration rising as 
seen in the other patients from 3.1mM to 3.8mM and that is paralleled by a lactate increase from 
0.4mM to 0.6mM.  Then the inferior mesenteric artery is cut and glucose falls transiently to 
2.9mM and then rebounds quickly to 3.3mM only to decrease steadily afterwards when the 
specimen is out to reach 0.9mM at  the end of the recording. Lactate however, after the last 
arterial transection increases steadily from 0.3mM to reach 1.2mM at the end of the recording. 
v. Patient 5: 20/2/07  
68-year-old female is presenting with cancer in her sigmoid colon for elective resection 
of the sigmoid colon. The graph of the concentration traces is the following: 
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 Figure 2.21. Monitoring graph of patient 5 
The microdialysis concentration levels of glucose and lactate seem fairly stable until the 
major feeding artery, IMA, is cut then we see the glucose concentration dropping from to 1.3mM 
to 1.1mM only to rebound increase to 1.4mM just before the marginal artery transection. After 
that, it remains fairly stable for about 7 minutes where we see after that a rebound increase to 
1.9mM after which the remaining mesorectum is cut and the specimen is out. After that, there is 
a steady decrease in glucose concentration to 0.3mM. Lactate, on the other hand, remains fairly 
constant until the transection of the last feeding artery where it rises steadily from 0.5mM to 
1.5mM.  
 
 
 
109 
 
vi. Patient 6: 23/2/07  
This is a 62 year old man presenting with cancer is his sigmoid colon for elective 
resection of his sigmoid. The graph of the microdialysate concentrations of glucose and lactate is 
the following: 
  
 Figure 2.22. Monitoring graph of patient 6 
The traces of glucose and lactate behave similarly to the other patients traces. Glucose 
after each artery transection decreases only to rebound increase back again until its final decrease 
when the specimen is out. After IMA transection it falls from 1.4mM to 1.1mM back up again to 
1.4mM. After the marginal artery is cut, it falls with an increment of 0.4 from 1.3mM to 0.9mM 
but then regains some of that fall by rising to 1.36mM. At that time the mesentery is almost all 
transected and hence it decreases steadily, and after specimen is out, to 0.3mM. Lactate, on the 
other hand, remains constant until the last major feeding artery is transected and then it increases 
gradually from 0.5mM to 2.1mM.  
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vii. Patient 7: 30/3/07 
This is a 70 year old male presenting with a cancer in the sigmoid colon for elective 
resection of his sigmoid colon. The graph of the concentration traces is as follows: 
 
 
 Figure 2.23. Monitoring graph of patient 7 
The trace also shows the same behavior for glucose concentration. After the IMA 
transection it falls from 1.6mM to 1.3mM, only to regain its fall back to 1.6mM. After the 
marginal artery is cut; it falls from 1.6mM to 1.5mM only to have a significant rebound back to 
2.4mM which almost the same value of its initial value at the start of sampling. At that time the 
mesorectum is almost all transected and it decreases steadily to 1.5mM at the end of the 
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recording. Lactate on the other hand remains fairly stable until both arteries are transected and 
then rises gradually from 0.4mM to 1.1mM at the end of the recording. 
The average of the changes of the concentrations in all patients was then calculated. The 
change in concentration at any one point after major artery transection is the increment or 
decrement from its baseline value before artery transection at time zero. We used the average in 
the change because we were dealing with a group of patients and definitely not all patients have 
the same physiology in their intercellular fluid; not to mention that we were monitoring with 
interest to see how the levels react to an ischaemic insult, i.e. how they change. So after 
calculating the change in glucose and lactate in the patients, these were averaged together (major 
artery transection being always time zero) to yield the following graph of glucose and lactate. 
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Figure 2.24: The respective average changes of the cohort. Lactate in green and glucose 
in red in the cohort of the colectomies monitored. The bars show standard error. 
In the above graph time zero was the time of major feeding artery transection to the 
specimen; hence the time when ischaemia started. The time axis after that reflects the average 
change in glucose in red and lactate in green. Before that point, it shows the stable levels of 
glucose and lactate in the same colors. We notice on the above graphs that following arterial 
transection glucose levels decreased significantly at 10 minutes [-0.261±0.085mM (p=0.0175, 
n=7)] to recover to previous levels by about 17 minutes [0.062± 0.232mM (p=0.795, n=7)]. It is 
past the 20 minutes mark that glucose levels show a dramatic steady and significant decrease 
reaching -1.89±0.39mM (p=0.0135, n=6)  towards the end of the recording when the specimen 
was delivered outside the surgical field, hence definitely ischaemic. Lactate levels on the other 
hand, do not show any difference from baseline (it was -0.07±0.11mM (p=0.5480, n=7) at 
t=10mins), until 17 minutes where lactate concentrations increased steadily throughout the 
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procedure reaching +1.47±0.53mM (p=0.0331, n=7) towards the end of the monitoring. Values 
presented are mean ± standard error. 
The change histograms are displayed as follows and it gives a visible representation in 
bars of the changes at 10, 17, and end of recording. 
 
Figure 2.25. The ischaemia changes histograms.  Glucose and lactate in red and green 
respectively, * p<0.05  **p<0.01.   
The table below shows the distinct concentrations of each patient at the respective times 
that were deemed significant after the above analysis was done: 
Patient mM t=0 t=10 t=17 t=end 
Pt 1 G 1.50 3.40 5.20 0.90 
L 0.40 1.40 2.00 9.30 
Pt 2 G 3.06 5.60 3.50 2.00 
L 0.78 1.60 1.20 2.03 
Pt 3 G 2.41 2.37 2.63 0.62 
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L 0.71 0.61 0.77 3.63 
Pt 4 G 3.78 2.70 1.90 1.02 
L 0.67 0.61 0.62 1.16 
Pt 5 G 1.31 1.09 0.99 0.36 
L 0.65 0.55 0.46 1.45 
Pt 6 G 1.39 1.03 1.27 0.40 
L 0.35 0.51 0.94 2.08 
Pt 7 G 1.60 2.02 2.00 1.50 
L 0.49 0.70 0.85 1.02 
Table 2.7: G and L concentrations in the 7 patients at the t=0, t=10, t=17, and t=end.  
The L/G ratio has also been plotted on the data, and it is a better way to represent the 
change of the two metabolites in relation to each other. The ratio was calculated in the six 
patients (excluding patient 3 due to short monitoring period) then averaged out as a plot vs. time, 
time zero being major feeding artery transection. We observe that the ratio remains constant at 
0.410±0.063 before t=20 minutes after which it increases steadily to a significant value of 
8.051±0.452 (16 fold increase) at the end of the procedure (P < 0.001, n=6). Values presented are 
mean ± standard error. 
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Figure 2.26. The L/G ratio of the cohort of the cohort of the colectomies. 
2.5 Interpretation of results of the pilot study (study I). 
2.5.1. Metabolic interpretation. 
The use of this technology and its application in the real-time analysis has shown that it is 
feasible to use it in the clinical setting. The interesting result that is shown here is that glucose 
concentration tends to increase after the main artery transection for a short time before the 
expected drop due to the onset of ischaemia. This phenomenon is repeated with every transection 
of a feeding artery until the specimen is in complete ischaemia where glucose concentration 
decreases indefinitely. This may be explained by several theories. There might be a mechanism 
which senses the scarcity of the glucose supply and hence the cells start taking whatever glucose 
is available from the arterial tributaries and storing it in the extracellular fluid leading to an 
increase in glucose concentration, which eventually is picked up by the microdialysis system. 
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Another reason can be a decrease in the metabolism of the cells where the glucose accumulates 
outside since it is not being used intracellularly. This is strongly negated by the fact that the 
lactate rises steadily directly after the transection of the artery emphasizing the fact that the 
metabolic rate is kept constant; and the cells have switched to anaerobic metabolism  (due to the 
scarcity of the oxygen supply) to meet their energy requirements. This increases the production 
of lactate which is steadily sampled by the microdialysis system. 
This finding of transient glucose increase can be explained by the compensatory 
autoregulatory responses, which are mediated by local arteriolar vasodilatation governed by two 
mechanisms. The myogenic response dependent on the endothelial generation of nitric oxide 
152, 
153
 and this response is a direct reflex to the decrease in perfusion pressure. The metabolic 
response which kicks in later and is a reflex response to the increased levels of adenosine as a 
consequence of decreased pH from lactate production and decreased oxygen tension from 
ischaemia
154, 155
. As the ischemic insult continues the tissues respond by increasing oxygen and 
nutrient extraction 
156
 and this is facilitated by the relaxation of the precapillary sphincters 
thereby increasing the surface area for nutrient extraction and decreasing the distance for nutrient 
diffusion resulting in a net increase in nutrients in the intercellular fluid.
83, 157
 This mechanism 
that leads to increase in nutrient extraction was demonstrated by the rapid sampling 
microdialysis analyzer and we were able to show this transient increase in glucose for the period 
expected until these compensatory mechanism fail due to the persistence of the ischaemia and 
then tissue injury occurs 
83
. These autoregulatory compensatory mechanisms work well in 
maintaining adequate supply to the intestine in scenarios with mild to moderate ischaemia where 
there are some blood collaterals still available to supply the tissue, like in atherosclerotic 
ischaemia of the gut. However, they fail in cases of severe ischaemia, where the system has been 
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completely cut off from any supply as in embolic ischaemia of the gut, where the insult exceeds 
their compensatory capabilities and irreversible injury occurs. The microdialysis system showed 
significant irreversible glucose decrease and lactate increase when the specimen was delivered 
from the operating field. The results of this study show that the increase in lactate happens late in 
the sequence of events. This further proves that ischaemia sets in late after all the above 
responses fail and after there are no more available nutrients for extraction through any 
mechanism from the collateral circulation. 
Furthermore, the use of L/G ratio did prove that the ischaemic injury happens late in the 
process and after cessation of all collateral flow. The ratio in this study was shown to be constant 
at 20 minutes post ischaemia when there was still collateral flow, and increases significantly at 
the cessation of collateral flow at the end of the recording.  This ratio is an adequate indicator to 
ischaemia as  proven before by Parkin et al. 
106, 107
 
 This change in bowel lactate concentration cannot be attributed to the systemic 
hyperlactatemia as shown by Tenhunen et al.
143
 The difference from the above referenced study 
is that they used extraction methods of 
131
I –Albumin or 86Rb or velocity measurements to assess 
the glucose and oxygen consumption but did not use a real-time quantitative method like the 
microdialysis method explained in this study.  
Rapid sampling on-line microdialysis has shown that a safe non-ischaemic window exists 
in which glucose and lactate levels are sustained following major blood supply cutoff in the 
bowel. The tissue apparently thrives on collateral circulation. This is of important clinical 
relevance. Surgeons can rely on this window to ensure that after resection of dead bowel in 
ischaemic splanchnic phenomena, the remaining bowel can thrive from collaterals. Likewise, 
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colorectal surgeons can rely on this window to ensure that colorectal anastomosis is adequately 
perfused despite main arterial transection in oncologic resections of the colon.  
There are artifacts that would be expected from this study. These include recovery 
artifacts due to motion of the bowel and the iatrogenic motion by the manipulation of the bowel 
by the surgeon as he proceeds in the operation. Bowel peristalsis during surgical procedures is 
minimal however if such motion or iatrogenic motion by the surgeon did affect the recovery of 
the probe this would be seen as a parallel increase or decrease in both glucose and lactate 
dialysate concentrations: an effect that was not seen in this study and as explained by Parkin et. 
al.
107
 This is why the use of the L/G ratio is important in the analysis to minimize on the effect of 
recovery changes on the results. 
2.5.2 Clinical application of the system. 
Bowel ischaemia remains to be an intriguing process to the surgeon often facing him with 
many complications because of failure or lateness in diagnosis. The numbers in literature are not 
that reassuring; the overall incidence of ischaemic colitis after abdominal aortic repair surgery 
can reach as high as 40% if the subclinical cases were reported rising up to 60 % in the 
emergency rupture setting  hence the earlier the diagnosis the better the prognosis.
39, 40
 
Several modalities have been developed to monitor intestinal ischemia such as laser flow 
Doppler, Doppler sonography, tonometry, injection of intravenous fluorescein, and radiological 
studies be it CT scan or magnetic resonance (MR) angiography. 
71, 74, 76, 80, 83, 85, 86, 89
 As we can 
notice, none of the above modalities are real time bedside technology and they only give you a 
snapshot of the bowel status and perfusion without the ability to follow on the status in a real 
time fashion for extended periods. They are usually ordered in the clinical setting when the 
physician wants to rule out the diagnosis of intestinal ischaemia after the major systemic and 
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hemodynamic changes have already set in and usually when ischaemia is too late to reverse after 
the bowel has undergone irreversible changes. 
The other modalities available are the biochemical markers like the leukocyte count, 
acid-base status, serum electrolyte disturbances, and various enzymes and substrates the most 
important of which is the lactate where the D isomer is the best predictor of intestinal 
ischaemia.
117
 This often fails to correlate significantly with the perfusion and may reflect also 
increase in aerobic glycolysis in patients with septicemia or injury.
158
 In addition, the liver plays 
an important role in filtering the metabolites of ischaemia before they reach the blood stream and 
hence blood values of these substrates are not the exact indicator of the extent of ischaemia. 
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All the above techniques have failed to prove that there is a gold standard in the diagnosis 
of intestinal ischaemia. Patients are often subjected to interventional radiological procedures and 
laparotomies late enough to find out that the ischaemia has set in and is too late to reverse, 
keeping in mind that the ischaemia is diagnosed by the surgeons’ expertise and subjectiveness. 
Real time microdialysis provides, in contrast to all the above techniques and modalities, a minute 
to minute monitoring of the bowel. It has proved that it can monitor the changes in the 
metabolites of ischaemia as soon as they occur being sensitive enough to even pick the very 
transient compensatory increase in the tissue glucose just as ischaemia sets in, not to mention 
that it was able to pick up the instantaneous rise in lactate. Developing this technology further 
and studying its use in randomized clinical trials to accept it as a clinical bedside tool to 
quantitatively monitor for bedside intestinal ischaemia can add a lot to the tools that the surgeon 
relies on to diagnose intestinal ischaemia way before its systemic consequences manifest in the 
patient.  
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Despite its limitations listed in the next section, this technology has the potential to be 
applied in so many surgical applications. In the ICU setting, the surgeon is faced several times 
with the dilemma of the bowel viability especially in the peri-operative setting. This technique 
could be used in the future to monitor the bowel for ischaemia in vascular cases and general 
surgery cases, or even bowel anastomosis cases, where the catheter can be left intramural and 
tunneled outside the abdominal wall for analysis hence replacing second look laparotomies to 
assess for bowel viability. Such applications are only hypothetical and need to be explored more 
with clinical studies. 
Changes in both biochemical markers and imaging modalities occur too late to reverse 
the structural damage caused by ischaemia. By contrast, rapid sampling microdialysis measures 
the changes in the metabolism with more temporal resolution, being sensitive enough to detect 
the transient fluctuations in tissue glucose after division of individual feeding arteries.  The 
current study demonstrated the feasibility of using the microdialysis system in clinical practice 
and the reproducibility of the measurements with consistent results. In addition, on-line rapid 
sampling microdialysis provides a method for continuous measurement of tissue viability. Alarm 
systems can be integrated to warn clinicians if the concentration of glucose and lactate reach 
certain critical levels. This will be of particular value to avoid second look laparotomy for 
suspected small bowel ischaemia or ischaemic colitis following aortic surgery. In those cases, the 
steady change in dialysate lactate or glucose concentration indicates established bowel 
ischaemia. Further studies are required to test the usability of on-line rapid sampling 
microdialysis in routine clinical practice as an alarm system that monitors bowel ischaemia. 
The additional value that this system portrays different from all other microdialysis 
system, used to monitor bowel before in animal and human subjects, is its temporal specificity. 
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This system takes a snapshot of the metabolic state of the intestine every 30 seconds in contrast 
to all the other studies that were explained in the introduction that are sampled in the range of 
hours. Hence, the physician is monitoring the bowel viability, using rapid sampling 
microdialysis, in truly an online fashion. As a contrast to what was available in the market 
before, where offline analysis samples with frequency of hours. Hence, the chances of missing 
ischaemic events in these hours are annulled, and we can assess the bowel every thirty seconds. 
This is important since the bowel manifests irreversible mucosa ischaemic injuries in the order of 
minutes, and if this injury goes unnoticed for hours in between the sampling periods, then a 
whole segment can go ischaemic without having any medical system alarm signaling that.   
2.5.3 Current Limitations of this technology. 
There are limitations in using this technology. Deployment of the catheter is an additional 
invasive procedure. Nevertheless, it is done during the phase where the patient is under general 
anaesthesia and is deployed like any surgical drain in the abdomen. Removal is not painful and 
can be done bedside with no anaesthesia needed. The analyzer is still a crude custom-made 
apparatus and needs some technical changes done to render itmore robust. Several technical 
problems occurred throughout the studies and all had to be attended to directly, for the slightest 
technical fault would stop the apparatus from functioning. 
2.5.4 Technical problems encountered. 
Many problems occurred. The apparatus as explained above is made of so many small 
parts each with a problem of its own. A summary of the numerous problems encountered would 
be as follows.  
1. The HPLC pump is pressure dependent and any increase in pressure in the system 
due to backpressure from the beds or resistance from the micro-diameter 
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connecting tubes would cause a leak in the buffer from the pump and the 
sampling stops. This was attended by adding a backpressure regulator valve 
and making sure, the chemical beds have low resistance to ensure a low-
pressure system. Debris, from the solutions used, blocked the system so many 
times despite ultra filtration of all solutions and the system had to be cleaned 
repetitively by running ultra filtered methanol and distilled water at a high flow 
rate of 2000μL/min for many hours. Before deploying the back pressure 
regulator, the system built so much internal pressure, due to repetitive use, that 
exceeded the flow pressure of the catheter and henceforth impeded its 
sampling in the Valco valve in one of the cases (Patient 10).  
2. The enzyme beds lose their reactivity over time and have to be constantly 
calibrated over the sampling period and the reactivity change accounted for in 
the analysis. This was not a problem in this study since we were sampling over 
a period of one hour maximum; but it was a problem in the coming studies that 
needed sampling over a period of 2 days.  
3. The chemical beds are made of filter paper loaded with enzymes.These block and 
the system pressure increases, so the beds have to be changed when this 
happens.  
4. The BAS electrodes sometimes saturate with static from the potentiostats, and 
have to be disassembled, cleaned, and grounded.  
5. The connections from the electrodes to the potentiostats are in a form of clip on 
switches and they dislodge with manipulation of the system and especially the 
beds.  
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6. The connections of the beds to the solution tubes are padded by gaskets, which 
leak sometimes and have to be changed.  
7. Software failure in the laptop occurred many times. The pump software stopped 
overnight and had to be reset and reprogrammed. The Chart program in two 
occasions also failed and had to be reset.  
2.6 Conclusions from study I. 
This study has shown that the real time rapid sampling microdialysis is an efficient 
technique in monitoring of bowel ischaemia. Its applicability to the clinical setting needs further 
clinical studies to study it in the postoperative setting as this protocol has paved the way by using 
it in the operative setting. It also is highly dependent on technical changes that will render the 
sampling analyzer more robust. 
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Chapter 3 
 
Monitoring ischaemia in a swine anastomosis model 
 
In this chapter we explain the methods, results, and interpretation of using the rs- 
microdialysis technique in monitoring simulated ischaemia in a swine model of bowel 
anastomosis. This study was a bridging study done to explore the feasibility of using the 
microdialysis technique prior to taking it to the clinical bedside setting, especially if we want to 
use the catheter and the analyzer in a clinical setting to monitor the ischaemia around a bowel 
anastomosis in a human subject. So, this was a crucial bridging study to be done prior to taking 
the apparatus to monitor in the bedside clinical setting. 
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3.1. Methods of study II: Swine model anastomosis monitoring. 
3.1.1. The setting 
The apparatus had to be available in the labs where the studies conducted. The animal 
research facility was in Elancourt, France. In order to move the apparatus to France, we could 
not send it as a trolley in one piece since it is too large and too heavy a piece, and full of fragile 
parts that can easily break. All the constituents of the apparatus had to be disassembled to their 
original components and then shipped.  
The trolley was not shipped, and we had to fill in for it by a regular lab trolley in the labs 
at Elancourt. The custom-made box disassembled and cushioned well with the valve in situ and 
packaged. The remaining components were all packaged and cushioned well. These include the 
HPLC pump, the potentiostats, the CMA pump, and the tubings, valves, connectors, and gaskets. 
We also had to ship over there the consumables like the beds, the perfusates, the sterile ultra 
filtered water for the solutions and the respective chemical equipment needed to dissolve, filter, 
and prepare all the solutions in the system. This was covered by the bioengineer on the project. 
In total there were four boxes each weighing about 30 kilograms. These boxes were air shipped 
to Elancourt in the suburbs of Paris, France to the animal research facility before we went.  
The catheters were also changed and we did not use the human CE approved CMA 61 
Gastrointestinal catheter but the MAB 7.11 (Microbiotech se/AB, Stockholm, Sweden) probe 
was used instead. This is because of several reasons. It is much more expensive (in the order of 
tenfold) to use the CMA human catheter rather than the MAB one. The MAB catheter gives the 
similar results as the CMA catheter (proven by the bioengineer partner) but is lot cheaper since it 
is not CE approved for human use, but we are using it on pigs anyhow. We did not need to have 
inflow and outflow extensions from the catheter to the system since sterility was not an issue 
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here. Therefore, we did not do any modifications like we did in the previous intraoperative 
monitoring study to make the catheter fit for adapting it from a sterile field to a non sterile one. 
In Elancourt labs, the stack that we used was a mobile trolley available in the lab there 
and not like the stack, we had used previously, however the components were all the same. The 
analyzer was assembled in the same manner only with difference in the location of the 
components. The valve box, laptop, CMA pump, ferocene buffer, and the disposal container 
were all in the top shelf of the trolley, which is the same height of the operating table. The valve 
box and the CMA pump were brought to the edge of it so only minimum extensions were needed 
for the catheter inflow and outflow. The second shelf below housed the potentiostats. The third 
shelf below housed the UPS and the HPLC pump along with the electric connections that were 
adapted to the French electric sockets by conversion adaptors (Boots Ltd. Nottingham, UK).  
The analyzer was assembled as follows. The microdialysis probe MAB 7.11 
(Microbiotech se/AB, Stockholm, Sweden) outflow tube was connected to the system dual 
internal loop valve (Valco Instruments, Schenkon, Switzerland) after elongation with 20 cm of 
FEP tubing (Microbiotech se/AB, Stockholm, Sweden) that was deemed necessary to alleviate 
tension. A syringe pump (CMA 400 pump, CMA, Stockholm, Sweden) was used to infuse saline 
solution with the following ions contents: [Na
+
] = 147 mM, [K
+
] = 4 mM, [Ca
2+
] = 2.3 mM, [Cl
-
] 
= 153 mM) at a flow rate of 4 µl/min. The dialysate stream was sampled into custom-made valve 
(Valco Instruments, Schenkon, Switzerland) with 200nl dual internal loop. In the valve, the 
dialysate is accelerated by an analysis buffer solution of sodium citrate (0.1 M), sodium chloride 
(10 mM), ferrocene monocarboxylate (1.5 mM) and Ethylenedeamine tetraacetate EDTA (1 
mM) at pH of 7.0 and pumped at 200 µl min
–1
 by an HPLC pump (Rheos 2000, Flux 
Instruments, Basel,  Switzerland). Every 15 seconds the valve switches to one of the sampling 
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channels and a 200nl dialysate sample is injected alternately into one of the two analysis flow 
streams. Each stream is connected to enzyme reactors containing the appropriate oxidase enzyme 
(glucose oxidase for glucose or lactate oxidase for lactate) and horseradish peroxidase (Genzyme 
Diagnostics, Kent, UK). The system is coupled to radial flow glassy carbon electrode (BASi, 
West Lafayette, IN) held at a potential of –100mV (Ag/AgCl, [Cl-] =10 mM) by a potentiostat 
(E-DAQ, Sydney, Australia), where the electrochemical detection of the analytes occurs. The 
ferricinium ions being the product of the oxidation of the buffer from the enzymatic reaction are 
reduced on the surface of the electrode, resulting in a current peak, within typically 3 seconds, 
that is proportional to the substrate concentration.  Data was collected using a Powerlab data 
collection system (8 S/P, ADInstruments, New South Wales, Australia) controlled by a 
Powerbook portable computer (Apple Computers, Cupertino, CA) running Chart 5.6® 
(ADInstruments, New South Wales, Australia). 
 
Figure 3.1. The setup shown with corresponding labels. 
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3.12. Animal Preparation. 
Experiments were conducted on three 6-month old male large white strain piglets 
weighing between 25-30 kg. They were fed regular standard diet and fasted 36 hours before the 
surgical procedures. Pigs were premedicated with intramascular injection of ketamine 20 mg/kg 
and acepromazine 0.5 mg/kg. The marginal ear vein was canulated and anesthesia induced by 
intravenous injection of pentobarbital 6 mg/kg and endotracheal intubation was carried out. The 
tracheal tube was connected to the Servo 900®ventilator (Siemens, Elma-Schonander, Sweden) 
and ventilation was set at a rate of 15 breaths per minute and 20cm H2O positive pressure. 
Isoflurane was titrated according to the pig’s heart rate. The anaesthesia was induced by a 
licensed veterinary medicine physician. All experiments were carried out under specific license 
in the animal facility from the French Ministry of Agriculture: license number n° A 78760.   
A midline incision was performed using hand held electrocautery on pure cutting mode, 
and the subcutaneous fat and fascia dissected with the blend mode. The sigmoid colon was 
exposed and mobilized. A segment of the colon was exposed and an 18-guage ventflon was used 
to tunnel the catheter in the colon. The ventflon was inserted in the seromuscular layer and 
tunneled superficially and then extruded at the end of the length of the ventflon. The needle was 
withdrawn leaving the plastic catheter in situ. The MAB 7.11 catheter was then thread through 
the plastic ventflon tube and the tube withdrawn for the other end leaving the MAB 7.11 catheter 
in situ. The inflow tube of the catheter was connected to the syringe on the CMA pump on the 
top shelf of the analyzer that was in turn brought to closest proximity to the operating table. The 
outflow catheter was connected to the Valco valve also on the top shelf using a 20 cms extension 
FEP tube. The CMA pump was started at a rate of 4 μL/min, and the sampling started. The base 
levels of glucose and lactate from the healthy colon was collected for 60 minutes. The feeding 
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artery was then occluded using a clip for 30 minutes. When ischaemia set in, the clip was 
removed allowing for reperfusion and data was collected again for 35 minutes. This pilot 
ischaemia-reperfusion run was done just to see if the system runs after re-assembly and monitors 
the changes in the bowel wall when ischaemia is simulated. 
Then, we had to start monitoring the surgical anastomosis for ischaemia. A colo-colic 
anastomosis was constructed in the pig’s colon in the following manner. The sigmoid colon in 
pigs is called the spiral colon and it extends to a minimum of four times the length of the pig 
itself
159
 allowing ample length for construction of multiple colo-colic anastomosis. Two limbs of 
the spiral colon was fixed to each other using 3/0 vicryl sutures. A colotomy was done in each 
limb through which the two sides of a GIA stapler (Covidien, Hamilton, Bermuda) was 
introduced. The microdialysis catheter was tunneled on the stapler’s rail to ensure the 
homogeneity of the sampling area; and consequently the GIA stapler deployed. Then the 
resulting joint colotomy was sutured hand sewn and the MAB 7.11 catheter was fixed in situ by 
two 3/0 vicryl sutures on the PEBAX fixator to the seromuscular colon wall.  
 
Figure3.2. The colo-colic anastomosis constructed between limbs A and B.  
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The microdialysis catheter was connected to the CMA 400 pump in the inflow tube and 
ran at 4μl/min. This rate was chosen to ensure adequate delivery of dialysate through the outflow 
tube, which was connected to the analyzer valve on the top shelf of the analyzer. The tissue was 
monitored for 20 min after microdialysis probe implantation to achieve baseline physiologic 
values. Then the feeding mesentery of both segments of the anastomosis was clamped for 25 
minutes to simulate ischaemia. The microdialysis was left to run for 25 minutes and sampling 
done every 30 seconds for glucose and lactate. There was no reperfusion done in the anastomosis 
monitoring. To decrease animal use in this second experiment, three piglets were used. Five 
anastomoses were constructed in total and monitored for physiologic versus ischaemic 
conditions. Where two anastomoses were constructed in the same animal, they were separated by 
more than one meter of colon length distally.  
In this second experiment of monitoring the anastomosis, an independent control 
microdialysis probe MAB 7.11 (Microbiotech se/AB, Stockholm, Sweden) was deployed in a 
separate segment of colon to allow control samples for glucose and lactate concentrations to be 
measured in an off-line manner throughout the anastomosis procedure. Off line analysis was 
used for this probe since the online analyzer can sample one catheter at a time. All the animals 
were sacrificed humanely without waking them up by the use of euthanasia and injection of 
ethanol with fentanyl at the end of the data collection.  
3.1.3. Statistics relevant to study II. 
In this study, the time lag between the diaylsate outflow and the peak displayed was very 
short in the order of two minutes since the analyzer box was very close to the catheter outflow, 
and only a 20cms extension was needed. The current peaks were converted to dialysate 
concentration using the method of study I. The graphs plotted represent the change in glucose 
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and lactate concentrations after the feeding mesentery of the anastomosis was clipped at time 
zero. Before that, the baseline values of the metabolites and after that are the changes of 
ischaemia. The increments of concentration for five anastomoses were plotted versus time. The 
microdialysis average values of the five anastomoses were presented as mean ± standard error. 
This can be done since the traces were normalized at time zero when the clamping of the feeding 
artery was performed and the changes are given as increment of concentrations. The L/G ratio 
was calculated for the average of the five anastomoses.  Pair t –test was performed between the 
ischaemia and healthy values of the anastomosis; and from the on-line probe and the control 
values from the off-line probes. Mean response plots and area under the curve (AUC) calculated 
between time zero and time 30 minutes in the monitoring trace. The area was compared to a null 
hypothesis of zero using an excellent one sample Student’s t-test. Significance level was set at 
5%. 
3.2. Results Study II. 
 
For the pilot run conducted just to see if the system was operational, we show the trace 
from the ischaemia reperfusion monitoring in the first pilot experiment. The current peaks 
generated from glucose oxidation had a baseline of 0.20μA. On clamping the mesentery, the 
current increased to 0.28μA but decreased to 0.14μA after 11 minutes. This was maintained until 
the time of unclamping where the current then increased gradually to its baseline value of 
0.22μA. Lactate, on the other hand, had a baseline current of 0.66μA and stabilized at this level 
even after clamping by 10.5 minutes. Then it increased to1.07μA and remained at this level for 
15 minutes after unclamping. Later, it dropped to 0.87 μA but did not reach the baseline value. 
This is presented to show how we get the trace and then after calibrating the analyzer we change 
it to concentrations. Values presented are mean ± standard error. 
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Figure 3.3. The traces of the current peaks. As seen over time and before conversion to 
concentration for analysis. Glucose in red and lactate in green. 
 
In the second experiment to monitor the anastomosis, similar recordings were obtained in 
the vicinity of the anastomosis. These were converted to dialysate concentrations according to set 
calibrations and shown as follows for the five different anastomoses. Each anastomosis tracing 
was analyzed separately and then the five anastomoses were pooled and analyzed together as a 
cohort. Appendix B shows a sample of raw data from the cohort. 
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i. The first anastomosis tracing was as follows: 
 
Figure 3.4. Monitoring trace of first anastomosis, Glucose in red, and lactate in green. 
The glucose concentration dropped from a value of 0.055mM before ischaemia to 
0.020mM 40 minutes post ischaemia. Lactate concentration on the other hand, increased from 
0.25mM to 0.35mM after 40 minutes. 
 ii. Anastomosis 2: 
The glucose trace starts with an artifact and then stabilizes at 0.039mM and then as 
ischaemia is simulated the concentration decreases to 0.03mM. Lactate on the other hand starts 
with 0.3mM and increases to 0.55mM after simulation of ischaemia. 
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Figure 3.5. Monitoring trace of the second anastomosis, Glucose in red and lactate in 
green. 
iii. Anastomosis 3: 
The glucose concentration was 0.07 mM and then after simulation of ischaemia it 
dropped to 0.035mM. Lactate behaved similarly to the previous anastomosis and it increased 
from its baseline value of 0.13mM to 0.31mM towards the end of the simulation. 
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 Figure 3.6. Monitoring trace of the third anastomosis, glucose in red and lactate in 
green. 
iv. Anastomosis 4: 
The glucose concentration as expected decreased from 0.07mM to 0.04mM towards the end; 
while lactate increased from 0.21mM to 0.98mM towards the end of the recording. 
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Figure 3.7. The monitoring trace of the fourth anastomosis, glucose in red and lactate in green. 
v. Anastomosis 5: 
Glucose concentration also shows a decrease from 0.13mM to 0.03mM; and likewise the 
previous anastomosis lactate increased from 0.41mM to 0.65mM but then we show a sharp 
decrease in values. At that point (t=16:51:21) the chemical beds were tested with the preset 
standards and were found to be suboptimal as opposed to how we started. 
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 Figure 3.8. The monitoring trace of the fifth anastomosis, glucose in red and lactate in 
green. 
 
The cohort was then pooled  for the concentrations of glucose and lactate. The 
differences between the individual concentrations of glucose and lactate at a given time and time 
zero were calculated. The increments/decrements of concentrations of metabolites for five 
anastomoses were plotted versus time. 
The dialysate baseline values for glucose and lactate were 0.049±0.007mM (n=5) and 
0.28±0.046mM (n=5), respectively. After arterial clamping by 30 minutes, the glucose level 
decreased by 0.044±0.003mM (n=5) . The AUC analysis for glucose showed this fall to be 
significant (-0.90±0.10mM/min n=5, p=0.001). Lactate levels increased by 0.39±0.14mM to 
reach its maximum at 17min after arterial clamping and then decreased by 0.20 to reach the 
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increment value of 0.18±0.056mM at the end of the recording at 30 minutes. The AUC analysis 
for lactate was 4.89±1.06mM/min (n=5, p=0.009). Values presented as mean ± standard error. 
 
 
 Figure 3.9. The average change values traces. Glucose in red and lactate in green 
showing the respective change with time. The error bars are the standard error. 
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 Figure 3.10. AUC changes presented as a histogram, glucose in red and lactate in green. 
** p<0.05. 
The lactate/glucose ratio (L/G) baseline was 2.96±0.48, n=5 and then increased to its 
maximum at 17 minutes with value of 23.64±8.33, n=5 only to decrease again to 15.35±3.18, 
n=5 at the end of the recording (t=28 min) (p=0.022 paired t-test). Values presented as mean ± 
standard error. 
140 
 
 
 Figure 3.11. The L/G ratio curve of the average of the cohort.  
The independent control probe yielded constant concentrations throughout the period 
where the anastomosis was subject to the above changes. The mean control glucose 
concentration was 0.004±0.002mM and the lactate mean control value was 0.012±0.01mM 
(n=5), while the on-line monitoring probe in the anastomosis yielded -0.052±0.0086 mM, n=5, 
p=0.005 for glucose and 0.43±0.11mM, n=5, p=0.017 for lactate, which is non-significant 
throughout the ischaemia study. Values presented as mean ± standard error.  The following 
figure shows the values of the control probes versus the changes in ischaemia values at the 
anastomosis. 
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Figure 3.12. The comparison histogram: the control probe v. the anastomosis probes 
during ischaemia, *p<0.05, **p<0.01. 
3.3. Interpretation of results of study II. 
3.3.1. Metabolic interpretation. 
The study showed that online microdialysis can monitor ischaemic changes at the 
anastomotic site. A significant increase in the lactate concentration and a decrease in the glucose 
concentration can be detected within 17 minutes of simulated ischaemia. The rise in lactate can 
be attributed to anaerobic metabolism due to insufficient oxygen delivery to the tissue. This 
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change in bowel lactate concentration cannot be due to the systemic hyperlactatemia as shown by 
Tenhunen et al.
143
 The decrease in glucose concentration can be explained by the consumption of 
glucose by the tissue metabolic process that cannot be replenished from the compromised blood 
supply; and highlighting the fact that bowel is more vulnerable to damage with surgical stress 
and previous ischaemic insults. Furthermore, glucose to lactate ratio combines both the 
consumption of glucose and the excessive production of lactate as the signature for metabolic 
changes that happen when tissue is subjected to ischaemia. The lactate to glucose ratio is used as 
it is insensitive to transient changes in recovery efficiency of the microdialysis probe.
107
 The L/G 
ratio also has been found in other human tissue monitoring with microdialysis to be an indicator 
of ischaemia.
160
  
The pilot study done here to prove the functionality of the system (refer to figure 3.3), did 
show also that this system can monitor ischaemia and reperfusion and show that after reperfusion 
lactate levels do not totally normalize but still maintain a high level even after considerable time 
has passed. Ischaemic changes did not normalize completely within 30 minutes of reperfusion 
confirming the findings of Kuzu et al done in rat subjects.
161, 162
 
3.3.2. Positioning of the microdialysis catheter. 
The intramural microdialysis approach employed in the present study overcomes the 
limitations of intra-abdominal and luminal microdialysis. Monitoring in the peritoneal cavity has 
the disadvantage that changes due to the ischaemic segments are diluted by the metabolites from 
the non-ischaemic segments and from the peritoneum supplied by the systemic circulation.
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Luminal monitoring is subject to significant artifact due to passing luminal contents and position 
of the catheter.
137
 By contrast, intramural monitoring responds most quickly to tissue ischaemia 
and has less dilution artifacts.
160
 However, the intramural approach has a few limitations. The 
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careful tunneling of the catheter is critical to minimizing tissue damage and to ensure that the 
sampling membrane is entirely intramural in order to avoid the artifacts from intra-luminal 
position. As the analyzer is an electrochemical system that is calibrated before and after the 
experiments, the decrease in lactate in later stage following ischaemia is real, and can be 
explained by the flushing effect of the catheter. Once the tissue glucose level falls, due to 
unavailability of glucose as a substrate for the production of lactate the production of lactate 
stops. This occurs in all the ischaemic tissue including in the cylinder of tissue around the 
dialysis probe. In this cylinder of tissue however, dialysis of lactate by the microdialysis probe 
still occurs, giving a small but significant rate of removal of lactate from the tissue. As 
microdialysis levels are always the balance between tissue supply and removal rates; this is seen 
as a slow fall in microdialysis lactate levels.. 
Offline sampling of intra-abdominal microdialysis (every 3-4 hours) was used clinically 
in the peri-anastomotic area to monitor leakage. Mathiessen et al. showed very encouraging 
results depicting ischaemia, as a rise in dialysate lactate and a fall in dialysate glucose 
concentrations,  as early as the first 24-48 hours.
163
 This would alert the physician to the process 
of anaerobic metabolism in the vicinity of the anastomosis either from anastomotic ischaemia or 
an overwhelming inflammatory response due to a leak. However, classical off-line sampling is 
labour intensive, introduces a long lag period, and may initially miss events due to dilution into a 
pooled sample. All those factors are eliminated by rapid-sampling online microdialysis which 
was used with proven efficiency in monitoring ischaemia
151
 in post- neurosurgical procedures.
106, 
107
 In this method the analyzer samples every 30 seconds in an automatic mechanism giving 
immediate results to the clinicians.
151
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The applications of this technique in the clinical setting are numerous but are conditional 
on the refinement and modifications of the catheters before embarking on clinical trials. 
Nevertheless, the study has proven that online rapid sampling microdialysis is a feasible method 
in monitoring ischaemic changes at the anastomotic site and can offer an alert system to be used 
by surgeons to monitor bowel anastomoses for leaks before the clinical sequel of leaks develop 
systemically in the patient. 
3.3.3. Clinical applications. 
Clinical applications that can be developed are endoscopic microdialysis for measuring 
metabolites in bowel of questionable viability like in ischaemic colitis, or even questionable 
anastomotic viability. The microdialysis probe can be deployed through the colonoscope to 
sample from whichever area is of questionable viability when the endoscopoic images are not 
clearly ischaemic.  
It can also be used during laparoscopic assessment of bowel viability without the need to 
laparotomies. In this application the technology and the expertise of deploying the catheter 
laparoscopically have to be explored, but the principle remains the same. Even miniaturization of 
the analyzer to be used as a bed side tool, can be contemplated as future works are developed in 
Imperial College. All these, however, are subject to technological advances in designing and 
manufacturing of the catheters and their respective on-line analyzers. 
 
 
. 
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Chapter 4 
The monitoring of intestinal ischaemia in the clinical bedside setting 
 
 In this chapter we take the microdialysis apparatus a step further from piloting and animal 
testing. We incorporate it in the clinical setting on the bedside of a patient to monitor for colon 
ischaemia in patients who had aortic surgery. We explain the methods, results, and interpretation 
of the results in this setting and show that microdialysis can be used in the clinical setting as a 
monitoring tool. 
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4.1. Methods of study III: ITU monitoring 
 
 After the above two studies had proven the efficacy of the system in monitoring bowel 
ischaemia in the pilot and the animal model setting; we wanted to take it a step further to the 
clinical bedside setting which was our goal to begin with. We proposed a clinical scenario where 
patients are at risk of developing colon ischaemia. Patients having abdominal aortic aneurysm 
(AAA) repair are at risk of developing the above complication since their IMA is occluded in the 
operation and the colon survives on collaterals from the marginal artery. In 10-15% these 
collaterals are not sufficient to sustain the colon and hence the colon develops ischaemia. We 
propose a method to monitor the colon viability after the operation. We intend to implant the 
microcathater in the colon wall and tunnel it out through the abdominal wall. Then when the 
patient is on bed rest in ITU for postoperative care, we intend to use our rs-microdialysis 
analyzer to monitor for any significant changes of glucose and lactate from the colon wall as 
sampled by the catheter.  
 An amendment to the ethics approval of study I was submitted and approved. Approvals 
from the infection control team, ITU staff and nurses, and the vascular team approval had to be 
obtained. This took time (in the order of 4-6 months) to get but finally we had the go ahead. 
Certain modifications were made and are explained as follows.  
4.1.1. Catheter choice. 
The catheter for this study had to be changed. From the previous experience we acquired; 
it was found that if a catheter is left in the abdominal cavity tunneled in a bowel wall, it needs to 
have some spare length to make up for the colon movement. In the previous work (study I), it 
was fixed to the colon wall in the operative setting because it was going out with the specimen. 
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In this scenario, we had to leave it with no fixing since we need to take it out from the patient’s 
abdomen in a later stage. We had to find a catheter that had some spare length in its shaft from 
the CMA armamentarium of catheters. The hepatic CMA 70 catheter is the same as the CMA 61 
gastrointestinal catheter as far as the semi-permeable membrane, with minor differences in their 
dimensions as summarized in the following table: 
Millimeters  CMA 61 Hepatic Probe CMA 62 GI Probe 
Inner shaft 310 180 
Outer shaft 280  
Membrane length 30 30 
Inlet tube 400 600 
Outlet tube 70 220 
Table 2.8. Table of comparison between the CMA 61 and 62 probes 
 
Figure 4.1. The CMA 61 hepatic catheter for microdialysis. Under permission CMA95 
However, both catheters have the same cut off 20 kDa weight and the same 
semipermeable membrane length of 30 mm.  As you see the inner shaft of the hepatic probe is 
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longer by 130mm making this the spare length we are looking for; hence if the colon moved in 
the abdomen the probe has ample length to compensate for that without dislodging from its 
seromuscular position. The membrane is the same in both catheters so there will be no change in 
the microdialysis process if the flow rate is the same. The inlet/outlet tubes are also longer which 
helps even more in the bedside clinical scenario and can decrease on the use of inlet/outlet 
extensions. 
4.1.2. Operative methods. 
The patients after being consented to be enrolled in the research undergo their operative 
procedure to repair the AAA. During the operation, the surgeon applies a cross clamp at the 
proximal neck of the aneurysm. Then the aneurysm is slit open and replaced by a synthetic tube 
like graft that acts as an aorta channeling the blood from the thoracic aorta to the iliac 
bifurcation. If the AAA involves them, the ceoliac artery, SMA, and renal arteries are re-
implanted on the graft. The IMA however is not, but is tied off and the colon is then fed by 
collaterals, mainly the marginal artery of Drummond. During the cross clamping time when the 
graft is being sewn into place the lower part of the body that is usually fed by the descending 
aorta is ischaemic and using anaerobic metabolism. These parts are reperfused when the cross 
clamp is out and all arteries re-implanted. The time of cross clamping is better known as the 
ischaemia time of the operation.  
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Figure 4.2. AAA repair. Schematic showing the steps with the comments showing the IMA 
cutoff. Illustration by TT redrawn from164 
At the end of the operation and before closing the laparotomy, the research fellow is 
called in. He scrubs in the operative field and the circulating nurse opens the sterile CMA 61 
catheter on the field. The fellow then prepares the catheter for implantation in the following 
manner: The sleeve of the catheter is cut to around 10 centimeters allowing enough length to 
tunnel it in the abdominal wall. The long fixing suture that comes with the catheter is also cut 
since it is not needed. The sleeve of the catheter is tunneled without the catheter through the 
abdominal wall in the left iliac fossa region by cutting a 2mm skin incision and passing a blunt 
mosquito clip through it and through the abdominal wall en masse. The clip then guides the 
sleeve through the same abdominal wall tunnel. The catheter is then thread through the sleeve 
from outside inwards to the still open abdominal cavity. The catheter is now tunneled through its 
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sleeve and ready for deploying in the seromuscular layer of the sigmoid colon. An area of the 
sigmoid is designated, and an 18 Gauge angiocath (Abott labrotories, Il) is used to tunnel the 
catheter in place. The angiocath is tunneled in the seromuscular layer from one side to the other 
on the mesenteric border of the colon just where the mesentery meets the colon wall. The needle 
is withdrawn and the plastic angiocath is left in place to thread the catheter through it and then 
withdraw it from the other end to keep the catheter in place in the colon wall. The catheter along 
with the sigmoid are tucked in the left iliac fossa and covered by the omentum, and the catheter 
outside is secured in the following fashion. The PEBAX fixating device is clipped on the catheter 
in its sleeve just as it outtakes from the skin and two 2/0 vicryl ties are tied around it just to keep 
it in place so that it does not snap out from around the catheter sleeve. Then two 2/0 silk sutures 
are taken to fix the PEBAX to the skin hence fixing the catheter in place as it goes out from the 
abdominal wall. The catheter is then dresses and the operation continued by closing the 
laparotomy in the usual running fashion. It takes the nursing staff about 30-45 minutes to transfer 
the patient from the operating table to the ITU bed and the nurses settle the patient in ITU. It is 
only after all the nursing care has been completed that we come in. 
 
Figure 4.3. The catheter as it appears out of the patient’s abdomen after implantation 
and fixation 
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4.1.3. The ITU methods. 
The microdialysis analyzer is wheeled down to ITU and it is calibrated with preset 
standards of 1, 2, and 4mM of glucose and lactate solution; and then wheeled in next to the 
patient’s bed waiting to be attached to the catheter. The perfusion fluid ampoule is opened and 
the 5ml of perfusate T1 (CMA, Stockholm, Sweden)) is withdrawn into two 2.5 ml syringes. One 
of the syringes is attached to the Alaris 0.4 ml extension tubing (Alaris Medical, California) and 
then deployed in the CMA 400 (CMA, Stockholm, Sweden) pump; the syringe along with the 
extension is flushed until all air leaves the extension. The extension end is then connected to the 
inflow tube of the catheter and ran at a rate of 10μL/min for a period of about ten minutes until 
the outflow tube of the catheter starts delivering fluid. 
 
 
Figure 4.4.  Connection of the extension from the pump to the inflow tube. 
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 This means that the catheter is primed and microdialysis has started. Then the outflow cartridge 
of the catheter is cut and the previously explained connecting bell is attached to the outflow tube 
manually. 
 
Figure 4.5. The connection bell attached to the cut end of the outflow tube from the catheter. 
 
 The bell is then attached to the 1.2-meter long FEP extension tube that is in turn attached to the 
inflow 22 gauge-needle (Hamilton, GR, Switzerland) that fits in the Valco valve of the analyzer. 
 
Figure 4.6. The outflow attachment from the catheter to the analyzer. 
Bell connected to 
outflow and then 
to FEP extension 
Needle 
connected to 
other end of FEP 
fits in valve of 
analyzer 
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 The FEP tube is very fragile and its connections are loose due to the fragility of the connectors. 
Therefore, the outflow extension had to be made robust. To do so, we taped the FEP extension 
with the more sturdy Alaris inflow extension, this way the Alaris extension will bear the shear 
forces attributed to pulling while the patient is moved or positioned. When the Alaris extension 
was not available to be fixed to the FEP tube, as we get near to the analyzer, plastic splints were 
used for fixation. 
 
 
Figure 4.7. The splinting of the FEP tube. 
The extension of the 
FEP strengthened 
by taping it to a 
splint of plastic 
(needle cover) 
The FEP tube 
made sturdy by 
splinting it to the 
Alaris extension.. 
154 
 
A period of about 12 minutes is needed for the dialysate to reach the analyzer, and the 
CMA pump rate was then decreased to 2μ/min to allow for adequate dialysis and dialysate 
delivery into the valve. Usually one syringe full of 2.5ml of perfusate lasts for 11 hours in the 
pump. The system is left to run on automatic sampling every one minute for glucose and lactate 
and the data is collected with the Chart program.  
 
Figure 4.8. The Laptop displaying the glucose and lactate peaks over 48hrs. 
The beds in the analyzer are calibrated three times a day and are changed to new ones 
with the system re-calibrated when the old beds lose their activity. This is left to run for 
approximately 48 hours, with short periods of interrupted data where the patient was repositioned 
in bed, the system calibrated, or where there has been a period of inadvertent detachment of the 
tubes.  
Glucose peaks 
(red) and lactate 
peaks (green) as 
Chart displays 
them every 
minute. 
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Figure 4.9. The patient in ITU monitored by the rs-analyzer. The inflow and outflow 
tubes highlighted in yellow and red respectively splinted together near the patient. 
 
4.1.4 The analysis: 
Data was analyzed in a similar manner to the previous two studies. The peak amplitude 
was converted to concentration according to the conversion coefficient method explained earlier. 
However, in this study, because the beds were used for extended periods of time, they lost part of 
their reactivity. To accommodate for that, we used a formula that would account for the change 
in coefficient and we applied it at four hourly intervals in the data analysis: 
 
Where tf is the time final, t0 is the time 0 at the beginning of the 4-hour interval, and t is the time 
at that point in time, with their respective slopes. So, at any one time the slope at that time was 
calculated to accommodate for the change in bed reactivity at that time.  
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 After conversion of the peaks to concentrations the graphs of glucose and lactate were 
plotted against time in minutes in red and green respectively. The plasma concentration of the 
two metabolites was also measured in the patients arterial blood gases (ABG’s) and recorded on 
the graph. The L/G ratio was also calculated for each individual patient.   We had six patients in 
total, one of whom the catheter dislodged and consequently was not incorporated into data 
analysis.  
So, the data of the five patients were pooled together and averaged. The average was that 
of the glucose and lactate at one given time, time zero being the beginning of the sampling in 
each data set. Then the average was plotted out versus time; along with the average of the L/G 
ratio. 
4.2. Results study III. 
In the short period we had, we managed to recruit six patients in the study, one of which 
the catheter dislodged and hence was not included in the pooled analysis.  
 The period that we were allowed by ethics to monitor the colon in post AAA repair 
patients was a maximum of 48hours. The raw data was changed to concentration by the 
conversion coefficient calculated as shown in the methods (refer to 4.1.4) and the graphs of the 
metabolite traces were displayed as follows. The glucose concentration in the metabolite is the 
red trace and the glucose in the plasma level as recorded by the frequent ABG’s taken on the 
patients is in the red bar on the graph according to the time scale. The lactate concentration graph 
is the green trace and the lactate in the plasma as read by ABG’s is in the green bar on the graph 
according to the time scale. Appendix C shows a sample of raw data from the cohort. 
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i. Patient 1: 
81 year old male known to have a 9.2 cm type IV thoracoabdominal aortic aneurysm with 
symptoms of intestinal angina presenting for elective repair. The patient had his repair surgery 
on 22/5/08 and was monitored for 48 hours in the intensive treatment unit (ITU). The following 
is his glucose and lactate graphs of the dialysate concentration over that period. As you notice 
from the trace; data was missing between 14:44 the first day afternoon and 17:09 due to 
detachment of the outflow connection from the catheter to the valve; and between 19:59 that 
same day evening and midnight 00:06 am due to a leak occurring in the buffer pump that had to 
be addressed. At that time, the analyzer had to be disconnected from the patient’s microdialysis 
catheter and wheeled outside ITU. The pump had to be reconnected and the leak bypassed; after 
which the analyzer had to be wheeled back into ITU and connected to the patient. 
 
 
Figure 4.10. The monitoring trace of patient 1, glucose in red and lactate in green with 
the plasma levels in same color in the bars. 
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The glucose dialysate concentration is between 2.2 and 5.8mM throughout the 
monitoring. However if we follow the trace we find some interesting behavior. At the onset of 
monitoring; the patient’s plasma glucose was in the range of 10mM while the catheter 
concentration was in the range of 4mM. This was expected since the patient is in a stress 
situation and his glucagon (stress hormone) and glucose levels are high as a stress reaction to 
mobilize the energy stores in the patient, however this is not seen in the colon wall and its 
concentration is low. The body mobilizes these energy reserves to insure adequate delivery of 
glucose to vital tissue like heart and brain. Later on, after about 8 hours (480 mins) of monitoring 
the plasma glucose decreases to the range of 5mM and the colon dialysate one also parallels it to 
the range of 3.4 from 4.4mM. This shows that the dialysate concentration does not parallel the 
plasma concentration, and we attribute the local change of glucose in the colon wall to regional 
blood flow changes that meet the metabolic demands of the colon irrespective of systemic 
regulatory effects.  
Lactate on the other hand, is elevated in the plasma to begin with. This is expected after 
this long procedure where there is a large portion of the body mainly the lower extremities that 
are ischaemic for a long part of the operation due to cross clamping; and then all that lactate 
produced is shed in the system after unclamping. The colon lactate shows this also where it 
decreases from 1.8mM to 1.1mM throughout the first 4 hours (240
 
mins) of monitoring. After 
which it tends to slowly rise up and stabilize at 1.7mM as compared to the plasma lactate which 
has normalized by now to 1.12mM and this level of lactate and the difference between the 
dialysate and the plasma lactate is maintained throughout the recording. This also shows that the 
colon metabolites do not reflect the plasma ones and the energy metabolites of the regional 
circulation is independent of the systemic one but not necessarily vice versa. These differences 
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cannot be attributed to recovery effect since if that is the case then the tissue lactate must be less 
than the plasma lactate and that is not the case, as the results show.  
To further show that a graph was plotted between the 200 minute and 5oo minute mark to 
see if the changes that we see are parallel in both metabolite concentration behavior in the 
dialysate. The following shows it with the blue arrows showing where the metabolites are 
behaving opposite to eachother, further proving that this is not recovery artifact but true changes 
in the concentrations themselves: 
 
Figure 4.10a: The graph of the concentrations of glucose in red and lactate in green vs. 
time between 200 and 500 minutes, with blue arrows showing opposite behavior. 
 
As used before the L/G ratio was calculated to reflect the change of the metabolites as 
reference to themselves. The following graph explains the change of L/G ratio with respect to 
time in patient 1. 
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 Figure 4.11. The L/G ratio of patient 1 vs. time, trace in blue. 
As you see the trace of the ratio seems to be stable throughout the monitoring with a 
minor increase from 0.6 at time 1500mins to an average of 0.704 ±0.26 (from time 1500mins to 
1919mins) where the L/G ratio showed a slight increase with some variation. That increase 
hardly shows any ischaemic events; as compared to the results of the L/G increase in the pilot 
study where ischaemia is seen as a 16 fold increase in the ratio. The patient did well and was 
never diagnosed with intestinal ischemia throughout his postoperative course.  
 
ii. Patient 2: 
This is a 74 year old male presenting with an 8-centimeter type IV thoracoabdominal 
aneurysm with symptoms of back pain and thigh claudication on walking a distance of 100 
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meters for elective repair on the 13/8/08. The graph of his mural colon metabolite rs-MD 
sampling is as follows. 
 
Figure 4.12. The monitoring trace of patient 2: glucose in red and lactate in green with 
the plasma levels in same color in the bars. 
It is observed that there was no data in the first 6 hours; this is due to a technical fault in 
the sampler that was addressed on site in ITU. The system was demonstrating a high pressure 
throughout its tubes and connections. We had to dismantle and test every component by itself to 
diagnose where the blockage was from. It was found to be at the connector of the glucose bed. 
Therefore, we had to bypass the glucose bed and work with the lactate one until we were able to 
get a spare connector from the labs the next day afternoon. Hence the gap in glucose during the 
first day of monitoring, and consequently we had to rely on lactate concentrations in this patient. 
From the above graph we can easily see that the lactate trace starts in the range of 1.5-2.5mM at 
around the 8
th
 hour (480 mins) and maintains that range over the first 12-14 hours and then starts 
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to decrease gradually to the range of 0.5 to 1.5mM after 24 hours of monitoring (1440 mins). 
When comparing with the plasma levels of the metabolites we see the following pattern. The 
lactate in the plasma starts as high in the range of 4-5mM but then decreases to 2-3mM at about 
the time when the system is online again. The lactate in the colon starts in the range of 2.5-3mM 
at that time and parallels the decrease in lactate of the plasma. This is expected since the colon 
along with the entire portion of the ischaemic body (due to cross clamping of the aorta) was in 
anaerobic metabolism and lactate concentrations are expected to be high. At the time of re-
perfusion all that lactate is flushed out and circulates in the system to be picked up by the ABG’s 
and regionally by the MD catheter. At about the 16
th
 hour (1000 mins) down the trace the lactate 
increases from 1.6mM to about 2.3mM against the plasma lactate behavior which is a decrease. 
This is probably due to local changes in blood flow where the blood is shunted away from the 
splanchnic circulation to more vital circulations in the body such as heart, brain, and kidneys to 
perfuse these vital organs and hence we pick up this as a transient increase in the lactate of the 
mural colon. After 36 hours of monitoring (2000 mins), the lactate in the colon decreases in 
parallel to the plasma to stabilize at about 0.5-1.0mM. This is probably due to stabilization of the 
blood flow throughout the body systems and adequate reperfusion of all organ systems; however, 
recover artifact cannot be excluded to explain this since we lack the glucose data. 
From the incomplete glucose trace we can see an oscillatory pattern of the concentration 
of the glucose in the colon wall irrespective to plasma at that time which is an increasing pattern 
due to stabilization of the patient and deployment of the glucose reserve due to the stress reflex 
post surgery. The oscillatory pattern in the colon wall can be explained by local flow changes 
due to regional auto regulatory mechanisms: the lactate in the colon wall increases at about the 
16
th
 hour (1000 mins) and then we see glucose increases as well (from the interrupted data 
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around the 1000
th
 minute). This is a mirror of the blood flow regulation regionally. The tissue is 
in transient reversible ischaemia, hence the blood flow increases bringing in more glucose. After 
that, the lactate decreases and stabilizes followed by a decrease in glucose at about the 20
th
 hour 
(1200 mins) and stays low. At about  the 30
th
 hour (1800 mins) the lactate increases again from 
0.9 to 1.6mM paralleled by a transient glucose increase to meet the metabolic demands then the 
two metabolites decrease together after the supply of the blood has met the demand of the tissue 
metabolism. Plasma levels at those points behave independently to tissue levels for glucose is on 
the increase while lactate is on the decrease irrespective of the colon regional changes. 
As for his L/G ratio graph the following shows it with respect to time. 
 
Figure 4.13. The L/G ratio of patient 2 vs time. Trace in blue. 
The trace starts at the 1000
th
 minute, since before then we had no glucose concentrations.As 
noticed the trace starts as high in the order of 3-4 but then directly stabilizes to levels ranging in 
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the 0.5 to 1.5 with no sharp significant changes. The patient also did well throughout his 
postoperative course and no clinical intestinal ischaemia was diagnosed. 
iii. Patient 3: 
This is a 75 year old gentleman that was found to have an abdominal pulsatile and 
expansile mass on routine examination by his GP. Workup included a CT scan that found a 7.1 
cms type IV thoracoabdominal aortic aneurysm, presenting for elective repair on 11/9/08. 
An interesting trace was monitored in this patient. The microdialysis catheter was 
displaced out of the colon wall at around the first hour (70
th
 mins) from the onset of sampling. 
We knew this since the catheter itself was dislocated from its fixing cuff over a distance of about 
15 cms, but not out of the patient completely. Consequently, it was monitoring but it was 
monitoring the intraperitoneal cavity not the intramural colon wall. At about the 5
th
 hour (270
th
 
mins) the catheter, due to its inadequate loose fixation, fell out of the peritoneal cavity and hence 
MD stopped. This was evident in the trace as a parallel decrease in the metabolites at that point 
in time down to zero value. 
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 Figure 4.14. The monitoring trace of patient 3: glucose in red and lactate in green with 
the marks showing the time of partial and total displacement of the probe. 
As we see at the onset of MD we see the same effect of change in perfusion fluid rate, but 
soon afterwards the catheter is dislodged to the intraperitoneal cavity where both metabolites are 
less in concentration and that is read as a parallel decrease in both the glucose and lactate 
metabolites in the dialysate. This due to a decrease in recovery of the probe and a decrease of 
metabolite concentrations in the intraperitoneal cavity. About 200 minutes later the whole 
catheter falls out and the levels go down to zero since no dialysate is being delivered to the 
analyzer. The L/G ratio in this case shows a step manner increase at every dislodgement of the 
catheter, this is due to a decrease in recovery but not an ischaemic event.  
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Figure 4.15. The L/G ratio of patient 3 vs. time. The marks show the dislodgement of the 
catheter. 
iv. Patient 4: 
This is a 65 year old gentleman presenting with back pain, and was found to have an 8 
cms type IV thoracoabdominal aneurysm for elective repair on 17/9/08. In this monitoring the 
HPLC pump software crashed during the first night after 6 hours of monitoring (360 mins) and 
hence the buffer did not go through to the beds; unfortunately we lost the first night’s data. Then 
towards the end of the second night (1200 mins) and while the nurses were moving the patient in 
bed for the routine care the catheter got tangled with the patients left upper extremity and was 
pulled inadvertently. Therefore, we did not get the full 48-hour data. The trace of the metabolites 
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is shown below, glucose in red and lactate in green versus time. The lost data is explained in the 
graph box. 
 
 Figure 4.16. The monitoring trace of patient 4. Glucose in red and lactate in green with 
the plasma levels showing in same color in the bars. Pump failure showing in the white box. 
 
As we notice in the first 20 minutes, the glucose and lactate traces parallel each other in 
decrease and increase. This might be attributed to the recovery artifact in the beginning of the 
monitoring. As you recall we start our perfusion rate of 10 μL/min to enhance the catheter and 
FEP tube priming, and then as soon as we see dialysate coming out we drop down the rate to 
2μL/min to allow a better recovery. This is seen here as a parallel decrease in both concentrations 
and then an increase up to a steady level a few minutes later. At that point, the levels of glucose 
and lactate increase from 3.2 to 5.7mM and from 2.3 to 3.1mM, respectively. This parallel 
increase is, most probably, attributed to a better recovery than regional blood flow changes since 
in previous tracing we showed antagonistic changes due to change in blood flow. Towards the 
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time where we had a software crash, glucose tends to have stabilized down to 2.6mM which is 
not that dissimilar to the levels we got after we fixed the crash, which was 2.4mM. The question 
wether this was a stable reading throughout the night or it was a reading full of changes remains 
only for speculation. Lactate on the other hand, was cut off at a concentration of 3mM and was 
then resumed the next day at a value close to that which was in the order of 3.1 to 3.2mM.  
When compared to the plasma levels of the metabolites, we show that glucose in the 
colon wall was increasing in the first few hours as opposed to a decrease in plasma levels, and in 
the final hours glucose was stable in the tissue as opposed to a decrease in plasma. Lactate on the 
other hand was increasing in the tissue as opposed to a decrease in plasma. This can be attributed 
to an increase in regional flow after the operation bringing in glucose to meet the metabolic 
demands that was high to begin with hence the high lactate, and then stabilized at the end of the 
recording hence the decrease in glucose and stabilization of lactate in the colon wall. 
The L/G ratio of this monitoring is the following: 
 
 Figure 4.17.  The L/G ratio of patient 4 vs. time. Trace in blue. 
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We notice that the ratio stabilizes in the first few hours to an average of 0.66 ±0.19 and 
an average of a 1.15 ±0.15 toward the end, which is also not enough to claim ischaemia. This 
patient did well in his post operative course and no intestinal ischaemia was diagnosed. Values 
are presented as mean ± standard error, since in this patient we calculated the average in the pre 
and post crash periods. 
v. Patient 5: 
This is a 67-year-old woman presenting with a 5.9 cms type IV thoracoabdominal 
aneurysm because of pain in the back and distal embolic phenomena, for elective repair on 
10/11/08. 
The nursing staff disconnected the catheter after the onset of the monitoringat around the 
3rd hour (178 mins) while they were working next to the analyzer and did not notice that. So 
unfortunately, we lost the trace in the first night.  
 
 Figure 4.18. The monitoring trace of patient 5. Glucose in red and lactate in green with 
the respective plasma values in the bars. 
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We see the same pattern of both metabolites at the start of the microdialysis monitoring 
due to the change of the perfusion rate that corresponds to a change in recovery. As soon as the 
levels stabilize, the MD was disconnected and we lost the data. The next day after reconnection 
at the 12
th
 hour (737 mins) the levels of glucose and lactate tend to decrease in parallel with each 
other and with the plasma levels only towards the 1500-minute mark. There the glucose levels 
increase independent of lactate, that in turn decreases; and that probably is because of adequate 
perfusion. The tissue is now taking up glucose more than its needs, so it is utilizing the glucose 
in an aerobic process, storing the rest, and clearing out the ischaemia time lactate. 
The L/G ratio of this trace is shown in the following graph. 
 
   Figure 4.19. The L/G ratio of patient 5 vs. time. Trace in blue. 
 
Where we see a decrease from an average of 0.55 ± 0.17 in the first 178 minutes (just 
before loss of connection) where we see a higher ratio to a more stable ratio average of 0.25 ± 
0.12 in the last period of the recording from 750 minutes (after resuming connection) onwards to 
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the end. This patient did well and no regional or systemic signs of intestinal ischaemia were seen. 
Values are presented as mean ± standard error. 
vi. Patient 6: 
This is a 48 year old gentleman presenting with pulsatile and expansile mass in his 
abdomen, with mild back pain. Workup revealed an 8.9-centimeter type IV thoracoabdominal 
aneurysm. He is presenting for elective repair on the 08/12/08. There were minimal 
disconnection periods of the analyzer from the catheter and we managed to monitor for the 
planned 48 hours.  
The glucose and lactate concentrations were plotted versus time, as usual glucose in red 
and lactate in blue. The red and green bars in the graph show the respective plasma 
concentrations at the given time. 
 
 Figure 4.20. The monitoring trace of patient 6, glucose in red and lactate in green with 
their plasma levels in the bars. White boxes show disconnection times. 
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As we see with this graph that the lactate concentration also starts on the high side after 
the onset of sampling and gradually decreases from 0.81mM to 0.35mM towards the morning of 
the 2
nd
 day, 8 hours after onset of monitoring (480 mins). It then stabilizes at around that level 
while glucose increases in concentration contrary to the plasma concentration behavior. 
The L/G ratio of this patient’s metabolites is the following. We notice that the trend of 
the trace is to decrease from 0.8 to 0.2 towards the end of the recording. This signifies that the 
tissue is perfused and washing off the excess lactate from the cross clamping, and in 48 hours it 
was well reperfused. The patient did well and no signs of intestinal ischaemia were ilicted. 
 
 Figure 4.21. The L/G ratio of patient 6 vs. time, trace in blue, D*  signals where the 
disconnection happened in the trace. 
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vii. The average of the L/G ratio 
The five patients (excluding patient 3 which had the catheter dislodged) monitored 
showed that their respective L/G ratio never increased by a factor of two fold, but on the other 
hand there was some variation of glucose and lactate levels from one patient to the next. This 
depends highly on patient factors and local regulatory factors in each patient. However, we 
notice that the L/G ratio is a reliable parameter where we can look upon and notice that it had the 
same behavior and level amongst all patients. This was averaged in the five patients excluding 
the one where the catheter dislodged (patient 3) and an average of the L/G ratio was plotted with 
time, accounting for the data loss in each patient. 
               
 Figure 4.22. The L/G average of the five patients vs. time. 
As we clearly notice that the average of the five patients show a stable curve between 0.4 
and 0.8 with some fluctuation after the 1600 minute due to data missing in some cases, since in 
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some we were not able to monitor for the whole 48 hours. Never the less the ratio never went 
more than 0.8, and never increased more than the order of two fold from the baseline. 
4.3. Conclusion and interpretation of the results of study III: 
4.3.1. Obstacles faced when started.  
In this study, after passing all the hurdles facing us we were able to translate the lab, 
pilot, and animal work and feasibility studies and get the experimental system to the bedside of a 
patient. We picked the ITU setting for several reasons. The ITU is a closed ward with no 
distracting factors and each patient is allotted his space of a bed and a good 3 meter on either 
side of the bed for the supporting equipment such as ventilators, intravenous pumps, venous 
filters, and isolation material. This is a good environment for the analyzer for it will allow its 
docking next to the patient in a space allotted for it. This would decrease the chance of having its 
connections from the patient accidentally severed by moving staff. With all this, we still had 
problem with disconnections and lost some data in our patient cohort.  
The patient in ITU is bedridden on ventilator support and mostly under sedation. Hence, 
we can maintain the system and do the necessary repairs when the system breaks down; which is 
common with this system due to its multi-minute-components and the fact that it is custom made. 
The patient is non-ambulatory and hence the system will be non ambulatory which is a big 
advantage for having to wheel that heavy system (more than 100 kg) while a patient is 
ambulating is impractical not to say impossible.  
The nursing staff in ITU is well-trained and can alert us if any problems arise not to 
mention that they are well equipped and can help with all our clinical and technical needs when 
the situation arises that we need such help. Some of the nursing staff learned the system and used 
to connect the tubes back when accidental disconnection occurred during the night; unfortunately 
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not all were that helpful and we ended up sometimes losing the whole night worth of data 
because of a disconnection that went unnoticed by the nurse in charge of the patient that night.   
The patients are always sedated to ease of the pain and hence if we need to work with the 
microcatheter and its connections on the patient’s side, this will go unnoticed by the patient; 
hence alleviating any discomfort associated with our work on the catheter. The catheter is 
withdrawn in 48 hours from the patient while they were still under sedation and we did not get 
any patients complaints of pain or discomfort attributed to this issue. None the less; none of the 
patients remembered the catheter, the work on it during the monitoring period, or the withdrawal 
of it from the abdomen later. 
The reasons of choosing this scenario to monitor patients’ colons for ischaemia were as 
follows. The ethics committee forbids any research on emergency patients, and the patients in 
ITU are almost all emergency cases. The only cases that we can label electives in ITU 
admissions and have a considerable risk of ischaemia to the colon post surgery are the aneurysm 
cases. Another reason is that these cases are done through an open technique enabling the 
deployment of the catheter. The only foreseen risk of this deployment is accidental perforation of 
the colon wall whilst deploying the catheter through tunneling the needle. This is why we 
changed the place of deployment. Instead of tunneling in the anti mesenteric border (where we 
did in the pilot study), we tunneled in the mesenteric border of the colon. This means the needle 
goes through an area where, if an accidental perforation happens, there is a second line of fatty 
tissue (from the mesentery) that would help in sealing that perforation without causing any 
secondary complications to the patient.  
 The supervising ITU consultants were very helpful in facilitating this research. The 
problem we faced to begin with after getting all the necessary paperwork of ethics and ITU 
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approval was patient recruitment. We were only recruiting patients presenting for one vascular 
consultant and that did not yield a large number of patients. This was a surprise for us for ITU 
data showed that the year preceding the year of the recruitment there was 65 elective ITU 
admissions of patients having AAA repairs. We were only recruiting one patient every 6 weeks! 
The problem was that endovascular repair of the AAA have gained quite a momentum, and a 
good percentage of patients were having the endovascular repair not the open repair. This repair 
is done through a small incision in the femoral area and a plastic stent inserted to seal off the 
AAA with no open surgery needed as shown in figure 4.23.  
Figure 4.23. Endovascular repair of AAA; a stent is inserted in the lumen of the AAA 
percutaneously through a femoral approach. Illustration by TT redrawn from165 
This clearly would hinder us from deploying the catheter.  In addition to that, there were 
many cancellations to patients for bed unavailability after the operation. So, we decided to 
expand our recruitment to all the vascular team, and that took further 6-8 weeks to negotiate with 
all the vascular consultants available at that time, and a presentation to the vascular team all 
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together so that they understoond the project and its benefits. After that, we started recruiting two 
patients a month, which was an acceptable rate.   
4.3.2. Interpretation of the results. 
 Clearly, we see from our five graphs that the results of the individual traces of the 
patients are not identical, not to mention that we had data missing for technical reasons in every 
patient. However, and as stated before, we were looking at the pattern of change in the 
metabolite concentrations not the actual concentrations themselves. This was done to control for 
all the confounding factors associated with this monitoring study. Factors like chemical bed 
reactivity, catheter recovery, patient factors like diabetes and hypercholesterolemia all add to the 
fact that not all patients exhibit the same concentrations of metabolites in their tissues. However 
if we monitor for changes and behavior of the metabolites in one patient using the same analyzer 
and same beds  that are calibrated constantly, then we can assess ischaemia; if there was drastic 
changes in the concentrations and especially the L/G ratio as proven by study I.  This is done to 
avoid relying on individual values of glucose and lactate in any one patient since we did not 
monitor a large cohort of patients to have enough statistical power to conclude that certain 
concentrations of glucose and lactate are critical concentrations corresponding to ischaemia. 
These conclusions need large multi center randomized controlled trials to be valid.  
In our data, we noticed that all patients monitored did not manifest with ischaemic colitis 
during their postoperative course, and they all had fairly stable L/G ratios as seen in their graphs. 
None of the patients had more than three folds increase of L/G ratio in their monitoring; and as 
we see in study I; the tissue manifest an increase in the order of 16 fold in L/G when it becomes 
ischaemic. This was never witnessed in our patients’ cohort L/G ratios. It would have been ideal 
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to get a patient that develops ischaemic colitis; fortunately enough for the patients, none did in 
our cohort. 
There were many changes that occurred in the metabolites from the sampled dialysate. 
These broadly are the following. The lactate concentration always starts higher in any one patient 
and then decreasingly stabilizes after a certain period in the patient’s sampled dialysate. This is 
expected because of the nature of the procedure. While bypassing the AAA, the surgeon applies 
an aortic cross-clamp on the aorta proximal to the aneurysm. In doing so, he cuts off the blood 
supply to all the viscera and organs that are distal to the clamp. This is known as ischaemia time 
and it is the time needed to suture the vascular graft in place and release the clamp for 
reperfusion to occur. In this time, all the organs are metabolizing anaerobically to produce their 
required energy needs and lactate is a byproduct of that metabolism. As a result of reperfusion, 
all that lactate in all the organs including the colon gets flushed out and is replaced by the 
byproducts of aerobic metabolism, hence the lactate tends to be high towards the beginning of 
reperfusion and then stabilizes to normal in due time. This is seen in all organs and reflected by 
the patients ABG’s where it was always high and then settles of a few hours later. The dialysate 
lactate however is different from the systemic ABG’s lactate. The difference is that the systemic 
one is a mirror of all the lactate from all the organs and lacks specificity. Any organ with an 
ischaemic insult will eventually pour its lactate in the circulation causing an increase in lactate. 
However, the colon dialysate lactate is a product of the regional production in the colon wall, and 
the changes we see from one hour to the other without affecting, or being a sequel, of the 
systemic lactate reflects the metabolic signature in the colon. Of course if there is anaerobic 
metabolism in the colon for a sustained period of time then the lactate will diffuse into the 
interstitial fluid from the cells, then into the capillary circulation to ultimately reach the systemic 
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circulation and if maintained will increase the plasma lactate to alarming values. This takes time 
to happen especially if the lactate is produced by the gut. The reason for this is the liver acts as a 
filter to all the products of the gut cells including lactate. Lactate produced by the intestine from 
anaerobic metabolism will reach the portal system, which empties into the liver prior to reaching 
the systemic circulation.  
 
  
Figure 4.24. The Cori cycle where lactate is changed back to pyruvate in the liver. 
Illustration by SD from92 
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Figure 4.25. The splanchnic venous return to liver prior to systemic return to the heart. 
IMV: inferior mesenteric vein, SMV: superior mesenteric vein, SV: splenic vein, PV: portal vein, 
IVC: inferior vena cava. Illustartion by SD from22 
 
In the liver, the lactate changes back to pyruvate through the Cori cycle to be incorporated in 
several metabolic pathways to end up in glucose synthesis or energy production. Henceforth the 
liver will mask to some extent the production of lactate from the gut prior to that reaching the 
systemic circulation. Clinically this will mask the increased production of lactate in the ABG’s 
and the physician will have a false sense of security when the lactate is low in ABG’s but 
definitely high in the splanchnic circulation due to bowel ischaemia.  This method of rapid 
sampling alleviates this problem and samples from the colon wall itself relaying instantaneously 
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and quantitatively the lactate concentration in the colon wall prior to any transport of lactate to 
the splanchnic circulation or the systemic circulation later on. This in itself is a very early 
warning to the physician that there is ischaemia in the colon wall.  Rapid sampling adds to the 
microdialysis systems present in the market the online analysis, which has been explained 
before, and the physician will not have to wait for the pooled sample of the microdialysate to 
quantify the metabolites but gets an on spot reading every 30 seconds.  
  The transient changes other than the above reperfusion changes in glucose and lactate in 
the dialysate can be explained as follows. The colon whilst being reperfused, after the ischaemia 
time, has its own regulatory mechanism to control blood flow through the capillaries in the 
colon. The body and according to the needs of metabolism, especially after a tremendous 
surgical insult such as a repair of an aneurysm, shunts blood to organs that are vital. Amongst 
these organs are the kidneys, especially in the postoperative hours. The kidneys’ blood flow is 
regulated by hormonal and regional mechanisms, the main system controlling the renal blood 
flow is the renin-angiotensin system, and the increased amount of sympathetic system discharge 
that all work hand in hand to constrict the renal vessels and decrease its blood flow. The body 
tries to alleviate that by shunting more blood towards the kidneys and hence away from the 
splanchnic circulation. When the kidneys are well perfused and the patient starts to produce good 
amounts of urine, then the blood volume is redistributed to less vital structures like gut and 
muscle. We see these changes and redistributions in the colon metabolites. Whenever blood is 
shunted away we see a decrease in glucose and an increase in lactate, whenever blood is 
reperfused in the colon we see a rebound increase in glucose in parallel to a decrease in lactate. 
This rhythmical change persists until the body uniformly distributes the blood volume to all the 
viscera and then we see a decrease in this rhythm towards a more stable form, which is evident in 
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patient 1 monitoring graph. We note that although all these changes indicate a trend towards 
ischaemia, perfusion is enough to maintain the basic needs of the tissue at that point in time. That 
is, the blood flow is decreased but not to an extent to cause overwhelming ischaemia; but mild to 
moderate one, which is easily reversible once the blood has reperfused the main organs and 
shunted back to the colon. The gut in the postoperative period is at rest by keeping the patient nil 
by mouth and hence there is no need for additional blood for the splanchnic circulation for 
digestion. All these changes portray to us what happens at the metabolic level of the cells which 
mirrors the tissue perfusion.  
 As for the plasma glucose and lactate levels, they rarely paralleled what was happening in 
the tissue dialysate. This is because as explained above the plasma levels mirror the whole 
viscera of the body and not one organ alone. The trend after a successful AAA repair operation 
where we have adequate reperfusion of all the organs with slight differences in the distribution is 
towards a stabilization of lactate from a high level directly postoperatively to a normal level, and 
a glucose level which is fairly constant throughout. 
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Chapter 5 
Conclusions and future work 
 
 
In this chapter we conclude our findings, having taken a monitoring tool from the laboratory to 
the clinical setting in a true translational fashion. We also explore the future work proposed on 
this project and future applications of microdialysis in the clinical setting. 
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5.1—Conclusions of the project 
This project started as an idea when exploring tools to monitor bowel ischaemia which is 
a burden on both patients to suffer and physicians to diagnose. All the available tools presently 
available to physicians are non specific and non quantitative. After seeing the feasibility of using 
rs-MD to monitor brain ischaemia
151
, we hypothesized that this technology can be used to 
monitor bowel ischaemia. We were able to construct and optimize an appararus to monitor bowel 
ischaemia in the labs of the Bioengineering Department of Imperial College London. Pilot 
studies did show the feasibility of using this technology to monitor bowel ischaemia. The results 
also showed that the bowel can withstand a period of relative ischaemia from the main feeding 
vessels and can mobilize reserve and collateral glucose for metabolism even anaerobically to 
meet the demands. This window is crucial for the surgeon and means that the surgeon can rely on 
collaterals to the colon to construct a viable anastomosis. It is only when the bowel is completely 
denuded of any supply through the mesentery that it manifests the ischaemia signature in the 
metabolite concentrations of lactate and glucose. 
 Further animal testing also proved its applicability and safety to monitor ischaemia even 
in the vicinity of anastomosed bowel, where its clinical applicability can be of utmost importance 
especially to monitor for leaks early in the postoperative course. Diagnosing these leaks early on 
in the clinical course is of great importance to decrease the mortality and morbidity associated 
with this dreaded complication of bowel anastomosis.  
We were finally able to take this apparatus to the clinical setting in a translational fashion 
and apply it on the ward and in a high dependency unit to monitor patients for colon ischaemia in 
the post operative period after aortic surgery. These patients have a considerable chance of 
developing colon ischaemia after their operation and that complication also carries a high 
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mortality and morbidity rate. Diagnosing this complication early on will reduce the burden on 
patient and physician. The system proved efficacious and promising results need further 
multicenter trails before adoption of this technique in the clinical setting as an accepted tool used 
in the clinical bedside scenario to monitor high risk patients for intestinal ischaemia and 
anastomotic leaks. We explore the future work proposed for this project and the clinical 
applications that can adopt this technology. 
5.2. Future work  
 5.2.1. Planned work in progress 
 As seen above and by the time we had we were only able to monitor 6 patients. This 
study needs to have more patients recruited and at least two exhibiting ischaemic colitis. This is 
important to show the difference in the L/G ratio between the two populations. We can 
extrapolate from the results of study I that the L/G ratio will be high since we were monitoring 
ischaemic colons, but it needs to be confirmed in the bedside since there are a lot of confounding 
factors in this environment. Mr. Samir Damji, the researcher that took over this work, will 
continue this work and will take the rs- analyzer further all under supervision by Lord Ara Darzi. 
This is because the work presented above did prove the efficacy of the rs-system in monitoring 
ischaemia and it has been studied and piloted and then taken to the bedside clinical environment. 
Its two main disadvantages are its bulkiness, and its fragility.  
 Two proposals are being discussed currently on the clinical side by the Department of 
Bio Surgery and Surgical Technology and on the technical side by the Department of Bio 
Engineering at Imperial College London. The first is to develop a miniaturization of the current 
system to be more practical, reliable, and robust for continuous rs-monitoring. This system gave 
good results when it was functioning properly, but as was explained earlier in the methods, there 
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were a lot of problems that occurred each causing cessation of the sampling. A more robust and 
miniature analyzer is needed. This miniature analyzer would be ideally placed under the patient’s 
bed and not beside, hence decreasing on the distance of the tubes needed for the inflow and 
outflow needing lower flow rates and yielding higher recoveries. The connections between the 
catheter and the analyzer will be more secure in the abovefashion since they run from the patient 
to the analyzer underneath the bed and not across the bed where nursing staff working might 
disconnect them inadvertently like what happened with us in many instances. This is currently 
under study in the Department of Bioengineering in Imperial College London. It can also have 
the potential to be used as a mobile unit when the patient is transferred between care units and 
even to assess for metabolism in transplant organs transported between medical centers. 
The second proposal is to develop a handheld sampling analysis device that assesses 
metabolic factors near an implanted probe to give the physician a spot check on the metabolism 
in any tissue of questionable viability. This device will portray the result of its spot analysis of a 
dialysate sample as a traffic light signal where green is healthy, amber is border line and needs 
close follow up, and red being ischaemic necessitating intervention. This would give a lot of 
clinical input to the physician considering a bedside diagnosis of intestinal ischaemia.  
The two devices will be pioneered and constructed in the Department of Bioengineering 
under Dr. Boutelle’s supervision. Clinical pilot testing will be done in The Department of Bio 
Surgery and Surgical Technology at Imperial College London in the coming three years.   
5.2.2. Proposed work on microcatheters 
Catheters did break during implantation and did kink during sampling. The catheters are 
very fragile and any shear stress applied to the membrane causes the catheter to malfunction. 
Further technology in the fabrication of the catheters should be contemplated to make the 
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catheters sturdier to withstand the shear forces attributed to implanting the catheters. 
Furthermore, the catheters currently are being deployed in open procedures when the patient has 
had a laparotomy to allow adequate access for the surgeon to use the tunneler and then deploy 
the catheter through the tunneler. A great addition is a catheter that can be tunneled without the 
use of a tunneler. This means the catheter should have a smaller diameter and a hard 
microdialysis probe to be able to withstand the shear forces of tunneling them in tissue with no 
external support. 
This would be a great advance in clinical application for that catheter would be implanted 
in laparoscopic procedures without the necessity to convert to open procedures. It can also be 
used to percutaneously deploy it to assess for bowel ischaemia especially after endovascular 
repair of aortic aneurysms to monitor for bowel ischaemia that is not a rarity after these cases.
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This catheter can also be used in colonoscopic procedures to tunnel it in borderline ischaemic 
segments of the bowel and leave it behind to sample for the metabolites of ischaemia allowing 
the physician a closer follow up on the status of the borderline ischaemic bowel if the 
metabolites are progressing towards an increase in lactate and L/G ratio. Hence, a decision is 
made for surgical intervention without the need of rescoping the patient, losing time and 
subjecting the patient to an extra diagnostic intervention. 
Fixing the catheter in position is also another aspect that can be worked on. While 
working on this project, we had to learn from our mistakes and the catheter breakdowns to arrive 
at a way of fixing the catheter without breaking it. It was noticed always that the problem is in 
the distal tip of the catheter since it lacks any anchoring mechanism. That tip being always free is 
liable to move and hence kink the membrane or break it; no matter how sturdy is the fixation of 
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the proximal tip of the catheter. Two point fixation of the semipermeable membrane would 
greatly increase the sturdiness of the catheter.  
 
Figure 5.1: one point vs. two point fixation of the semipermeable membrane. Illustartion by 
SD 
 
 Henceforth, a mechanism should be incorporated into the catheter tip that can be tunneled 
with the catheter and then self deploy when the tip is free at the other end. We propose a spring 
like mechanism easily compressed when the probe is tunneled and then springs open when the 
probe is in place at the end of the tunnel. This mechanism would hold the probe in place until the 
probe is then withdrawn and the spring will compress at that time to allow withdrawal. This 
would ensure the sturdiness of the catheter and the position of the catheter since it anchors it in 
place allowing no chance for dislodgement from the tunneled position. 
 
Figure 5.2: Spring mechanism to hold catheter in place. Illustration by SD 
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5.2.3. Proposed work on the analyzer. 
The analyzer was also a major source of breakdown as explained in the methods section. 
Some advances can be made on the analyzer to avoid these breakdowns. The enzyme beds are 
assembled using filter paper saturated with the enzyme needed for the redox reaction. This, with 
time as the sampling goes ahead, lose reactivity and hence we always have to recalibrate for that. 
A good application to add to avoid the above is a flow cell instead of the chemical bed. The flow 
cell has the enzymes in it, the dialysate flows through it to allow for the redox reaction, and then 
the cell generates the respective current according to the chemical redox reaction and the 
concentration of the substrate. This is currently under development in the Department of 
Bioengineering to incorporate in the above-proposed prototype of the miniature analyzer. 
 The potentiostats used in this analyzer are old type and model which can be 
replaced by new ones available in the market that are smaller and more efficient. The HPLC 
pump used is also old, big and heavy and can be replaced by two smaller and newer pumps with 
no need to split the circuit of flow between the two chambers of the valve and every chamber 
will have its own pump. The problem of splitting the flow current is seen when the two beds 
have different backpressures, which is usually the case since they are assembled manually and 
every filter paper has its own resistance that causes a different backpressure from other filter 
papers. Hence, when the flow is split the current tends to go preferentially towards the bed with 
less resistance; this adds artifact to the readings. If the current of each is independent of the 
other, this problem will be solved. 
Processing of the current peaks can be integrated also with the analyzer. So far we have 
been processing the current peaks post sampling. This is time consuming, laborious, and liable 
for human error. A program is being developed to recognize the signal from the current peak, 
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convert it to concentration according to the concentration coefficient at that point in time and 
display the result as concentration and not current, and to display automatically the L/G ratio 
with an alarm to critical values of both.  
5.2.4. Proposed future clinical studies. 
As explained above the third study data will be expanded to provide a cohort of patients 
presenting with bowel ischaemia so that we can have two cohorts to compare results of. This 
technology started in the labs of the Department of Bioengineering at Imperial College and then 
got transferred to St. Mary’s to a lab on the tenth floor where all the benchtop work was done. 
Slowly it managed to find its way through to be piloted on patients to test its efficacy. Then it 
was tested on animal models before going a step further to be another tool directed at optimum 
patient care. Finally after a lot of push from both teams on the project it reached the clinical 
bedside. After achieving this status, the team taking over will be conducting the further necessary 
steps for the acceptance of this technology as a clinical application directed towards the delivery 
of excellent care to the patients with its potential diagnostic ability. The ideas summarized above 
in conjunction with more powerful (in number of patients) studies should be undertaken to prove 
(and not simple to suggest) its potential. 
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Appendix 
Appendix A: Study I sample data of the individual patients and their analysis. time G: time at 
glucose sampling, G con: glucose concentration at the time of sampling, time L: time at lactate 
sampling, L con: lactate concentration at time of sampling. 
Patient 1  
 time G G con mM  time L L con  mM 
01:04.6 0.545167 01:23.4 0.394691 
 01:34.7 1.13379 01:53.4 0.811789 
 02:04.6 1.844878 02:23.5 0.82213 
 02:34.6 1.686858 02:53.4 1.44433 
 03:04.6 1.618383 03:23.4 0.994485 
 03:34.7 1.929155 03:53.4 1.675284 
 04:04.6 2.951014 04:23.4 1.661496 
 04:34.6 2.24651 04:53.4 1.335746 
 05:04.7 2.033184 05:23.4 0.937608 
 05:34.7 1.983145 05:53.5 1.816615 
 06:04.6 3.053727 06:23.5 2.600827 
 06:34.6 3.942586 06:53.4 2.425026 
 07:04.6 3.494864 07:23.4 2.314719 
 07:34.7 3.340795 07:53.5 2.442261 
 08:04.6 4.209903 08:23.4 2.307825 
 08:34.6 3.908349 08:53.4 2.016546 
 09:04.7 4.254675 09:23.4 2.013099 
 09:34.6 4.169081 09:53.5 1.564978 
 10:04.6 3.086647 10:23.4 1.151327 
 10:34.6 2.46247 10:53.4 1.182351 
 11:04.6 3.1064 11:23.4 1.402964 
 11:34.6 3.292073 11:53.5 1.466736 
 12:04.6 3.509349 12:23.4 1.4788 
 12:34.7 2.970766 12:53.4 1.328852 
 13:04.7 3.298657 13:23.5 1.371941 
 13:34.6 3.29734 13:53.5 1.370217 
 14:04.6 3.213063 14:23.4 1.380558 
 14:34.7 3.43429 14:53.4 1.334023 
 15:04.6 3.306558 15:23.5 1.270252 
 15:34.6 3.460627 15:53.5 1.282316 
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16:04.6 3.436924 16:23.4 1.203033 
 16:34.7 3.307875 16:53.4 1.261634 
 17:04.6 3.54227 17:23.5 1.358152 
 17:34.6 3.475112 17:53.4 1.318511 
 18:04.6 3.583092 18:23.4 1.452947 
 18:34.7 3.78325 18:53.4 1.483971 
 19:04.6 3.633131 19:23.5 1.511548 
 19:34.6 3.993943 19:53.4 1.620131 
 20:04.7 3.914933 20:23.4 1.430541 
 20:34.7 4.025546 20:53.5 1.678731 
 21:04.6 4.091388 21:23.5 1.627025 
 21:34.6 3.750329 21:53.4 1.351258 
 22:04.7 2.588886 22:23.4 0.866942 
 22:34.7 2.32552 22:53.4 0.60324 
 23:04.6 3.043192 23:23.5 0.453292 
 23:34.6 1.189097 23:53.4 1.573595 
 24:04.7 3.533052 24:23.4 1.25991 
 24:34.6 3.365815 24:53.5 1.423647 
 25:04.6 3.031341 25:23.4 1.845915 
 25:34.6 3.918883 25:53.4 1.811444 
 26:04.7 4.205952 26:23.4 1.778697 
 
26:34.6 1.510403 26:53.4 0.436057 
artery 
resection 
27:04.6 0.89281 27:23.4 0.29645 
 27:34.7 0.683434 27:53.4 0.260255 
 28:04.7 0.643929 28:23.5 0.215443 
 28:34.6 0.761127 28:53.5 0.337815 
 29:04.6 0.840137 29:23.4 0.324026 
 29:34.6 0.828285 29:53.4 0.341262 
 30:04.7 0.830919 30:23.5 0.337815 
 30:34.6 0.786147 30:53.4 0.313685 
 31:04.6 1.015275 31:23.4 0.484316 
 31:34.7 1.402423 31:53.4 0.651499 
 32:04.6 1.534106 32:23.5 0.623923 
 32:34.6 1.381354 32:53.4 0.618752 
 33:04.6 1.621017 33:23.4 0.806618 
 33:34.6 1.964709 33:53.4 0.920372 
 34:04.6 2.10956 34:23.5 1.030679 
 34:34.6 2.210956 34:53.4 0.973802 
 35:04.7 2.520411 35:23.4 1.08928 
 35:34.7 2.698183 35:53.5 1.127198 
 36:04.6 2.875955 36:23.5 1.266805 
 36:34.6 3.3803 36:53.4 1.3909 
 37:04.7 3.260469 37:23.4 1.31334 
 37:34.6 3.460627 37:53.5 1.363323 
 38:04.6 3.534369 38:23.5 1.368494 
 38:34.6 3.404003 38:53.4 1.256463 
 39:04.7 3.299974 39:23.4 1.25991 
 39:34.6 3.244667 39:53.5 1.294381 
 40:04.6 3.713458 40:23.4 1.483971 
 
203 
 
40:34.6 4.315249 40:53.4 1.589107 
 41:04.7 4.278378 41:23.4 1.625302 
 41:34.6 4.751119 41:53.5 1.756291 
 42:04.6 4.78404 42:23.4 1.747673 
 42:34.7 4.827495 42:53.4 1.79938 
 43:04.7 5.176455 43:23.5 2.002758 
 43:34.6 5.19094 43:53.5 2.014822 
 44:04.6 5.59389 44:23.4 2.126853 
 44:34.7 5.02502 44:53.4 1.902792 
 45:04.7 4.427179 45:23.4 1.866598 
 45:34.6 4.599684 45:53.5 1.961393 
 46:04.6 4.320516 46:23.4 1.973457 specimen out 
46:34.7 4.599684 46:53.4 2.273354 
 47:04.6 4.369239 47:23.5 2.380214 
 47:34.6 4.224388 47:53.4 2.316443 
 48:04.6 4.303397 48:23.4 2.533609 
 48:34.7 4.199368 48:53.4 2.469838 
 49:04.6 4.045299 49:23.4 2.974836 
 49:34.6 4.781406 49:53.4 3.33678 
 50:04.7 4.282328 50:23.4 3.210962 
 50:34.7 4.408744 50:53.5 3.22475 
 51:04.6 4.134843 51:23.5 3.25405 
 51:34.6 3.875428 51:53.4 3.240262 
 52:04.6 3.978141 52:23.4 3.341951 
 52:34.7 3.551488 52:53.5 3.178214 
 53:04.6 3.654201 53:23.4 3.267839 
 53:34.6 3.689755 53:53.4 3.464323 
 54:04.7 3.393469 54:23.4 3.229921 
 54:34.6 3.465894 54:53.5 3.517752 
 55:04.6 3.292073 55:23.4 3.333333 
 55:34.6 3.169608 55:53.4 3.372975 
 56:04.6 3.091915 56:23.4 3.485005 
 56:34.6 2.858836 56:53.5 3.502241 
 57:04.6 3.097182 57:23.4 3.660807 
 57:34.7 3.02739 57:53.4 3.87625 
 58:04.7 3.073479 58:23.5 3.898656 
 58:34.6 3.306558 58:53.5 4.346777 
 59:04.6 3.234132 59:23.4 4.493278 
 59:34.7 3.521201 59:53.4 4.481213 
 00:04.7 3.439558 00:23.5 4.889693 
 00:34.7 3.323677 00:53.5 4.61565 
 01:04.6 3.468528 01:23.5 5.044812 
 01:34.7 3.286805 01:53.5 5.022406 
 02:04.7 3.203845 02:23.5 4.865564 
 02:34.6 3.107717 02:53.4 4.820751 
 03:04.6 2.845668 03:23.5 4.69838 
 03:34.7 2.916776 03:53.4 4.934505 
 04:04.7 2.707401 04:23.5 4.901758 
 04:34.7 2.636292 04:53.4 4.567391 
 05:04.7 2.5665 05:23.5 4.594967 
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05:34.7 2.299184 05:53.5 4.596691 
 06:04.7 2.475639 06:23.5 4.646674 
 06:34.6 2.37556 06:53.4 4.939676 
 07:04.7 2.333421 07:23.5 4.738021 
 07:34.7 2.578351 07:53.5 5.186143 
 08:04.7 2.536213 08:23.5 5.191313 
 08:34.7 2.781143 08:53.4 5.261979 
 09:04.7 2.979984 09:23.5 5.332644 
 09:34.6 2.960232 09:53.5 5.215443 
 10:04.7 3.228865 10:23.4 5.113754 
 10:34.6 3.037925 10:53.4 5.117201 
 11:04.7 3.097182 11:23.5 4.837987 
 11:34.6 3.18541 11:53.5 5.05343 
 12:04.7 3.11035 12:23.5 5.208549 
 12:34.7 3.442191 12:53.4 5.496381 
 13:04.7 3.317092 13:23.5 5.775595 
 13:34.6 3.35528 13:53.5 5.594623 
 14:04.7 3.745062 14:23.4 6.070321 
 14:34.7 3.569924 14:53.4 6.056532 
 15:04.7 3.681854 15:23.5 6.309893 
 15:34.6 3.824072 15:53.5 6.782144 
 16:04.7 3.59626 16:23.5 6.508101 
 16:34.7 3.892547 16:53.4 7.026887 
 17:04.6 3.547538 17:23.5 7.178559 
 17:34.6 3.67922 17:53.5 7.449155 
 18:04.7 3.668686 18:23.4 8.479835 
 18:34.7 3.340795 18:53.4 8.466046 
 19:04.7 3.372399 19:23.5 9.324371 
 19:34.6 3.044509 19:53.5 10.13099 
 20:04.7 2.856202 20:23.5 9.386418 
 20:34.7 2.742955 20:53.5 9.825922 
 21:04.6 2.400579 21:23.5 9.412272 
 21:34.6 2.322886 21:53.5 8.840055 
 22:04.7 2.025283 22:23.4 8.435022 
 22:34.7 1.784303 22:53.5 7.766287 
 23:04.7 1.767185 23:23.5 7.776629 
 23:34.6 1.609165 23:53.5 7.752499 
 24:04.7 1.577561 24:23.5 7.240607 
 24:34.7 1.543324 24:53.5 7.51465 
 25:04.6 1.507769 25:23.4 7.618063 
 25:34.6 1.597314 25:53.5 8.08342 
 26:04.7 1.460363 26:23.4 8.129955 
 26:34.7 1.518304 26:53.5 7.664598 
 27:04.7 1.542007 27:23.4 7.995519 
 27:34.7 1.40769 27:53.5 7.771458 
 28:04.7 1.4867 28:23.5 7.835229 
 28:34.7 1.436661 28:53.5 8.214409 
 29:04.6 1.426126 29:23.4 7.849018 
 29:34.7 1.468264 29:53.5 8.066184 
 30:04.7 1.332631 30:23.5 7.743881 
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30:34.7 1.37872 30:53.5 7.521544 
 31:04.7 1.37477 31:23.4 7.711134 
 31:34.7 1.254938 31:53.5 7.487073 
 32:04.6 1.312879 32:23.5 7.778352 
 32:34.7 1.248354 32:53.4 8.092037 
 33:04.6 1.256255 33:23.4 7.557739 
 33:34.7 1.260205 33:53.5 8.08859 
 34:04.6 1.19173 34:23.5 8.095484 
 34:34.7 1.276007 34:53.5 8.052396 
 35:04.7 1.222017 35:23.4 8.485005 
 35:34.7 1.21675 35:53.5 7.769735 
 36:04.6 1.236503 36:23.5 8.440193 
 36:34.7 1.179879 36:53.4 8.514305 
 37:04.7 1.225968 37:23.4 8.16615 
 37:34.7 1.196998 37:53.5 8.757325 
 38:04.6 1.161443 38:23.5 8.417787 
 38:34.7 1.225968 38:53.5 8.576353 
 39:04.7 1.143008 39:23.4 8.957256 
 39:34.6 1.160126 39:53.5 8.321269 
 40:04.6 1.173295 40:23.5 8.926232 
 40:34.7 1.074533 40:53.4 8.817649 
 41:04.7 1.124572 41:23.4 8.650465 
 41:34.7 1.062681 41:53.5 9.141675 
 42:04.6 1.075849 42:23.5 8.571182 
 42:34.7 1.115354 42:53.5 9.01758 
 43:04.7 1.041612 43:23.5 8.872802 
 43:34.6 1.085067 43:53.5 8.400552 
 44:04.6 1.041612 44:23.5 8.941744 
 44:34.7 1.008691 44:53.4 8.553947 
 45:04.7 1.071899 45:23.5 8.926232 
 45:34.7 1.016592 45:53.5 8.914168 
 46:04.6 1.003424 46:23.5 8.974492 
 46:34.7 1.048196 46:53.5 9.689762 
 47:04.7 0.954701 47:23.5 9.160634 
 47:34.6 1.021859 47:53.4 8.829714 
 48:04.6 0.959968 48:23.5 9.060669 
 48:34.7 0.944166 48:53.4 8.376422 
 49:04.7 0.934949 49:23.5 8.74526 
 49:34.7 0.891493 49:53.4 8.698725 
 50:04.7 0.923097 50:23.5 8.164426 
 50:34.7 0.905978 50:53.5 9.007239 
 51:04.7 0.896761 51:23.5 8.464323 
 51:34.6 0.933632 51:53.4 8.903826 
 52:04.7 0.903345 52:23.5 9.374354 
 52:34.7 0.945483 52:53.5 8.795243 
 53:04.7 0.927048 53:23.5 9.557049 
 53:34.7 0.902028 53:53.4 9.31403 
 54:04.7 0.941533 54:23.5 9.045157 
 54:34.6 0.883592 54:53.5 9.191658 
 55:04.7 0.878325 55:23.4 8.724578 
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55:34.6 0.895444 55:53.4 9.250259 
 56:04.7 0.855939 56:23.5 8.466046 
 56:34.6 0.744008 56:53.5 7.475009 
 57:04.7 0.506979 57:23.5 5.234402 
 57:34.7 0.409534 57:53.4 3.853844 
 58:04.7 0.337108 58:23.5 2.330231 
 58:34.6 0.126416 58:53.5 1.311617 MD out 
59:04.7 0.05399 59:53.4 0.617029 
 
  
59:53.4 0.617029 
 
  
59:53.4 0.617029 
 
  
59:53.4 0.617029 
  
 
 
Appendix B: Sample data from study II. 
Anastomosis  1:  G time: time where glucose sampled, G con: glucose concentration at that time, 
L time: time where lactate sampled, L con: lactate concentration at that time. 
G time G con mM L time L con mM 
10:25:14 0.1087551 10:24:31 1.0773443 
10:25:44 0.1518468 10:25:01 2.1738535 
10:26:14 0.1682627 10:25:31 2.2477755 
10:26:44 0.1662107 10:26:01 2.019165 
10:27:14 0.1415869 10:26:31 1.8767967 
10:27:44 0.1395349 10:27:01 1.8001369 
10:28:14 0.1025992 10:27:31 1.6563997 
10:28:44 0.1087551 10:28:01 1.6413415 
10:29:14 0.0923393 10:28:31 1.54141 
10:29:44 0.0738714 10:29:01 1.5304586 
10:30:14 0.0779754 10:29:31 1.5249829 
10:30:44 0.0595075 10:30:01 1.4360027 
10:31:14 0.0615595 10:30:31 1.4387406 
10:31:44 0.0492476 10:31:01 1.4483231 
10:32:14 0.0389877 10:31:31 1.4195756 
10:32:44 0.0410397 10:32:01 1.5030801 
10:33:14 0.0246238 10:32:31 1.4140999 
10:33:44 0.0369357 10:33:01 1.4729637 
10:34:14 0.0287278 10:33:31 1.4743326 
10:34:44 0.0307798 10:34:01 1.4606434 
10:35:14 0.0205198 10:34:31 1.3415469 
10:35:44 0.0574555 10:35:01 1.3073238 
10:36:14 0.0205198 10:35:31 1.2635181 
10:37:53 0.0082079 10:36:01 1.2607803 
10:38:20 0.0164159 10:38:01 1.1498973 
10:38:50 0.0246238 10:38:31 1.1772758 
10:39:20 0.0184679 10:39:01 1.1909651 
10:39:50 0.0123119 10:39:31 1.2032854 
10:40:20 0.0102599 10:40:01 1.192334 
10:40:50 0.0143639 10:40:31 1.1540041 
10:41:20 0.0123119 10:41:01 1.0896646 
10:41:50 0.0184679 10:41:31 1.0527036 
207 
 
10:42:20 0.0307798 10:42:01 1.0527036 
10:42:50 0.0164159 10:42:31 1.0157426 
10:43:20 0.0123119 10:43:01 1.0130048 
10:43:50 0.0143639 10:43:31 0.9924709 
10:44:20 0.0225718 10:44:01 0.9336071 
10:44:50 0.0082079 10:44:31 1.0047912 
10:45:20 0.004104 10:45:01 0.9856263 
10:45:50 0.0184679 10:45:31 0.9308693 
10:46:20 0.0143639 10:46:01 0.9158111 
10:46:50 0.0082079 10:46:31 0.8829569 
10:47:54 0.0102599 10:47:01 0.9048597 
10:48:54 0.0266758 10:47:31 0.91718 
10:49:24 0.004104 10:48:01 0.8583162 
10:49:54 0.006156 10:48:31 0.8665298 
10:50:19 0.0102599 10:49:01 0.8104038 
10:50:49 0.0082079 10:49:31 0.8542094 
10:51:19 0.0123119 10:50:01 0.8856947 
10:51:53 0.0123119 10:50:31 0.843258 
10:52:53 0.006156 10:51:01 0.8774812 
10:53:23 0.0143639 10:51:31 0.8774812 
10:53:53 0.0164159 10:52:01 0.8843258 
10:54:23 0.0143639 10:52:31 0.9021218 
10:55:13 0.0082079 10:53:01 0.8843258 
10:55:43 0.0123119 10:53:31 0.8281999 
10:56:19 0.0143639 10:54:01 0.8227242 
10:56:49 0.004104 10:54:31 0.7953457 
10:57:19 0.0082079 10:55:01 0.8610541 
10:57:49 0.0143639 10:55:31 0.8692676 
10:58:19 0.0143639 10:56:01 0.7953457 
10:58:49 0.0102599 10:56:31 0.8049281 
10:59:19 0.0082079 10:57:01 0.7857632 
10:59:49 0.0184679 10:57:31 0.8035592 
11:00:25 0.0164159 10:58:01 0.825462 
11:00:55 0.0102599 10:58:31 0.8008214 
11:01:19 0.0102599 10:59:01 0.8008214 
11:01:49 0.0102599 10:59:31 0.7488022 
11:02:19 0.0184679 11:00:01 0.7652293 
11:02:49 0.0102599 11:00:31 0.6762491 
11:03:19 0.0082079 11:01:01 0.7556468 
11:03:49 0.0164159 11:01:31 0.7474333 
11:04:49 0.0246238 11:02:01 0.7296372 
11:05:19 0.006156 11:02:31 0.7542779 
11:05:49 0.0123119 11:03:01 0.7775496 
11:06:19 0.0102599 11:03:31 0.6899384 
11:06:49 0.006156 11:04:01 0.6872005 
11:08:19 0.0164159 11:04:31 0.696783 
11:08:49 0.0143639 11:05:01 0.7173169 
11:09:19 0.0123119 11:05:31 0.7268994 
11:09:49 0.0082079 11:06:01 0.7118412 
11:10:49 0.0164159 11:06:31 0.6858316 
208 
 
11:11:19 0.0082079 11:07:01 0.7227926 
11:11:49 0.0102599 11:07:31 0.7132101 
11:12:56 0.0102599 11:08:01 0.7871321 
11:13:26 0.0143639 11:08:31 1.118412 
11:13:56 0.0082079 11:09:01 1.4236824 
11:14:23 0.0082079 11:09:31 1.559206 
11:15:23 0.006156 11:10:01 1.028063 
11:15:53 0.0102599 11:10:31 0.7036277 
11:16:23 0.0164159 11:11:01 0.6283368 
11:16:53 0.0123119 11:11:31 0.8145106 
11:17:23 0.0123119 11:12:01 0.8336756 
11:18:52 0.0225718 11:12:31 0.78987 
11:19:16 0.0266758 11:13:01 0.8199863 
11:19:46 0.0143639 11:13:31 0.881588 
11:20:22 0.0225718 11:14:01 0.8637919 
11:20:52 0.0184679 11:14:31 0.8323066 
11:21:22 0.0184679 11:15:01 0.788501 
11:21:52 0.0246238 11:15:31 0.9650924 
11:22:22 0.0184679 11:16:01 1.0444901 
11:22:52 0.0164159 11:16:31 1.1101985 
11:23:22 0.0225718 11:17:01 0.9828884 
11:25:22 0.0164159 11:17:31 0.9253936 
11:25:52 0.0164159 11:18:01 1.6454483 
11:26:22 0.0143639 11:18:31 1.9644079 
11:26:52 0.0184679 11:19:01 1.3319644 
11:27:22 0.0164159 11:19:31 1.2908966 
11:27:52 0.0143639 11:20:01 0.9199179 
11:28:22 0.0184679 11:20:31 0.7843943 
11:29:22 0.0184679 11:21:01 0.9568789 
11:29:52 0.0184679 11:21:31 1.1772758 
11:30:22 0.0205198 11:22:01 1.2922656 
11:30:52 0.0143639 11:22:31 1.4086242 
11:31:22 0.0123119 11:23:01 1.467488 
11:31:52 0.0184679 11:23:31 1.3853525 
11:32:22 0.0164159 11:24:01 1.2087611 
11:32:52 0.0082079 11:24:31 1.1772758 
11:33:22 0.0123119 11:25:01 1.2881588 
11:33:52 0.0164159 11:25:31 0.9281314 
11:34:52 0.0143639 11:26:01 0.8952772 
11:35:22 0.0205198 11:26:31 0.6872005 
11:36:52 
 
11:27:01 0.45859 
11:37:22 0.0143639 11:27:31 0.6379192 
11:37:52 0.004104 11:28:01 0.954141 
11:38:22 0.0143639 11:28:31 0.8145106 
11:38:52 0.0164159 11:29:01 0.7953457 
11:39:22 0.0164159 11:29:31 0.7104723 
11:40:22 0.0123119 11:30:01 0.5927447 
11:40:52 0.006156 11:30:31 0.4229979 
11:42:22 0.0143639 11:31:01 0.3408624 
11:42:52 0.0123119 11:31:31 0.440794 
209 
 
11:43:22 0.0184679 11:32:01 0.6625599 
11:43:52 0.0143639 11:32:31 0.4161533 
11:44:52 0.0164159 11:33:01 0.3258042 
11:45:22 0.0143639 11:33:31 0.2450376 
11:45:52 0.0123119 11:34:01 0.2094456 
11:46:22 0.006156 11:34:31 0.1820671 
11:57:22 0.006156 11:35:01 0.1889117 
 
 
 
 
 
 
 
 
 
Appendix C: Sample data from study III 
Patient 1: Time: time in minutes of the sampling, G con: Glucose concentration at time of 
sampling, L con: Lactate concentration at time of sampling. 
Time min G con mM L con mM time/min G con mM L con mM 
0 1.4502841 0.8215722 1108 5.6118596 1.878175 
1 1.9492934 1.0263267 1109 5.5402976 1.906569 
2 1.9559754 1.0209277 1110 5.5490391 1.880375 
3 1.9888775 1.0424074 1111 5.643832 1.855069 
4 2.0669327 1.0367863 1112 5.6671901 1.873255 
5 2.0482023 1.0500267 1113 5.5642912 1.902313 
6 2.0270495 1.0619323 1114 5.4417581 1.873014 
7 2.1654725 1.1368606 1115 5.3737186 1.799113 
8 2.280564 1.2285771 1116 5.301109 1.773808 
9 2.2803588 1.2243871 1117 5.1267217 1.808636 
10 2.1452866 1.1660585 1118 4.9295734 1.808405 
11 1.9389045 1.0997844 1119 4.8424253 1.765127 
12 1.9688129 1.0711347 1120 4.8573753 1.775991 
13 2.2999011 1.1399124 1121 4.856364 1.841216 
14 2.615332 1.240787 1122 4.8222494 1.890909 
15 2.6421346 1.2411874 1123 4.8410168 1.876699 
16 2.4967505 1.1719858 1124 4.928393 1.844516 
17 2.4227232 1.1162968 1125 5.011756 1.858929 
18 2.3619855 1.0885953 1126 4.9694584 1.879111 
19 2.2599399 1.061095 1127 4.8336567 1.85536 
20 2.213408 1.0327569 1128 4.7774602 1.811197 
21 2.224152 1.0371609 1129 4.8779895 1.78079 
22 2.3286339 1.0648058 1130 4.9676627 1.743506 
23 2.5928759 1.119327 1131 4.8801241 1.668503 
  
1.2736798 1132 4.7467135 1.60637 
30 
  
1133 4.7055018 1.66782 
31 4.0605221 
 
1134 4.7483794 1.854627 
32 4.3066822 1.4437609 1135 4.8297465 1.993065 
33 4.3954741 1.5317812 1136 4.9639304 1.971312 
210 
 
34 4.2304074 1.6814802 1137 5.1727804 1.918054 
35 4.0200117 1.8246397 1138 5.3717241 1.972401 
36 3.982652 1.7345215 1139 5.4509383 2.093308 
37 4.0493507 1.5778416 1140 5.400679 2.151204 
38 3.9793225 1.5436285 1141 5.3372604 2.145203 
39 3.7553118 1.5665963 1142 5.3670632 2.192448 
40 3.5147775 1.5737073 1143 5.4270238 2.27386 
41 3.4067261 1.5159557 1144 5.3855421 2.254991 
42 3.4698853 1.420237 1145 5.3103325 2.139169 
43 3.5279036 1.3595343 1146 5.2906989 2.112978 
44 3.635887 1.3615184 1147 5.3063635 2.279582 
45 3.9750501 1.3886283 1148 5.2894592 2.381403 
46 4.3233196 1.4182991 1149 5.2004906 2.198361 
47 4.5593997 1.4855428 1150 5.1414797 1.982485 
48 4.7204688 1.6503731 1151 5.1857744 1.95674 
49 4.6570269 1.8162177 1152 5.23751 2.012636 
50 4.4611463 1.8311196 1153 5.1774615 2.00109 
51 4.2270156 1.7366176 1154 5.088478 1.936965 
52 4.0194103 1.6490191 1155 5.0880645 1.886374 
53 4.0239286 1.6026039 1156 5.0854448 1.845323 
54 4.2054979 1.5808727 1157 4.9875154 1.792514 
55 4.4694258 1.5706486 1158 4.8571298 1.723067 
56 4.686921 1.5649176 1159 4.7599672 1.691557 
57 4.6718027 1.5930604 1160 4.6860872 1.72549 
58 4.5355177 1.6867663 1161 4.5677893 1.757648 
59 4.4484467 1.7964134 1162 4.420242 1.732793 
60 4.3022116 1.8357824 1163 4.3478401 1.705054 
61 4.1671732 1.8104212 1164 4.3998587 1.753627 
62 4.1795904 1.7785155 1165 4.4855482 1.823719 
63 4.2528257 1.7499523 1166 4.4354918 1.801083 
64 4.2634946 1.7452056 1167 4.3004479 1.716111 
65 4.2054607 1.7566118 1168 4.2604348 1.698355 
66 4.1177233 1.7344786 1169 4.3400281 1.758019 
67 3.9819334 1.6989633 1170 4.3986029 1.792172 
68 3.8643178 1.6682159 1171 4.4090334 1.763991 
69 3.8233357 1.6362846 1172 4.470806 1.75045 
70 3.9238218 1.5988673 1173 4.4786164 1.833626 
71 4.1817086 1.5594028 1174 4.3383599 1.925009 
72 4.4757566 1.5149965 1175 4.1502321 1.898381 
73 4.6870358 1.4751158 1176 
 
1.855115 
74 4.67612 1.4964435 1177 
 
1.891041 
75 4.4689776 1.5461178 1178 
 
1.961127 
76 4.3168909 1.5629027 1179 
 
2.01879 
77 4.3506173 1.5337923 1180 
 
2.013456 
78 4.4826816 1.4684622 1181 
 
1.984388 
79 4.6492059 1.4205829 1182 3.8685494 2.017428 
80 4.7789693 1.4284403 1183 4.1914551 2.043814 
81 4.7478641 1.4682476 1184 4.296636 1.973267 
82 4.6877763 1.4887958 
 
4.4054322 1.917137 
83 4.7571204 1.4730399 1209 4.7254911 1.974133 
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84 4.8494188 1.4630629 1210 4.9987992 2.020482 
85 4.8306457 1.4978546 1211 5.0118482 1.959917 
86 4.6387779 1.5413494 1212 4.9476268 1.880721 
87 4.360135 1.5571346 1213 4.9241035 
 88 4.2005334 1.5523849 1214 4.9438226 
 89 4.1715961 1.5319699 1215 4.9763582 
 90 4.1222098 1.4938181 1216 4.9488665 
 91 3.9717444 1.4620114 1217 5.0385082 
 92 3.8433307 1.4589248 1218 5.3777058 
 93 3.8637813 1.4686223 1219 5.5109794 1.550147 
94 3.7979869 1.4672626 1220 5.0289887 1.625671 
95 3.6683056 1.4574603 1221 4.3833161 1.648197 
96 3.7500567 1.4870488 1222 4.1002052 1.617114 
97 3.8593534 1.5303574 1223 4.1124781 1.585159 
98 3.833514 1.5445371 1224 4.0322206 1.606974 
99 3.7479665 1.542653 1225 3.9815833 1.605821 
100 3.6632157 1.5009414 1226 4.3989155 1.525092 
101 3.5845716 1.4671254 1227 4.9159445 1.472902 
102 3.4861797 1.4769117 1228 5.2135584 1.487893 
103 3.409118 1.4640876 1229 5.2646356 1.526491 
104 3.3363809 1.4113102 1230 
 
1.517652 
105 3.2868537 1.3664045 1231 
 
1.481226 
106 3.4136773 1.3470078 1232 
 
1.632097 
107 3.6803535 1.3420087 1233 
 
1.997658 
108 3.882793 1.369438 1234 
 
2.17564 
109 3.9312082 1.4275804 1235 
 
2.005012 
110 3.8872668 1.476357 
 
3.3381063 1.819047 
111 3.8648602 1.4930059 1475 3.6332787 1.773338 
112 3.9305372 1.4851412 1476 4.1062923 1.714532 
113 4.0646543 1.4731285 1477 4.4673848 1.666267 
114 4.1412786 1.4762128 1478 4.8138402 1.787765 
115 4.0837845 1.5018418 1479 5.1384065 1.894766 
116 3.9965225 1.5289816 1480 4.9642624 1.814958 
117 3.9641661 1.5252617 1481 4.5384694 
 118 3.9172747 1.5007393 1482 4.3520433 
 119 3.7844839 1.4788539 1483 4.0451183 
 120 3.6579051 1.4530497 1484 3.8552005 
 121 3.6686875 1.413484 1485 4.3260516 
 122 3.7319144 1.3765495 1486 4.6183322 1.210965 
123 3.7200241 1.3637455 1487 4.2195231 1.376777 
124 3.6473905 1.3658541 1488 3.8361397 1.561343 
125 3.5211108 1.386532 1489 3.7883813 1.541326 
126 3.3792581 1.4135098 1490 3.8360834 1.349229 
127 3.2544498 1.3946551 1491 3.8283074 1.340145 
128 3.1549458 1.3704235 1492 3.754695 1.39523 
129 3.1299206 1.3581182 1493 3.7480945 1.263755 
130 3.0993284 1.2961882 1494 3.8033378 1.272509 
131 3.0523528 1.2188505 1495 3.6997394 1.479079 
132 3.0983308 1.1690678 1496 3.5334227 1.516543 
133 3.2063819 1.1378773 1497 3.5002748 1.351518 
212 
 
134 3.345649 1.1286542 1498 3.525807 1.22475 
135 3.5253092 1.1465839 1499 3.5445476 1.24739 
136 3.6539643 1.17299 1500 3.6017223 1.333558 
137 3.6775884 1.1943063 1501 3.7725528 1.324263 
138 3.6215816 1.2280834 1502 3.9941339 1.22272 
139 3.4903546 1.2831258 1503 4.0339784 1.209679 
140 3.3149441 1.3373414 1504 3.858949 1.272663 
141 3.1172532 1.369191 1505 3.8438816 1.251165 
142 2.9551407 1.3710188 1506 4.2033072 1.169971 
143 2.8984827 1.3442723 1507 4.5319996 1.14034 
144 2.937376 1.3086643 1508 4.3714932 1.173188 
145 3.0674428 1.2726821 1509 3.7922065 1.208323 
146 3.2842566 1.2494574 1510 3.2779493 1.201342 
147 3.5299215 1.2564013 1511 3.0736941 1.190105 
148 3.782411 1.2471283 1512 3.0231852 1.225432 
149 4.0130772 1.2247357 1513 2.9893755 1.246728 
150 4.1443047 1.2690403 1514 3.0102208 1.205991 
151 4.2082917 1.344605 1515 3.1696723 1.194289 
152 4.229798 1.386281 1516 3.3619765 1.297756 
153 4.2254553 1.4308261 1517 3.3871885 1.43661 
154 4.2006945 1.4225453 1518 3.2513498 1.428583 
155 4.0896768 1.3242295 1519 3.1258307 1.26264 
156 3.9395863 1.2694984 1520 3.1001287 1.125195 
157 3.8273463 1.2814426 1521 3.1118035 1.107147 
158 3.7790541 1.2795165 1522 3.0606876 1.1194 
159 3.7659862 1.2590922 1523 3.0130969 1.087473 
160 3.769664 1.2395577 1524 3.15542 1.059199 
161 3.7817011 1.2097761 1525 3.4403763 1.109635 
162 3.7257132 1.1898694 1526 3.6398229 1.179859 
163 3.6258715 1.1922036 1527 3.747193 1.155861 
164 3.5566806 1.198573 1528 4.0121056 1.079592 
165 3.4574601 1.2145749 1529 4.3784959 1.05485 
166 3.3132838 1.214432 1530 4.3985316 1.08313 
167 3.1763765 1.1885104 1531 4.1285241 1.083671 
168 3.0785955 1.1703306 1532 4.0331437 1.027526 
169 3.0715187 1.1754728 1533 4.2232062 1.025585 
170 3.1196826 1.1734259 1534 4.5027599 1.160301 
171 3.1970088 1.1311322 1535 4.6494797 1.300066 
172 3.2715894 1.0953609 1536 4.6762454 1.31363 
173 3.2983915 1.0923203 1537 4.7311713 1.305001 
174 3.3572365 1.0911418 1538 4.7927191 1.405022 
175 3.4782182 1.0993709 1539 4.7862116 1.526628 
176 3.6003002 1.1201383 1540 4.6520824 1.504262 
177 3.627374 1.1412602 1541 4.4302215 1.388613 
178 3.5234879 1.1693335 1542 4.279351 1.369301 
179 3.4478401 1.2241882 1543 4.1658719 1.48076 
180 3.4758866 1.3112233 1544 3.985954 1.573579 
181 3.5209515 1.3687746 1545 3.8026848 1.542716 
182 3.4923019 1.3429112 1546 3.6726458 1.488599 
183 3.4097358 1.2763463 1547 3.6014824 1.537841 
213 
 
184 3.4397866 1.2469473 1548 3.5972315 1.635952 
185 3.5958404 1.2632989 1549 3.6104681 1.698855 
186 3.7369088 1.2768111 1550 3.8166258 1.787537 
187 3.8222153 1.2653352 1551 3.9432433 1.912836 
188 3.8753642 1.2459279 1552 3.5525191 1.961073 
189 3.8972295 1.2439426 1553 3.2178475 1.884809 
190 3.897263 1.2575019 1554 3.1616657 1.758763 
191 3.8411102 1.2637663 1555 3.0758397 1.720071 
192 3.7134652 1.2907587 1556 3.1474111 1.776749 
193 3.6028294 1.3151961 1557 3.578706 1.766651 
194 3.5482925 1.2634869 1558 4.0547892 1.628554 
195 3.4840933 1.1913242 1559 4.2019637 1.566608 
196 3.4102814 1.1544621 1560 4.0707382 1.722357 
197 3.3745986 1.1347855 1561 3.907463 1.880365 
198 3.3838322 1.1185841 1562 3.9072803 1.86854 
199 3.4438213 1.1017144 1563 3.9554898 1.821439 
200 3.4923569 1.0941157 1564 3.8529064 1.848019 
201 3.4882439 1.0874507 1565 3.6614117 1.86489 
202 3.4390164 1.0711417 1566 3.6140658 1.795974 
203 3.3907192 1.066713 1567 3.7834405 1.782869 
204 3.3769267 1.0780315 1568 4.0044543 1.831849 
205 3.3400079 1.1080692 1569 4.2074435 1.739849 
206 3.3146334 1.1310311 1570 4.4276691 1.59079 
207 3.3527777 1.1156431 1571 4.6229027 1.531416 
208 3.3803326 1.1034856 1572 4.7041674 1.569839 
209 3.350061 1.0970977 1573 4.6468468 1.631606 
210 3.3835388 1.0910432 1574 4.5801781 1.588726 
211 3.5232828 1.0979257 1575 4.6294088 1.481692 
212 3.666111 1.1103371 1576 4.6798558 1.466552 
213 3.7017038 1.1370601 1577 4.6291378 1.571376 
214 3.4913669 1.1595873 1578 4.5696145 1.630776 
215 3.193672 1.2082284 1579 4.5519286 1.608309 
216 3.1040704 1.2767621 1580 4.5982696 1.671797 
217 3.1636823 1.3076334 1581 4.6710217 1.809047 
218 3.1767192 1.3310888 1582 4.6381834 1.861429 
219 3.2200121 1.3245056 1583 4.5720321 1.799174 
220 3.3644737 1.266957 1584 4.5384436 1.730445 
221 3.4896484 1.2119378 1585 4.376466 1.75172 
222 3.5604736 1.2272512 1586 4.0219438 1.788262 
223 3.5826554 1.2834928 1587 3.6401314 1.711692 
224 3.6439697 1.3185295 1588 3.4089191 1.593905 
225 3.7961438 1.3677799 1589 3.3236556 1.591816 
226 3.9631833 1.3687202 1590 3.2552455 1.670145 
227 4.073731 1.2953615 1591 3.1313333 1.684888 
228 4.0993195 1.256817 1592 3.0448026 1.623471 
229 4.0397348 1.2613465 1593 3.0715425 1.605659 
230 3.8702801 1.2810759 1594 3.135939 1.668698 
231 3.6928064 1.3047858 1595 3.1954033 1.675738 
232 3.6102669 1.3063853 1596 3.2863941 1.549571 
233 3.5422827 1.2745521 1597 3.4275904 1.398112 
214 
 
234 3.4112702 1.2148401 1598 3.6121087 1.341983 
235 3.2525422 1.1643195 1599 3.8002547 1.346974 
236 3.1477531 1.1322743 1600 3.9747332 1.306106 
237 3.1235934 1.108477 1601 4.1825242 1.225108 
238 3.1368448 1.0956072 1602 4.3888113 1.198488 
239 3.1777658 1.0843691 1603 4.4696607 1.243028 
240 3.3076676 1.0687779 1604 4.415038 1.266857 
241 3.4821828 1.0625084 1605 4.3772369 1.234015 
242 3.5540458 1.0689071 1606 4.4144434 1.223489 
243 3.5260886 1.0836793 1607 4.3932488 1.29958 
244 3.554627 1.117559 1608 4.2967387 1.392557 
245 3.7170459 1.1826597 1609 4.2644623 1.396843 
246 3.8597628 1.2397992 1610 4.4034099 1.385459 
247 3.8438239 1.2383183 1611 4.6162131 1.473153 
248 3.7683101 1.2429514 1612 4.6250397 1.575523 
249 3.6836922 1.303056 1613 4.379746 1.574178 
250 3.5631275 1.381778 1614 4.1202759 1.515998 
251 3.5131641 1.431312 1615 3.9682426 1.513435 
252 3.6535468 1.4276643 1616 3.8360858 1.568648 
253 3.8408989 1.4074949 1617 3.7161477 1.573211 
254 3.8837631 1.373403 1618 3.7183166 1.491224 
255 3.934818 1.3301396 1619 3.8692957 1.437264 
256 4.0648737 1.338291 1620 4.096432 1.495058 
257 4.0509277 1.4230616 1621 4.2804736 1.583951 
258 3.9990836 1.4923065 1622 4.4565261 1.581557 
259 4.1185341 1.4696559 1623 4.7210459 1.49646 
260 4.2219935 1.4422763 1624 4.9164634 1.45176 
261 4.1137736 1.4788181 1625 4.9186305 1.466183 
262 3.9361988 1.518787 1626 4.7214318 1.416471 
263 3.9645414 1.5059739 1627 4.4300904 1.308822 
264 4.0813053 1.4805478 1628 4.2993706 1.285859 
265 4.1066441 1.4629064 1629 4.3669759 1.359793 
266 4.0937367 1.4133995 1630 4.4339403 1.41551 
267 4.0404521 1.3545867 1631 4.4228836 1.414502 
268 3.9558119 1.3323368 1632 4.4245899 1.417219 
269 3.9165378 1.3532744 1633 4.3899642 1.490977 
270 3.9378327 1.3969026 1634 4.2189791 1.584309 
271 3.9338274 1.3924341 1635 3.9965738 1.573428 
272 3.8812322 1.3501597 1636 3.8780096 1.491602 
273 3.820458 1.344677 1637 3.9093843 1.448197 
274 3.7534928 1.3598446 1638 3.9548702 1.4621 
275 3.7230048 1.3653768 1639 3.8849101 1.473329 
276 3.774741 1.3577847 1640 3.7499145 1.439467 
277 3.8122575 1.353657 1641 3.6525434 1.419676 
278 3.8030762 1.3730688 1642 3.6112003 1.473565 
279 3.8101783 1.4004774 1643 3.5785336 1.527495 
280 3.8407285 1.4359399 1644 3.4722732 1.46943 
281 3.9182593 1.4860555 1645 3.3447564 1.352529 
282 3.9938137 1.5261745 1646 3.3362804 1.324509 
283 4.0286577 1.5339979 1647 3.4027721 1.372154 
215 
 
284 4.1055088 1.5439706 1648 3.4509687 1.369405 
285 4.1813868 1.5874391 1649 3.5109799 1.309473 
286 4.1416655 1.6327209 1650 3.6431466 1.292505 
287 4.0394337 1.6368305 1651 3.9212315 1.334183 
288 3.8703131 1.6189472 1652 4.2796127 1.336227 
289 3.663034 1.6430821 1653 4.5142736 1.27266 
290 3.6270433 1.6500005 1654 4.6628982 1.235516 
291 3.7852276 1.5892268 1655 4.8312114 1.261102 
292 4.0661016 1.5160526 1656 4.9086526 1.28942 
293 4.3730864 1.4469396 1657 4.8743242 1.268889 
294 4.5517109 1.4002414 1658 4.8621541 1.233673 
295 4.5955571 1.3855032 1659 4.8810941 1.275805 
296 4.6188857 1.4116871 1660 4.8632537 1.38592 
297 4.6329093 1.4742751 1661 4.8022567 1.452544 
298 4.5994151 1.5107951 1662 4.7697343 1.480588 
299 4.5607127 1.505292 1663 4.8654848 1.584135 
300 4.4690805 1.4810044 1664 5.01581 1.725163 
301 4.3535461 1.464136 1665 5.0258827 1.772557 
302 4.3114605 1.4621304 1666 4.9367296 1.723832 
303 4.2536671 1.4569167 1667 4.9568188 1.672016 
304 4.1958625 1.4460012 1668 5.0329422 1.699839 
305 4.2471366 1.4236565 1669 4.9861904 1.757474 
306 4.3338059 1.3902196 1670 4.8605891 1.719461 
307 4.3862601 1.3638613 1671 4.764282 1.634088 
308 4.3605884 1.3606792 1672 4.707226 1.652617 
309 4.1982313 1.3692759 1673 4.6025573 1.752234 
310 4.0785588 1.3700108 1674 4.4226472 1.784409 
311 4.1017565 1.3750641 1675 4.3501564 1.723656 
312 4.0726194 1.376516 1676 4.4384561 1.698573 
313 3.9754937 1.3600181 1677 4.5596229 1.755815 
314 3.798524 1.3499756 1678 4.6554865 1.771673 
315 3.6423998 1.3528607 1679 4.6703157 1.698779 
316 3.7388557 1.3438436 1680 4.6482009 1.648517 
317 3.812128 1.3424199 1681 4.6216616 1.685239 
318 3.7354028 1.3593869 1682 4.4690258 1.731256 
319 3.7900941 1.3329642 1683 4.2667267 1.677553 
320 3.9847713 1.3036741 1684 4.1614567 1.567068 
321 4.133352 1.3144997 1685 4.0787794 1.553908 
322 4.1324636 1.3017426 1686 4.0038765 1.631198 
323 4.0810272 1.2901039 1687 4.0477097 1.647929 
324 4.083348 1.3089484 1688 4.2026953 1.591535 
325 4.0327553 1.3394827 1689 4.3659906 1.599072 
326 3.8710506 1.3780886 1690 4.5174793 1.680863 
327 3.6582891 1.4134925 1691 4.6272886 1.698618 
328 3.4738254 1.4588479 1692 4.6409187 1.607644 
329 3.378128 1.4987852 1693 4.6168854 1.508788 
330 3.389462 1.4916023 1694 4.572362 1.513682 
331 3.5261439 1.4499999 1695 4.4504634 1.569808 
332 3.8299643 1.4017126 1696 4.2012391 1.532647 
333 4.2214274 1.372062 1697 3.915689 1.442576 
216 
 
334 4.451593 1.3768832 1698 3.7830672 1.474243 
335 4.4989522 1.3986221 1699 3.8060306 1.607431 
336 4.4802716 1.4605893 1700 3.8590529 1.664315 
337 4.3868334 1.5536102 1701 3.9946696 1.617828 
338 4.3328709 1.5877351 1702 4.4958286 1.594213 
339 4.420995 1.5972662 1703 5.1880033 1.654981 
340 4.526303 1.5912068 1704 5.5735161 1.693697 
341 4.5514693 1.5170196 1705 5.7069896 1.616941 
342 4.502724 1.4568272 1706 5.7808876 1.507716 
343 4.4303366 1.4335661 1707 5.7504798 1.475879 
344 4.3750006 1.4128629 1708 5.6443826 1.489192 
345 4.3464486 1.4330595 1709 5.589353 1.461203 
346 4.3479497 1.4856509 1710 5.6763258 1.406208 
347 4.3063497 1.4928405 1711 5.8573416 1.430168 
348 4.1688123 1.4627817 1712 5.8572411 1.586878 
349 4.0775169 1.4479792 1713 5.5837803 1.750368 
350 4.0755515 1.4540872 1714 5.363726 1.778268 
351 4.0314311 1.4965435 1715 5.3610652 1.762097 
352 3.9829783 1.5367853 1716 5.3844623 1.821064 
353 3.9343817 1.5170739 1717 5.2620656 1.869405 
354 3.8879325 1.4849791 1718 5.0619267 1.798805 
355 3.8803815 1.4828889 1719 4.9140218 1.697231 
356 3.8109478 1.4837858 1720 4.795806 1.718708 
357 3.755624 1.4647024 1721 4.6780397 1.815567 
358 3.8207654 1.4410709 1722 4.5462462 1.809535 
359 3.9174997 1.4646426 1723 4.3526433 1.682723 
360 4.0372919 1.4995374 1724 4.2110461 1.615022 
361 4.1953783 1.4659669 1725 4.1799627 1.664364 
362 4.244632 1.4392424 1726 4.129654 1.696303 
363 4.1467513 1.4776935 1727 4.023569 1.632318 
364 4.056415 1.5158108 1728 4.0847181 1.562244 
365 4.0249139 1.5647168 1729 4.3301219 1.589806 
366 3.8948096 1.6201481 1730 4.3875241 1.635149 
367 3.7591994 1.6204208 1731 4.2712678 1.5764 
368 3.958724 1.6371967 1732 4.2492489 1.471794 
369 4.2108827 1.682968 1733 4.371799 1.448353 
370 4.229801 1.6446462 1734 4.4952805 1.483772 
371 4.2862325 1.5714967 1735 4.4369458 1.471997 
372 4.4064146 1.5756413 1736 4.2727449 1.406212 
373 4.4728968 1.5869857 1737 4.1855417 1.369645 
374 4.4623729 1.5511349 1738 4.350159 1.409206 
375 4.3912527 1.535242 1739 4.6873082 1.481948 
376 4.3950984 1.5524108 1740 4.9063734 1.486019 
377 4.4142851 1.5827269 1741 5.0032158 1.436383 
378 4.2511198 1.6053695 1742 5.1511518 1.474204 
379 3.9627877 1.5979191 1743 5.4471481 1.561669 
380 4.0761526 1.5831296 1744 5.7320378 1.56157 
381 4.540529 1.6675562 1745 5.941191 1.498405 
382 4.6217967 1.8234023 1746 6.2051291 1.489399 
383 4.4193986 1.8136892 1747 6.3839901 1.549243 
217 
 
384 4.3166375 1.7116819 1748 6.3785825 1.595219 
385 4.2603336 1.7811135 1749 6.3433571 1.610529 
386 4.1605164 1.9202487 1750 6.2225658 1.659348 
387 4.0650405 1.9645408 1751 5.8152117 1.778642 
388 3.9369808 1.9887177 1752 5.3001056 1.855883 
389 3.7753199 2.008582 1753 4.9293397 1.810808 
390 3.7038406 1.9737089 1754 4.6820359 1.761023 
391 3.6656987 1.9501848 1755 4.6194202 1.822479 
392 3.5816257 1.9277039 1756 4.6997459 1.922417 
393 3.4537483 1.8513784 1757 4.964061 1.916878 
394 3.2651192 1.7792527 1758 5.6150608 1.846026 
395 3.1334798 1.7494666 1759 6.2065435 1.863391 
396 3.2014153 1.7444286 1760 6.4395012 1.953937 
397 3.3255157 1.731066 1761 6.5738093 1.928661 
398 3.3373681 1.7204769 1762 6.5829496 1.775554 
399 3.3076817 1.7343712 1763 6.4610801 1.676585 
400 3.3421607 1.747094 1764 6.339661 1.682571 
401 3.3506795 1.7388278 1765 6.1288777 1.697112 
402 3.239609 1.7428929 1766 5.7921835 1.656932 
403 3.1725261 1.7628209 1767 5.5600016 1.643383 
404 3.2884368 1.7664882 1768 5.5363186 1.765421 
405 3.4712161 1.7630006 1769 5.4879142 1.926926 
406 3.504739 1.7303599 1770 5.2733881 1.956711 
407 3.4546097 1.6861161 1771 5.0926876 1.896334 
408 3.3895448 1.6865525 1772 5.0901712 1.907028 
409 3.2665205 1.7350071 1773 5.152919 1.981452 
410 3.3127436 1.8100072 1774 5.1781719 1.974883 
411 3.4486949 1.8450052 1775 5.2117995 1.862073 
412 3.6602221 1.8142477 1776 5.3466337 1.763016 
413 3.9482706 1.7794365 1777 5.5187662 1.76834 
414 3.9938277 1.7662729 1778 5.5652493 1.820277 
415 3.9060971 1.8055278 1779 5.5840737 1.75902 
416 3.8901861 1.8754756 1780 5.7758045 1.637484 
417 3.8776172 1.9063867 1781 5.9852275 1.668331 
418 3.8204065 1.8997609 1782 5.9962318 1.787191 
419 3.7252791 1.8570605 1783 5.9527126 1.821067 
420 3.5760894 1.7984763 1784 6.0488753 1.769654 
421 3.5220202 1.7555887 1785 6.1358981 1.778409 
422 3.6308836 1.7190871 1786 6.0738494 1.917916 
423 3.711105 1.6971737 1787 5.982476 2.040131 
424 3.662599 1.6910761 1788 6.0978807 2.006565 
425 3.5864493 1.6992645 1789 6.5541425 1.902192 
426 3.6024062 1.7164316 1790 7.0980213 1.85683 
427 3.5028025 1.7254678 1791 7.2494797 1.91187 
428 3.3478514 1.7628169 1792 7.2074643 1.9957 
429 3.3751994 1.788692 1793 7.5090282 1.983602 
430 3.3966925 1.7543175 1794 7.8303404 2.036232 
431 3.3951693 1.7236094 1795 7.8691783 2.196386 
432 3.3831193 1.7397353 1796 7.7945638 2.213093 
433 3.2921948 1.7636794 1797 7.7649073 2.099828 
218 
 
434 3.2592536 1.7261865 1798 7.8116273 2.058982 
435 3.3587139 1.6808564 1799 7.7568907 2.124216 
436 3.467574 1.6874871 1800 7.5081788 2.178368 
437 3.5231048 1.7044614 1801 7.2186868 2.148442 
438 3.5635925 1.7048866 1802 7.0559238 2.100501 
439 3.6368509 1.680827 1803 6.9499542 2.150654 
440 3.6984896 1.6721315 1804 6.7834397 2.256158 
441 3.6246587 1.6920897 1805 6.5475257 2.270239 
442 3.5133903 1.7221041 1806 6.3834775 2.194342 
443 3.5354046 1.7467424 1807 6.4382994 2.182886 
444 3.6311909 1.7534981 1808 6.565704 2.272404 
445 3.7189546 1.7510698 1809 6.5990694 2.292441 
446 3.7587022 1.7268528 1810 6.6614002 2.183909 
447 3.698654 1.7324135 1811 6.8186127 2.110106 
448 3.637409 1.7832551 1812 6.8689885 2.146472 
449 3.7043842 1.8072992 1813 6.7215856 2.106012 
450 3.888082 1.794819 1814 6.3979948 1.969364 
451 3.995328 1.7599796 1815 6.222716 1.953205 
452 3.9730225 1.7263492 1816 6.3261685 2.034825 
453 3.938881 1.7154353 1817 6.3427815 2.117799 
454 3.8857302 1.7031993 1818 6.5166983 2.138627 
455 3.8029071 1.6990146 1819 6.955103 2.089502 
456 3.6499798 1.7384888 1820 7.4533787 2.128205 
457 3.5609805 1.8170987 1821 7.9416049 2.251699 
458 3.664035 1.8775733 1822 8.0662136 2.275692 
459 3.7148414 1.8679848 1823 7.7878421 2.167048 
460 3.5624331 1.8426827 1824 7.5169303 2.087933 
461 3.4134771 1.8638191 1825 7.567496 2.14964 
462 3.3857026 1.8934999 1826 7.7167167 2.220916 
463 3.314852 1.8898962 1827 7.6412858 2.202494 
464 3.2440071 1.8627445 1828 7.5382402 2.190532 
465 3.2721398 1.8501369 1829 7.6958006 2.169815 
466 3.2595846 1.8675336 1830 7.9531872 2.121938 
467 3.1572799 1.8337329 1831 8.0242635 2.199152 
468 3.0308466 1.7431126 1832 7.9172996 2.406475 
469 2.9401837 1.7161157 1833 7.8408946 2.498074 
470 2.9333784 1.7394468 1834 7.8970727 2.386143 
471 2.9360903 1.7087855 1835 7.8797876 2.281643 
472 2.906382 1.6534672 1836 7.690175 2.320359 
473 2.9187724 1.6335231 1837 7.5110044 2.337543 
474 2.9576475 1.6404128 1838 7.2726186 2.244903 
475 2.9555756 1.6716444 1839 7.0594034 2.223059 
476 2.8254956 1.6994385 1840 7.1359854 2.305587 
477 2.7425146 1.6911616 1841 7.1811566 2.392762 
478 2.8394588 1.6637046 1842 7.0966771 2.375845 
479 2.8456503 1.6514756 1843 7.1994438 2.263387 
480 2.7999468 1.6496795 1844 7.3785784 2.250938 
481 2.9421633 1.6347437 1845 5.8457013 2.35748 
482 3.1767762 1.6448037 1846 4.1754001 2.40121 
483 3.2379616 1.6829247 1847 5.7287886 2.306306 
219 
 
484 3.1425195 1.6925607 1848 7.5173963 2.227198 
485 3.0639616 1.6855418 1849 7.5804733 2.276378 
486 2.9413084 1.6851042 1850 7.4937315 2.327767 
487 2.8734806 1.686874 1851 7.6947239 2.268836 
488 3.0179163 1.6996998 1852 8.0042088 2.169187 
489 3.1282032 1.7067788 1853 8.0219295 2.169009 
490 2.9573562 1.6771083 1854 7.9334955 2.275745 
491 2.7754482 1.6474181 1855 8.0314383 2.348988 
492 2.8186188 1.6753919 1856 8.1426178 2.286863 
493 2.8739933 1.7095788 1857 8.2082254 1.68629 
494 2.9615611 1.7198605 1858 8.3703866 1.291474 
495 3.137673 1.7654202 1859 8.6796396 1.997585 
496 3.1897832 1.8128094 1860 9.0248423 2.497651 
497 3.19044 1.8017664 1861 9.1281654 2.410052 
498 3.3069532 1.7706071 1862 8.845121 2.468505 
499 3.2581049 1.769405 1863 8.469195 2.585578 
500 3.0291212 1.8022993 1864 8.2903108 2.548424 
501 3.035936 1.8478423 1865 8.1371838 2.409711 
502 3.1996762 1.9128865 1866 7.8850064 2.410075 
503 3.2633907 1.9622569 1867 7.8327806 2.538011 
504 3.2293214 1.9187916 1868 8.0837364 2.560473 
505 3.2138846 1.893003 1869 8.2581571 2.452596 
506 3.2306396 1.9539227 1870 8.2318926 2.436426 
507 3.182755 1.9632598 1871 8.2308443 2.577887 
508 3.1261418 1.8905826 1872 8.3498019 2.696419 
509 2.9982773 1.8195751 1873 8.5234048 2.64099 
510 2.8179491 1.8230181 1874 8.6178408 2.504263 
511 2.7720937 1.846387 1875 8.5003293 2.477463 
512 2.6934766 1.8078064 1876 8.3076459 2.511663 
513 2.5360661 1.7797108 1877 8.3342652 2.456676 
514 2.5699885 1.7152622 1878 8.5427906 2.361629 
515 2.685196 1.6233243 1879 8.640012 2.385439 
516 2.7066172 1.6301932 1880 8.4860899 2.49064 
517 2.7758709 1.648431 1881 8.1337944 2.452002 
518 2.8463879 1.629998 1882 7.6500292 2.292881 
519 2.829031 1.6096566 1883 7.1091832 2.233924 
520 2.8242883 1.5915869 1884 6.5494356 2.29251 
521 2.88381 1.6002574 1885 6.1545647 2.330501 
522 2.901717 1.6320518 1886 6.1040038 2.258585 
523 2.7731613 1.6801446 1887 6.1244432 2.144206 
524 2.6520937 1.7093064 1888 5.9874004 2.137968 
525 2.5812869 1.6791256 1889 5.836053 2.240269 
526 2.4926553 1.6363741 1890 5.8113623 2.271615 
527 2.5789565 1.650796 1891 5.9149533 2.175537 
528 2.8391538 1.7169635 1892 5.9633523 2.118029 
529 3.1150985 1.7701933 1893 5.7761972 2.126441 
530 3.340672 1.7623164 1894 5.5210742 2.061008 
531 3.4342841 1.6879541 1895 5.4501171 1.909714 
532 3.4058003 1.6303673 1896 5.5002182 1.793755 
533 3.2586106 1.6364194 1897 5.5118703 1.809894 
220 
 
534 3.0614394 1.6495024 1898 5.6256194 1.877373 
535 2.9827915 1.6914046 1899 6.2079278 1.847168 
536 3.0292944 1.7654155 1900 6.9804947 1.760388 
537 3.0540331 1.8084534 1901 7.2061873 1.77002 
538 3.0327404 1.8322723 1902 7.0163551 1.859465 
539 3.1025772 1.8376557 1903 6.8782873 1.871907 
540 3.0798221 1.804669 1904 6.8116193 1.79224 
541 2.9891636 1.7863676 1905 6.9254465 1.744722 
542 3.1441625 1.8083964 1906 7.0815024 1.78134 
543 3.2940357 1.8652582 1907 7.0820486 1.812537 
544 3.2870187 1.9021623 1908 7.2219898 1.756625 
545 3.2774292 1.8565865 1909 7.3524424 1.717019 
546 3.2561587 1.8157787 1910 7.1554196 1.84542 
547 3.1740366 1.7996624 1911 6.926836 2.032856 
548 3.0723863 1.7427422 1912 6.9650784 2.053393 
549 2.9808702 1.7583262 1913 7.0427672 1.966306 
550 2.8826939 1.8516882 1914 6.8855755 1.953358 
551 2.8389132 1.84748 1915 6.5501145 2.008453 
552 2.8365804 1.8034117 1916 6.2694891 2.021202 
553 2.8186324 1.8200306 1917 6.1936656 1.976647 
554 2.8163061 1.810005 1918 6.0906272 1.952449 
555 2.8152378 1.7574067 1919 5.7198802 1.999126 
556 2.8259668 1.7352429 1920 5.2129705 2.054407 
557 2.8889717 1.7333661 1921 4.6858153 1.987894 
558 2.8826705 1.7300407 1922 4.1213277 1.877924 
559 2.8228052 1.7183995 1923 3.9627663 1.868825 
560 2.7784861 1.7385146 1924 4.2924836 1.90188 
561 2.7354327 1.7600253 1925 4.4575828 1.883491 
562 2.8250251 1.6940304 1926 4.4572482 1.810372 
563 2.9172071 1.6515217 1927 4.5376354 1.760985 
564 2.8662081 1.6612657 1928 4.5945048 1.796403 
565 2.7677037 1.6405749 1929 4.7786649 1.820398 
566 2.6346996 1.6459855 1930 5.3325247 1.745109 
567 3.2269306 1.6725117 1931 6.0762731 1.636685 
568 3.9788983 1.6616135 1932 6.5907103 1.583278 
569 3.4902517 1.6556835 1933 6.9025317 1.541363 
570 3.0165248 1.7131184 1934 7.3153912 1.474158 
571 3.1322314 1.7447877 1935 7.5109897 1.478531 
572 3.092932 1.6703581 1936 7.272806 1.514221 
573 2.9792504 1.5983137 1937 7.062812 1.484224 
574 2.9105824 1.5616175 1938 6.0851857 1.438595 
575 2.9655975 1.5627824 1939 4.2476204 1.491686 
576 3.0965845 1.5977601 1940 3.3856194 1.654655 
577 3.1797885 1.5968114 1941 3.379375 1.811495 
578 3.1977625 1.5876935 
 
3.3399209 1.889824 
579 3.185048 1.6513359 1971 3.3895611 1.964199 
580 3.1750024 1.7441827 1972 3.4671491 2.132541 
581 3.2386556 1.7492123 1973 3.3802544 2.270529 
582 3.3546548 1.7211385 1974 3.2373267 2.219691 
583 3.3997099 1.7621285 1975 3.3977418 2.114798 
221 
 
584 3.3965664 1.8096997 1976 3.880888 1.978529 
585 3.3476135 1.7855391 1977 4.8603553 1.72142 
585 3.2029846 1.7629428 1978 5.8378035 1.594723 
586 3.064877 1.8037106 1979 6.0254899 1.675774 
587 2.9655542 1.8470752 1980 6.2065735 1.748714 
588 2.9011875 1.8391307 1981 6.4952562 1.727337 
589 2.8948001 1.8184849 1982 6.3744495 1.691238 
590 2.8707481 1.8268794 1983 6.2089863 1.723173 
591 2.833156 1.8286041 1984 6.0653747 1.790987 
592 2.8660441 1.8185898 1985 5.7981851 1.847907 
593 2.8771506 1.8629919 1986 5.6027791 2.00024 
594 2.7850186 1.9042961 1987 5.6142131 2.403044 
595 2.7608666 1.8866094 1988 5.6902716 2.793918 
596 2.8332632 1.8668287 1989 5.7132853 2.878883 
597 2.8648718 1.8087107 1990 5.6317331 2.862362 
598 2.8419667 1.7324276 1991 5.4532303 2.895775 
599 2.8860797 1.6895372 1992 5.2401235 2.956909 
600 2.9314752 1.6641517 1993 5.042503 2.996773 
601 2.8194969 1.6927562 1994 4.8885539 2.866104 
602 2.7335113 1.717146 1995 4.8033078 2.676034 
603 2.7556579 1.6848828 1996 4.7245475 2.690595 
604 2.7833354 1.6650895 1997 4.567516 2.820952 
605 2.7959339 1.6545903 1998 4.3459005 2.819457 
606 2.772752 1.6608715 1999 4.0532639 2.706801 
607 2.829594 1.68651 2000 3.8357417 2.656616 
608 2.9319152 1.7317156 2001 3.8817702 2.690386 
609 2.8548325 1.7480033 2002 4.0578066 2.658487 
610 2.7806139 1.7122977 2003 4.1003607 2.530647 
611 2.8473054 1.7002378 2004 
 
2.474194 
612 2.8627797 1.660037 2005 
 
2.554436 
613 2.8437174 1.5954732 2006 
 
2.568899 
614 2.9385367 1.6113283 2007 
 
2.380821 
615 3.100188 1.6727735 2008 
 
2.15217 
616 3.1814146 1.6694854 
  
2.059944 
617 3.1750957 1.6562157 2031 
 
2.132276 
618 3.1771859 1.679634 2032 2.5524013 2.184177 
619 3.242116 1.6972562 2033 2.6602207 2.117435 
620 3.2637367 1.711722 2034 2.5056413 2.039964 
621 3.1903173 1.7192627 2035 2.2770818 
 622 3.1350076 1.7440472 2036 2.1406277 
 623 2.967187 1.757532 2037 2.1453727 
 624 2.7951084 1.7485136 2038 2.1947133 
 625 2.8910645 1.7729257 2039 2.2395344 
 626 3.0249896 1.800049 2040 2.4422336 
 627 3.045183 1.8002253 2041 2.77648 
 628 3.0301928 1.8188816 2042 2.9853498 2.490549 
629 3.0307298 1.8434966 2043 2.9545205 2.667875 
630 3.0142416 1.8067149 2044 2.8112137 2.634887 
631 2.8731715 1.7546761 2045 2.751705 2.469198 
632 2.7617523 1.7592042 2046 2.765319 2.340014 
222 
 
633 2.8102267 1.7811616 2047 2.7442958 2.315022 
634 2.8629714 1.7571873 2048 2.6846404 2.301159 
635 2.8504858 1.711282 2049 2.6523961 2.295359 
636 2.8252092 1.6888367 2050 2.7065425 2.451472 
637 2.9053547 1.6508551 2051 2.8061815 2.776414 
638 2.9141038 1.5769763 2052 2.8724612 3.01232 
639 2.7589166 1.5437781 2053 2.9082526 3.056917 
640 2.7163895 1.5606829 2054 2.9775964 3.055604 
641 2.7737658 1.5427084 2055 3.0610447 3.05217 
642 2.7165999 1.528681 2056 3.0628248 2.988003 
643 2.6509252 1.5728865 2057 2.9719495 2.883769 
644 2.7630682 1.6010184 2058 2.9302209 2.840392 
645 2.7846493 1.5841481 2059 3.0380501 2.880142 
646 2.7389825 1.5694933 2060 3.1373033 2.933396 
647 2.8919361 1.5788271 2061 3.0333359 2.956613 
648 3.0204892 1.5892766 2062 2.8172659 2.951256 
649 3.0383291 1.5784435 2063 2.7083425 2.98898 
650 3.0648759 1.5529788 2064 2.7070737 3.091027 
651 3.1132002 1.5398427 2065 2.7092903 3.135475 
652 3.1847896 1.5339507 2066 2.6819387 3.07652 
653 3.2173394 1.5348553 2067 2.6581386 3.047011 
654 3.1788547 1.5770729 2068 2.6946253 3.121154 
655 3.1257971 1.6267233 2069 2.7551407 3.216601 
656 3.1905653 1.6419251 2070 2.7774579 3.221176 
657 3.3689783 1.6236331 2071 2.7653848 3.1575 
658 3.4850054 1.5848033 2072 2.7793998 3.12097 
659 3.3836997 1.5401374 2073 2.8943398 3.094933 
660 3.187392 1.4964744 2074 3.029423 3.018907 
661 3.2322133 1.4721431 2075 3.0366694 2.888073 
662 3.4248177 1.5206161 2076 2.9971885 2.80714 
663 3.4740795 1.5822907 2077 3.0749603 2.847345 
664 3.4075679 1.5475102 2078 3.227423 2.924994 
665 3.367425 1.558395 2079 3.2951987 2.93222 
666 3.3550868 1.6401086 2080 3.226223 2.871401 
667 3.2173825 1.6492086 2081 3.150102 2.88508 
668 3.0131714 1.5969885 2082 3.181488 2.992754 
669 2.9754346 1.5126727 2083 3.2302718 3.050132 
670 3.0187332 1.4717924 2084 3.1891417 3.0643 
671 3.0162901 1.4859754 2085 3.11271 3.124778 
672 2.9886363 1.4856164 2086 3.1047121 3.206985 
673 2.9089824 1.5081177 2087 3.1497114 3.250913 
674 2.9080246 1.5470007 2088 3.1370796 3.247699 
675 3.2655628 1.5455489 2089 3.013333 3.28252 
676 3.5428788 1.5194638 2090 2.8997994 3.391836 
677 3.2411825 1.480912 2091 2.9221135 3.448128 
678 2.9513202 1.4487614 2092 3.0033068 3.361822 
679 2.9398371 1.4566546 2093 2.9967486 3.220361 
680 2.9552439 1.4485006 2094 2.9058919 3.176836 
681 2.9331823 1.4250186 2095 2.8995357 3.171463 
682 2.90218 1.4400241 2096 3.0220054 3.08969 
223 
 
683 2.9761899 1.4454956 2097 3.1286574 3.006524 
684 3.0457092 1.4188537 2098 3.1404563 2.976468 
685 3.0914562 1.4040964 2099 3.1762255 2.980697 
686 3.1643461 1.4083839 2100 3.3592316 2.938988 
687 3.1981994 1.4384811 2101 3.6147032 2.828993 
688 3.1823049 1.5088615 2102 3.8188162 2.76123 
689 3.1452559 1.5264587 2103 3.9234796 2.76826 
690 3.1823362 1.4949044 2104 3.965467 2.770603 
691 3.2603 1.5109034 2105 4.0252386 2.705199 
692 3.2868774 1.5377516 2106 4.0667407 2.628066 
693 3.2679674 1.5368672 2107 3.9509409 2.618717 
694 3.2779809 1.5050324 2108 3.728934 2.668507 
695 3.3580064 1.4828969 2109 3.6003917 2.721696 
696 3.4152843 1.522148 2110 3.6268026 2.738988 
697 3.3872567 1.5870848 2111 3.806351 2.826772 
698 3.3714961 1.6149483 2112 4.0838415 3.034527 
699 3.4061022 1.5921501 2113 4.2313983 3.197215 
700 3.3626101 1.5668791 2114 4.152351 3.18708 
701 3.2992391 1.5672988 2115 3.9218518 3.086402 
702 3.2048486 1.5874085 2116 3.5530139 3.039088 
703 3.1012066 1.6038508 2117 3.1738965 3.025312 
704 3.1866089 1.6049367 2118 2.8806913 2.931556 
705 3.2303041 1.5911584 2119 2.6940663 2.75311 
706 3.1339545 1.5686841 2120 2.6857743 2.648097 
707 3.1393781 1.5647734 2121 2.7359413 2.721207 
708 3.2421208 1.5832319 2122 2.6972777 2.877119 
709 3.3078945 1.5780019 2123 2.6291135 2.963869 
710 3.2963567 1.5572319 2124 2.6400193 2.980117 
711 3.2398135 1.5939819 2125 2.7416641 2.970887 
712 3.1847226 1.6275757 2126 2.8100367 2.867458 
713 3.1543772 1.6098781 2127 2.7692696 2.650947 
714 3.1457643 1.5952913 2128 2.7374647 2.412958 
715 3.1105614 1.5951348 2129 2.788566 2.216609 
716 3.0128478 1.6139393 2130 2.8646095 2.102923 
717 2.9759845 1.6435345 2131 2.8853301 2.072651 
718 3.0406684 1.6478557 2132 2.8248799 2.041487 
719 3.089781 1.5981982 2133 2.7750226 1.977174 
720 3.1155345 1.5382773 2134 2.7999554 1.934296 
721 3.08786 1.5291333 2135 2.8403338 1.975593 
722 2.865032 1.5153671 2136 2.8044658 2.046212 
723 2.7097688 1.5273166 2137 2.7253454 2.026979 
724 2.8440555 1.6065241 2138 2.7198889 1.973258 
725 2.954747 1.607497 2139 2.7676302 1.979882 
726 2.9552312 1.5482015 2140 2.7993898 1.997261 
727 2.8970921 1.5409001 2141 2.7944106 1.97012 
728 2.7342726 1.5606542 2142 2.7665476 1.906032 
729 2.598155 1.5804791 2143 2.7841406 1.862966 
730 2.6173602 1.6120801 2144 2.8307371 1.877066 
731 2.65869 1.6352904 2145 2.8101888 1.886837 
732 2.711439 1.6495427 2146 2.7322041 1.846002 
224 
 
733 2.8918185 1.6657623 2147 2.7000792 1.80089 
734 3.0773104 1.6676814 2148 2.7218273 1.805205 
735 3.14978 1.678151 2149 2.7309379 1.824418 
736 3.1088485 1.6564053 2150 2.7133634 1.791275 
737 3.1224725 1.5919401 2151 2.6828238 1.742304 
738 3.2434802 1.5463518 2152 2.6643838 1.749567 
739 3.321361 1.5025009 2153 2.692736 1.779851 
740 3.3271036 1.4618501 2154 2.7347501 1.77281 
741 3.3006787 1.4973017 2155 2.696041 1.725405 
742 3.2871209 1.5619303 2156 2.6324348 1.713357 
743 3.299335 1.6155981 2157 2.6675533 1.758741 
744 3.2921491 1.6694096 2158 2.7220771 1.771715 
745 3.2007523 1.7000865 2159 2.6992085 1.706294 
746 3.0898082 1.7081152 2160 2.6304468 1.634267 
747 3.0726943 1.6551152 2161 2.582979 1.643704 
748 3.0228728 1.6094839 2162 2.6108891 1.667717 
749 2.978029 1.6194405 2163 2.6678008 1.623045 
750 3.0746991 1.7287607 2164 2.6420774 1.561244 
751 3.1714869 1.817823 2165 2.5827433 1.559899 
752 3.1869134 1.7014448 2166 2.6374808 1.581064 
753 3.1435333 1.5965173 2167 2.7249717 1.545631 
754 3.1115855 1.5970304 2168 2.7335129 1.49003 
755 3.1385318 1.6016244 2169 2.7057995 1.486064 
756 3.0011863 1.6014493 2170 2.7233707 1.514117 
757 2.7027297 1.6499568 2171 2.8408045 1.515428 
758 2.5780639 1.6730325 2172 2.9453717 1.483175 
759 2.611036 1.6160037 2173 2.9273328 1.446528 
760 2.6688492 1.6090891 2174 2.8571855 1.443731 
761 2.6606168 1.635796 2175 2.7876567 1.463007 
762 2.6443014 1.7056185 2176 2.7292302 1.450342 
763 2.7653589 1.7470283 2177 2.7489346 1.415748 
764 2.8550288 1.6471327 2178 2.8023165 1.411325 
765 2.8188388 1.595812 2179 2.8348196 1.441748 
766 2.8042785 1.6094925 2180 2.157001 1.461555 
767 2.8695344 1.5625077 
 
0.7301565 1.459502 
768 2.9081948 1.5154317 2183 0 1.483184 
769 2.7465783 1.4701625 2184 0.8999441 1.542033 
770 2.5146571 1.4114243 2185 
 
1.576063 
771 2.4209753 1.3721536 2186 4.0043834 1.515223 
772 2.3889589 1.3390401 2187 4.8061792 1.404296 
773 2.5584166 1.3305994 2188 5.4633982 1.384072 
774 2.9245764 1.3603432 2189 5.8039144 1.470033 
775 3.1586618 1.4036889 2190 6.0756413 1.544415 
776 3.2975823 1.4500546 2191 6.2447895 1.546311 
777 3.3692379 1.4666107 2192 6.1732814 
 778 3.3635742 1.5105702 2193 5.8775735 
 779 3.4035434 1.5781551 2194 5.6841053 
 780 3.3554087 1.5572562 2195 5.4863813 
 781 3.3328995 1.536616 2197 4.6934268 
 782 3.4442498 1.5015656 2199 3.5684168 2.190232 
225 
 
783 3.4384633 1.4432853 2201 2.767318 1.854517 
784 3.3290095 1.5302926 2203 2.4415597 2.075225 
785 3.5195789 1.6457094 2205 2.3657463 2.203871 
786 3.9149421 1.6586412 2207 2.2542381 2.14765 
787 3.7743088 1.6557103 2209 2.0932091 2.024003 
788 3.1941782 1.6519625 2211 1.9255636 2.002979 
789 2.7274083 1.6614719 2213 1.810428 1.996847 
790 2.6044253 1.7024839 2215 1.7698079 1.881988 
791 2.9122404 1.7134804 2217 1.6798117 1.718495 
792 3.225547 1.6899739 2219 1.6502592 1.533941 
793 3.3901215 1.6626825 2221 1.7306423 1.240479 
794 3.5809582 1.635271 2223 1.7828014 0.923355 
795 3.6062936 1.6374545 2225 1.7410485 0.756099 
796 3.3844701 1.6782316 2227 1.6438386 0.690074 
797 3.0894494 1.6661714 2229 1.6336165 0.621332 
798 2.8960449 1.5690787 2232 1.6645041 0.549306 
799 2.7227486 1.4851485 2235 1.6495677 0.499656 
800 2.5439378 1.4322302 
 
1.6025776 0.477422 
801 2.462119 1.4054494 2249 1.4098002 0.451907 
802 2.3764868 1.4478247 2251 1.2252927 0.418342 
803 2.3396852 1.5008089 2253 1.2535702 0.408049 
804 2.3865775 1.565522 2255 1.3070767 0.410719 
805 2.4493908 1.6090825 2257 1.4202077 0.407982 
806 2.5351406 1.5632696 2259 1.5672764 0.38269 
807 2.582445 1.5211983 2261 1.5790155 0.343864 
808 2.6141464 1.4910219 2263 1.5052424 0.329552 
809 2.6881746 1.4086789 2265 1.37465 0.349831 
810 2.7552969 1.322259 2267 1.3105342 0.35137 
811 2.8403487 1.3026756 2269 1.396792 0.324176 
812 3.0883678 1.3070465 2271 1.4492131 0.31693 
813 3.4537279 1.2759807 2273 1.4507795 0.30526 
814 3.6905326 1.2279722 2275 1.4638691 0.280268 
815 3.8323583 1.2438214 2277 1.4620686 0.282478 
816 4.0136516 1.2924803 2279 1.5323688 0.310438 
817 4.1312571 1.3157321 2281 1.8517242 0.315723 
818 4.1869213 1.3422071 2283 2.2307433 0.301593 
819 4.1569166 1.3852788 2285 3.1762709 0.296111 
820 4.0805607 1.4787944 2287 4.7520675 0.284629 
821 4.1364869 1.5134823 2289 4.5569974 0.264077 
822 4.1636214 1.4508136 2291 2.6777643 0.245723 
823 3.9790504 1.4512173 
  
0.236238 
824 3.6574502 1.5814655 2303 
 
0.233725 
825 3.4846513 1.7295384 2307 
 
0.238485 
826 3.5021734 1.7493377 2311 
 
0.241351 
827 3.3425922 1.7024869 2315 1.4868613 0.267147 
828 3.1957458 1.7018013 2319 1.1028619 0.316058 
829 3.4140861 1.749967 2323 0.8509684 0.387477 
830 3.6543451 1.8344946 2327 0.7867446 0.533631 
831 3.7157456 1.7983009 2331 0.7874951 0.637197 
832 3.7282576 1.6002674 2335 0.7768008 0.546785 
226 
 
833 
 
1.5254642 2339 0.7555088 
 834 
 
1.6197357 2343 0.7446277 
 835 
 
1.6752516 2347 0.7173745 
 836 
 
1.702196 2351 0.6364576 
 837 
 
1.7283013 2355 0.5854476 
 838 3.378995 1.6553774 2359 0.627345 0.97092 
839 3.3707785 1.6391959 2363 0.7310451 0.749762 
840 3.1696107 1.7427471 2367 0.8681936 0.606406 
841 2.9182277 1.8311176 2371 0.9470049 0.561024 
842 2.8913976 1.8851663 2375 1.0451958 0.558163 
843 3.1985579 
 
2379 1.1824978 0.540839 
844 3.3803555 
 
2383 1.1981411 0.515705 
845 3.4001594 
 
2387 1.0879444 0.526103 
 
3.5089541 
 
2391 0.9760868 0.539593 
857 3.6217418 
 
2395 0.923725 0.469911 
858 3.7963559 1.811794 2399 0.84124 0.349552 
859 3.9134407 1.7926941 2403 0.7457087 0.293375 
860 3.8967429 1.71023 2407 0.7584816 0.320676 
861 3.8949741 1.6639731 2411 0.8820105 0.394248 
862 3.9943168 1.7420409 2415 0.8858274 0.494178 
863 4.1199771 1.873904 2419 0.7054402 0.633546 
864 4.09021 1.9270051 2421 0.7782859 0.762657 
865 3.9703211 1.8600472 2423 1.181356 0.830797 
866 3.8858593 1.8187098 2425 2.5339709 0.829119 
867 3.8105085 1.8887024 2427 4.006018 0.772604 
868 3.6461506 1.9734926 2429 3.2392947 0.763956 
869 3.3774102 1.9792876 
 
1.7692215 0.748232 
870 3.1648422 1.9923036 2435 1.4716246 0.639481 
871 3.0102363 2.0372682 2442 1.5077357 0.574715 
872 2.9065984 1.9945428 2456 1.2725758 0.562773 
873 2.8652473 1.93794 2463 0.8881741 0.57276 
874 2.8066679 1.9456319 2470 0.6359983 0.577932 
875 2.8529476 1.9137496 2477 0.6234312 0.492415 
876 2.8894956 1.824727 2484 0.8017122 0.782614 
877 2.7598384 1.7705799 2491 0.9597835 1.942008 
878 2.7086078 1.6938119 2493 1.0735313 2.708833 
879 2.8604815 1.5494788 2495 1.1353526 2.049095 
880 2.9471771 1.4427004 2497 1.6074741 
 881 2.8418389 1.4208048 2499 2.1072804 
 882 2.7884601 1.4594366 2501 1.6271759 
 883 2.8892229 1.5053435 
 
1.0533066 
 884 3.0056361 1.543469 2509 1.1301183 
 885 3.0081114 1.5962038 2511 1.4332103 1.311438 
886 2.9331815 1.6247497 2513 1.6441234 0.913518 
887 2.9999598 1.6137208 2515 1.571608 0.506534 
888 3.2262251 1.6317686 2517 1.1872171 0.344928 
889 3.2912167 1.6570181 2519 0.8983191 0.287887 
890 3.2319487 1.6615265 2521 0.8820975 0.242912 
891 3.3933916 1.6871076 2523 1.0314396 0.299563 
892 3.5665954 1.6732199 2525 1.5778234 
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893 3.7231212 1.6401874 2527 2.3691858 
 894 4.0212343 1.7167945 2529 2.7184385 
 895 4.2395256 1.8091657 2531 2.5848039 1.122817 
896 4.4153918 1.7657351 2533 2.4362037 1.282373 
897 4.526495 1.7001137 2535 2.3159445 1.392644 
898 4.4286663 1.7058016 2537 2.1928611 1.212847 
899 4.3169702 1.6786177 2539 2.1543616 
 900 4.3197248 1.6346451 2541 2.1147716 
 901 4.2131195 1.6722399 2543 1.9461872 
 902 4.0210581 1.7381327 2545 1.7395961 
 903 4.0255262 1.8130379 2547 1.5966617 
 904 4.1193898 1.8710946 2549 1.5546248 1.263828 
905 4.055776 1.8172568 2551 1.616376 1.152754 
906 3.8461296 1.7921683 2553 1.6817334 1.186075 
907 3.5557382 1.8775993 2555 1.7985744 1.521018 
908 3.3589645 1.9153608 2557 2.0225889 2.054159 
909 3.3582967 1.8476432 2559 2.2319996 2.349486 
910 3.2728091 1.7488392 2561 2.3364475 2.245051 
911 3.2278745 1.706613 2563 2.3542515 2.013349 
912 3.5136818 1.7193143 2565 2.3419269 1.872652 
913 3.8890113 1.7525146 2567 2.3411564 1.729204 
914 3.9088446 1.7672602 2569 2.3251946 1.572284 
915 
 
1.725364 2571 2.2289604 1.471504 
916 
 
1.6578023 2573 2.1058128 1.348774 
917 
 
1.5977284 2575 1.9876864 1.213028 
918 
 
1.5659676 2577 1.8290219 1.111289 
919 
 
1.5319013 2579 1.6978289 1.051578 
920 
 
1.4798614 2581 1.6703278 1.021548 
921 
 
1.4763966 2583 1.7244178 1.029748 
922 
 
1.5838221 2585 1.8811441 1.066262 
923 
 
1.7276347 2587 2.0831121 1.146147 
924 
  
2589 2.1575566 1.314245 
925 
  
2591 2.1249571 1.459099 
 
5.1305031 
 
2593 2.0660794 1.491006 
1066 4.9631906 
 
2595 1.9437399 1.465124 
1067 4.9481915 
 
2597 1.8474972 1.432719 
1068 4.9118551 
 
2599 1.8806059 1.397269 
1069 4.977566 
 
2601 1.9118376 1.359771 
1070 5.3117472 2.4813443 2603 1.7268104 1.3072 
1071 5.6880427 2.3583743 2605 1.7347775 1.241049 
1072 5.832178 2.36613 2607 2.3427802 1.15575 
1073 5.7598448 2.4320344 2609 2.8211073 1.072365 
1074 5.6600492 2.4588769 2611 2.6507557 1.037027 
1075 5.6491237 2.3652063 2613 2.1832329 1.047323 
1076 5.723215 2.2338067 2615 1.7961853 1.105369 
1077 5.7650972 2.1780888 2617 1.7106492 1.227359 
1078 5.6773571 2.1756363 2619 2.0579467 1.364073 
1079 5.5272049 2.1370087 2621 2.4367709 1.415358 
1080 5.4151066 2.1041513 2623 2.5592362 1.406299 
1081 5.3636952 2.2088921 2625 2.7392711 1.379562 
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1082 5.3120269 2.3420398 2627 2.8825718 1.315954 
1083 5.3160339 2.3231642 2629 2.9064398 1.277039 
1084 5.418458 2.2097466 2631 2.9367885 1.299197 
1085 5.5111107 2.1728948 2633 2.8792452 1.28138 
1086 5.4679336 2.2230391 2635 2.7382618 1.109167 
1087 5.2427936 2.2299076 2637 2.7111832 1.157291 
1088 5.0298746 2.1588805 2639 2.8687597 1.626977 
1089 4.9986979 2.0998376 2641 2.9809621 1.851043 
1090 5.0880161 2.0827388 2643 2.9715959 1.658973 
1091 5.2160244 2.063643 2645 2.965981 1.454519 
1092 5.3528825 2.023243 2647 2.9406784 1.354978 
1093 5.4835866 1.9559913 2649 2.7760104 1.485786 
1094 5.54943 1.9140387 2651 2.5512275 1.829439 
1095 5.5253086 1.942434 2653 2.3876893 2.091472 
1096 5.5163838 1.9448654 2655 2.1654642 2.243367 
1097 5.6038274 1.8689609 2657 1.9795559 2.4164 
1098 5.7088756 1.803043 2659 1.9840014 2.559016 
1099 5.7193021 1.7803986 2661 2.1833964 2.638001 
1100 5.6832405 1.7779484 2663 2.5783528 2.651648 
1101 5.6924795 1.754417 2665 2.9278115 2.666405 
1102 5.7485698 1.7233408 2667 2.9699966 2.707757 
1103 5.7351862 1.7550644 2669 2.8223408 2.865583 
1104 5.6052195 1.8333883 2671 2.7274369 3.117847 
1105 5.4925774 1.8615611 2673 2.5751701 3.164646 
1106 5.5107206 1.828266 2675 2.3762047 3.075073 
1107 5.6074177 1.8278126 2677 2.3374854 3.032636 
   
2679 2.5815771 2.94997 
   
2681 2.9289055 2.66695 
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Appendix D: Consent forms and information sheets handed out to patients in study I and III. 
Study I: Information Sheet 
Monitoring Bowel Health Using Microdialysis 
Patient information sheet and Consent Form 
 
 
‘You are being invited to take part in a research study.  Before you 
decide, it is important for you to understand why the research is 
being done and what it will involve.  Please take time to read the 
following information carefully and discuss it with others if you wish.  
Ask us if there is anything that is not clear or if you would like more 
information.  Take time to decide whether or not you wish to take part. 
 
1. What is the purpose of this study? 
 
This study aims to look at the changes that occur to human bowel after it 
has had its blood supply removed. We will be studying the segment of 
bowel that is already being removed as part of your planned operation. 
The measurement we take will have no effect on the treatment and 
postoperative care you receive. 
 
2. Why have I been chosen? 
You have been chosen for this study because you are undergoing bowel 
resection surgery. We are interested in the changes that occur to the 
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human bowel and maybe can understand better why complications 
occur after surgery and can help other patients in the future. 
 
3. Do I have to take part? 
It is up to you to decide whether or not to take part.  If you do decide to 
take part you will be given this information sheet to keep and be asked 
to sign a consent form. If you decide to take part you are still free to 
withdraw at any time and without giving a reason before the operation.  
A decision to withdraw at any time, or a decision not to take part, will not 
affect the standard of care you will receive. 
 
4. What will happen to me if I take part? 
You will have the same operation, and care before during and after 
surgery that you would have had if you were not enrolled in this study. 
We will be making some measurements on bowel that is already going 
to be removed as part of your planned operation. This will take place 
during your operation but will not affect the surgery you have.  
The study involves the use of an already existing technology (that has 
been used before on human liver, kidney, brain, and muscle) to study 
the effect of interrupted blood supply on human intestine. We will be 
using a micro-catheter in the intestinal wall of the segment of intestine 
that is to be removed. This micro-catheter is of miniature size measuring 
no more than 0.24 mm in diameter and 2cm in length and basically picks 
up the biochemical changes that occur in that segment of bowel. It will 
enable us to record data from that segment when it is subjected to 
interrupted blood supply. The only difference your taking part in our 
research will make to the length of a normal operation is that it will  take 
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5 to 10 minutes longer;  this is the time needed to secure the micro 
catheter in the section of the bowel that is to be removed. 
 
Under no circumstance will the healthy bowel (that is not to be removed) 
be subject to any study or handling other than the regular handling that 
happens with any other bowel surgery. 
 
5. What do I have to do? 
If you agree to take part in this study, there will be no difference in the 
treatment you receive or the time you spend in hospital after your 
operation. 
 
6. What are the possible disadvantages and risks of taking part? 
We do not foresee any disadvantages or risks of taking part in this study 
since it does not tackle but the segment of intestine that is destined for 
resection anyways.   
 
7. What are the possible benefits of taking part? 
Taking part in this study does not affect your treatment in any way. If you 
agree to take part you will be helping us understand the changes that 
take place in human bowel when its blood supply is removed. The 
measurements that we make may be of help in understanding how 
bowel heals and consequently help other patients. 
 
8. What happens when the research study stops? 
When the research study ends, we will look at the results and try to use 
these to understand how human bowel heals. If you would like any 
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information on our progress or the findings of this study, we would be 
more than happy for you to get in touch with us to discuss this. 
 
9. What if something goes wrong? 
Any problem with the devices we use to make the measurements on 
bowel will not affect you. The surgery will be carried out as planned by 
the experienced surgical team members.  
 
10. Will my taking part in this study be kept confidential? 
All information which is collected about you during the course of the 
research will be kept strictly confidential and kept in a secure place. 
 
11. What will happen to the results of the research study? 
The results of the research will be analyzed and published in scientific 
journals. We will happily provide you with a copy of the results. 
 
12. Who is organizing and funding the research? 
This is being undertaken by Imperial College London. 
 
13. Who has reviewed the study? 
The study has been reviewed and approved by the research ethics 
committee at St. Mary’s Hospital. 
 
 
 
 
14. Contact for Further Information 
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You may keep a copy of this information sheet with you for further 
reference. If you have any questions feel free to ask the person 
consenting you for the study. In case of further questions, please 
contact: 
 
Dr. Samer Deeba 
Clinical Research Fellow 
Department of Biosurgery & Surgical Technology, Imperial College 
10th Floor QEQM Building 
St. Mary’s Hospital 
London W2 1NY 
 
Email:  s.deeba@imperial.ac.uk 
Telephone:  07766700995 
Fax:   02078861310 
 
You will be given a copy of the information sheet and a signed 
consent form to keep. 
 
 
Study III: Information sheet 
Monitoring Bowel Healing Using Microdialysis 
Patient information sheet and Consent Form 
 
Ref#: 06/Q0403/160 
 
 
‘You are being invited to take part in a research study.  Before you 
decide, it is important for you to understand why the research is 
being done and what it will involve.  Please take time to read the 
following information carefully and discuss it with others if you wish.  
Ask us if there is anything that is not clear or if you would like more 
information.  Take time to decide whether or not you wish to take part. 
 
6. What is the purpose of this study? 
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This study aims to look at the changes that occur to human bowel while 
it is healing. We will be studying the segment of bowel that has no part 
in the operation you are having but is at a minor risk of being non viable 
after the operation. The measurement we take will have no effect on the 
treatment and postoperative care you receive. 
 
7. Why have I been chosen? 
You have been chosen for this study because you are undergoing repair 
of an abdominal aortic aneurysm surgery. We are interested in the 
changes that occur to the human bowel and maybe can understand 
better why complications occur after surgery and can help other patients 
in the future. 
 
8. Do I have to take part? 
It is up to you to decide whether or not to take part.  If you do decide to 
take part you will be given this information sheet to keep and be asked 
to sign a consent form. If you decide to take part you are still free to 
withdraw at any time and without giving a reason before the operation.  
A decision to withdraw at any time, or a decision not to take part, will not 
affect the standard of care you will receive. 
 
9. What will happen to me if I take part? 
You will have the same operation, and care before during and after 
surgery that you would have had if you were not enrolled in this study. 
We will be making some measurements on bowel that was not operated 
on but is at a minor risk of being non-viable after this operation. This will 
take place after your operation but will not affect the surgery you have.  
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The study involves the use of an already existing technology (that has 
been used before on human liver, kidney, brain, and muscle) to study 
the effect of interrupted blood supply on human intestine. We will be 
using a micro-catheter in the intestinal wall of the segment of intestine 
that is at minor risk of being non-viable after this operation. This micro-
catheter is of miniature size measuring no more than 0.24 mm in 
diameter and 2cm in length and basically picks up the biochemical 
changes that occur in that segment of bowel. It will be implanted in the 
wall of the base of the   intestine in question enabling us to record data 
from that segment when it is subjected to surgical trauma. The only 
difference your taking part in our research will make to the length of a 
normal operation is that it will  take 5 minutes longer;  this is the time 
needed to secure the micro catheter in the section of the bowel that is to 
be studied. 
Then the catheter will be tunneled outside the abdominal wall in the 
same manner that any surgical drain is tunneled and secured to the skin 
with regular sutures. The research fellow will be passing by the bedside 
after the operation in the ITU and a machine will be connected to the 
catheter while you are in bed to analyze the data from the catheter. 
 
10. What do I have to do? 
If you agree to take part in this study, there will be no difference in the 
treatment you receive or the time you spend in hospital after your 
operation. 
However, after the operation the research fellow will be passing by on 
ITU and will connect the catheter to a bedside machine that analyzes 
the catheter outflow while you stay in bed. The whole process will stop 
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when you become mobile and your contribution will only be 10 minutes 
every 4 hours when you are awake where a sample is taken from the 
catheter. 
Before your discharge the catheter will be taken out in the same manner 
that any surgical drain is withdrawn from the abdominal cavity and this is 
non painful but uncomfortable. We stress the fact that the catheter is 
smaller than any surgical drain available in the market; so while taking it 
out, the process will be uncomfortable but to a lesser extent than any 
surgical catheter withdrawal and this is simply due to the fact that it is 
very small in diameter. 
 
6. What are the possible disadvantages and risks of taking part? 
 We fore see minimal complications arising from this study; since we are 
monitoring nothing but the base of the colon and will not be violating any 
intestine side or wall.  
 
7. What are the possible benefits of taking part? 
Taking part in this study does not affect your treatment in any way. If you 
agree to take part you will be helping us understand the changes that 
take place in human bowel when it is in the process of healing. The 
measurements that we make may be of help in understanding how 
bowel heals and consequently help other patients. 
 
8. What happens when the research study stops? 
When the research study ends, we will look at the results and try to use 
these to understand how human bowel heals. If you would like any 
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information on our progress or the findings of this study, we would be 
more than happy for you to get in touch with us to discuss this. 
 
9. What if something goes wrong? 
Any problem with the devices we use to make the measurements on 
bowel will not affect you. The surgery will be carried out as planned by 
the experienced surgical team members. If any unforeseen risks is 
encountered the study will be abandoned directly. 
 
10. Will my taking part in this study be kept confidential? 
All information which is collected about you during the course of the 
research will be kept strictly confidential and kept in a secure place. 
 
15. What will happen to the results of the research study? 
The results of the research will be analyzed and published in scientific 
journals. We will happily provide you with a copy of the results. Your 
details will be kept anonymous in these articles. 
 
16. Who is organizing and funding the research? 
This is being undertaken by Imperial College London. 
 
17. Who has reviewed the study? 
The study has been reviewed and approved by the research ethics 
committee at St. Mary’s Hospital. 
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18. Contact for Further Information 
You may keep a copy of this information sheet with you for further 
reference. If you have any questions feel free to ask the person 
consenting you for the study. In case of further questions, please 
contact: 
 
Dr. Samer Deeba 
Clinical Research Fellow 
Department of Biosurgery & Surgical Technology, Imperial College 
10th Floor QEQM Building 
St. Mary’s Hospital 
London W2 1NY 
 
Email:  s.deeba@imperial.ac.uk 
Telephone:  07766700995 
Fax:   02078866950 
 
You will be given a copy of the information sheet and a signed 
consent form to keep. 
 
Consent form for study I and III: 
Study Number: 
Patient identification number: 
Consent Form 
 
Title of Project: 
Use of Microdialysis in the Intra-operative Biochemical Monitoring of 
Human Bowel 
 
Name of Researcher: 
 
Dr. Samer Deeba  
Clinical Research Fellow 
Department of Biosurgery & Surgical Technology, Imperial College 
10th Floor QEQM Building 
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St. Mary’s Hospital 
London, W2 1NY 
 
Email: s.deeba@imperial.ac.uk 
Telephone: 007766700995 
Fax: 02078861810 
 
 
 
 
       Please tick box 
 
1. I confirm that I have read and understand the information sheet dated ............................ 
 for the above study and have had the opportunity to ask questions. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any time,  
 without giving any reason, without my medical care or legal rights being affected. 
 
3. I understand that sections of any of my medical notes may be looked at by responsible  
 Individuals from Imperial College or from regulatory authorities where it is relevant to my 
 taking part in research.  I give permission for these individuals to have access to my  
 records. 
4. I agree to take part in the above study.    
 
 
________________________ ____________________ 
Name of Patient   Date Signature 
 
 
_________________________ ____________________ 
Name of Person taking consent Date  Signature 
(if different from researcher) 
 
 
_________________________ ____________________ 
Researcher   Date 
 Signature 
 
(COPIES: 1 for patient, 1 for researcher, and 1 to be kept with hospital notes) 
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Appendix E 
Ethics approval letters for study I and III: 
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